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"Where then does wisdom comefrom?
Where does understanding dwell?
It is hidden from the eyes ofevery living thing
God understands the way to it and he alone knows where it dwells,
And he said to man,
'Thefear ofthe Lord-that is wisdom, and to shun evil is understanding.' "
Job 28: 20-28, The Bible
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Abstract
KRAB-ZFPs (Kriippel associated box-zinc finger proteins) are known to be involved
in the transcriptional repression of genes. Direct interaction of the KRAB domain
with the co-repressor, KAP-1, recruits other heterochromatin-associated proteins
such as HP1 and histone deacetylases to the DNA and results in gene silencing
during vertebrate development. Although KRAB-ZFPs comprise the largest
transcription factor family in mammals, little is known of their specific biological
functions and functional redundancy has been postulated. Moreover, few KRAB-
ZFPs have known target genes.
In 2001, Sutherland et al., performed a gene-trap screen in mouse ES cells for
nuclear proteins. Seven novel KRAB-ZFPs were identified. I investigated the sub-
nuclear distribution of the trapped fusion proteins and found that all except one co-
localised with KAP-1 at pericentromeric heterochromatin in a subpopulation of cells.
Furthermore this sub-population of cells increased when induced to differentiate with
retinoic acid. I further investigated the localisation of these fusion proteins by
making full-length GFP-tagged constructs with KRAB-ZFP 492, and by producing
an antibody to the endogenous protein. KRAB-ZFP 492 mis-localised in the gene-
trap screen as AP492 antibody identifies both nuclear diffuse and nucleolar staining
in ES cells. This suggests that the zinc finger domain ofKRAB-ZFP 492 is required
for correct localisation of this protein in vivo. Furthermore, endogenous KRAB-ZFP
492 is not recruited to pericentromeric heterochromatin via KAP-1 upon
differentiation. However in differentiated cells, endogenous KRAB-ZFP 492 and
NT-2 is found associated with KAP-1 and HP1 proteins in smaller foci. This
suggests that KRAB-ZFP target genes may not be recruited to heterochromatin for
repression.
To gain insight into the functions of KRAB-ZFPs, 1 generated two mutant KRAB-
ZFP mouse lines using gene-trap ES cells. From these mice I was able to detect the
tissues in which each KRAB-ZFP was expressed. In 113+/" embryos, fusion protein
expression is initially restricted to the heart and thymus. In adults, expression is
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observed in the thymus. Expression is less specific in 492+/" embryos. KRAB-ZFPs
often lie in clusters of very similar genes, hence the redundancy ofKRAB-ZFPs 113
and 492 are being tested by examining the phenotype of homozygous mutants for
each gene. Information gained through these studies and the reagents generated will
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Our linear DNA sequence consists of ~6.6x 109 bp of DNA, which when fully
extended measures -2 m in length. Yet, it can be packaged into a nucleus barely 15
pm in diameter (i.e. one hundred thousand times smaller) by its hierarchical
organisation into chromatin. The DNA double helix alone, although fundamental to
our chromosomal inheritance, is no longer considered to be definitive to our genetic
make-up. Rather the rules that govern the epigenetic regulation of expression of our
-24,000 protein-coding genes (Ensembl release 27.35a. 1, December 2004) must lie
at the level of chromatin structure.
Proteins with related functions in the cytoplasm are often concentrated together in
three-dimensional (3-D) space, within the confines of discrete membrane bound
organelles, such as mitochondria and the Golgi apparatus. Similarly, the mammalian
nucleus is organised into domains associated with different facets of nuclear
function, despite the absence of membrane bound compartments. Nuclear
compartments are physical spaces where specific proteins, or protein complexes, are
concentrated even though these proteins are in dynamic flux with the rest of the
nucleoplasm (Chubb and Bickmore, 2003). It is now clear that the confinement of
biomolecules such as DNA and proteins within such nuclear compartments is crucial
for correct cell function, and disruption of this often results in human genetic disease,
cancers and during viral infection (Marsh et al., 1998; Koken et al., 1997; Bell et al.,
2000; Chen et al., 2004).
1.1 Gene regulation by trans-acting factors and
cis-acting DNA elements
The transcriptional status of every gene is controlled by at least two components of a
genetic switch; regulatory stretches of DNA in cis, such as the promoter and
enhancer sequences, and transcription factors that promote gene activation or
repression (Alberts et al., 1994). Genetic analyses in bacteria provided the first
evidence for DNA-binding transcription factors, the X repressor and the lac repressor
(Ptashne, 1967; Muller-Hill et al., 1968). Prokaryotic repressors such as the X
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repressor work in the simplest case by steric hindrance (Fig. 1.1A). Positive
regulation of prokaryotic genes occurs by either removal of a repressor protein from
DNA, or by binding of an activator protein (Fig. 1.1 A). The lac operon is an
example of a more complex genetic switch where positive and negative controls
combine (Muller-Hill et al., 1968).
The same basic strategies as above are used to control gene expression in eukaryotes,
but the genetic switches that are used are much more complex. Unlike prokaryotic
repression, transcriptional repression in eukaryotes is not dictated by the direct
competition of transcriptional repressors and RNA polymerases for access to DNA
(Fig. 1.1B). Firstly, eukaryotic RNA polymerases cannot initiate transcription on
their own. They require a set of 'basal transcription factors', which must be
assembled at the promoter before transcription can start. The assembly of the
'transcription machinery' is required for initiation by RNA polymerase II (Pol II). A
second difference between prokaryotic and eukaryotic transcription factors lies in the
location of DNA sequences they are able to bind. In eukaryotes, many gene
regulatory proteins can bind to DNA elements, for example, enhancer and/or
insulator sequences, thousands of nucleotides away from the promoter they influence
(reviewed by Cook, 2003; Sage et ah, 2005). In many cases the DNA between these
regions and the promoter loops out to allow the bound transcriptional regulator to
physically interact with RNA polymerase II or other members of the transcription
machinery. Sophisticated experimental techniques such as 'chromosome
conformation capture' and RNA TRAP (tagging and recovery of associated proteins)
have provided clear evidence of looping at the P-globin locus (Tolhuis et ah, 2002).
The effect of looping out enables proteins tethered at the distant region to collide
repeatedly with proteins bound at the promoter, which has the same effect as would
be obtained by increasing the protein's local concentration at the promoter. In order
to study the mechanisms of gene regulation by transcription factors it is essential to
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active homodimer inactive heterodimer
Figure 1.1 The mechanisms by which specific gene regulatory proteins
control transcription
A) Positive and negative gene regulation in prokaryotes. The addition of ligand (black box) can switch
off genes (negative regulation) either by removal of a gene activator protein (grey box) or by causing a
gene repressor protein to bind (grey box), where it blocks the binding of RNA polymerase (steric
hindrance). The addition of ligand can also switch a gene on (positive regulation) by removing a gene
repressor from DNA or by causing a gene activator protein to bind, both of which enhance transcription
by RNA polymerase. B) Negative regulation in eukaryotes. Gene activator (red) and repressor (blue)
proteins may compete for binding to the same regulatory DNA sequence (1). Masking of the activation
domain (AD) by a repressor protein can prevent it from contacting the transcription machinery (2). This
is a form of steric hindrance. Specific protein-protein interactions can interfere with the assembly of the
basal transcription machinery (3). Long-range cis-acting DNA elements may be involved in this active
repression model. Heterodimerisation by truncated transcription factors (black oval) with no DBD (grey
oval) can inhibit otherwise active homodimers (4).
t
1.1.1 The modular design of transcriptional regulators
and their affect on gene regulation
Many DNA binding proteins involved in gene regulation, are composed of at least
two distinct modules. One is always a DNA-binding domain (DBD) and proteins
may contain one or more of these. Other conserved modules govern specific protein-
protein interactions functions. In yeast, the acidic activation domain of the GAL4
DNA binding protein works by accelerating the assembly of the basal transcription
machinery at the promoter (Lin and Green, 1991). Other conserved modules found
in association with DBDs are responsible for mediating interactions with organic
ligands or other proteins. For example, the holi domain, found in the glucocorticoid
(GR) and retinoic acid (RAR) receptors is responsible for binding to the respective
hormone ligand (Govindan, 1990). The SCAN domain (Williams et al., 1995), also
known as the leucine-rich domain (LeR) (Pengue et al., 1994) serves as a protein-
protein interaction interface for proteins not necessarily associated with either gene
activation or repression (reviewed by Collins et al., 2001).
1.1.2 DNA-binding domains
Examples of DBDs include the helix-turn-helix (HTH), zinc finger (ZF), leucine
zipper (LZ) and helix-loop-helix (HLFI) motifs. All families are represented in
prokarya and eukarya alike, with the first structural evidence for a prokaryotic ZF
protein (SmtA) being recently described (Blindauer et al., 2001). In eukarya, the ZF
and the HTH DBDs are the most common (Alberts et al., 1994). Unlike the LZ and
HLH motifs, they do not require protein dimerisation. The ability of some
transcription factors to dimerise adds to the level of control and specificity they
exert. The LZ is so called because of the way two monomers are held together by
interactions between the hydrophobic amino acid side chains of leucine residues. LZ
homodimers bind to symmetric DNA sequences via a series of basic residues
adjacent to the LZ, but when two different monomers combine to form a
heterodimer, a hybrid DNA sequence is recognised. The way dimerisation can
inhibit gene expression is described in more detail in Figure LIB.
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1.1.3 The ZFP transcription factor factor family
The term ZF was first used to describe the 30 amino acid long repeat sequence motif
found in the TFIIIA transcription factor (Miller et al., 1985). A property unique to
the ZF DBD is its ability to bind RNA as well as DNA (Miller et al., 1985;
Caricasole et al., 1996). TFIIIA is a ZF DBD protein (ZFP) that binds to 5S DNA as
well as 5S ribosomal RNA but different regions of the protein are responsible for
binding to each (Theunissen et al., 1992). When the structure of a single ZF motif
from the Xenopus protein Xfin was solved using NMR (nuclear magnetic resonance),
it revealed each ZF motif to be folded around a central zinc ion to form an
independent mini-domain (Lee et al., 1989) that "grips" the DNA, as "fingers" of a
hand might grip an object (reviewed by Klug and Schwabe, 1995).
1.1.3.1 C2H2-type ZFPs
The ZFP super-family can be sub-divided into similar but distinct sub-families,
which have a preference to bind either nucleic acids, proteins or both. By far the
most abundant sub-family are those proteins that contain the classical C2Fl2-type
repeats similar to the repeats found in TFIIIA. The human proteome is predicted to
contain 1167 proteins that harbour C2H2-type motifs ZF (InterPro proteome
analysis, EMBL-EBI, January 2005), and therefore constitute one of the largest gene
families in higher eukaryotes. Drosophila tramtrack (TTK) is an example of a
C2E12-type zinc finger (Fig. 1.2A). In this repeat, one Zn atom is coordinated by the
tetrahedral arrangement of two cysteine (C) and two histidine (H) residues. The Zn
atom is buried in the interior and stabilises the module by binding a pair of cysteines
from the P-hairpin and a pair of histidines from the a-helix (Fig.l.2A) (Klug and
Schwabe, 1995). Residues from the N-tenninal part of the a-helix of each finger
fonn hydrogen bonds with three base pairs (bp) ofDNA in the major groove, and so
are responsible for the DNA/RNA binding specificity associated with ZFPs
(Theunissen et al., 1992). Multiple residues of each finger also make contact with
the sugar-phosphate backbone of DNA. Most ZFP genes encode multiple tandem
repeats of the ZF unit (up to 37 in Xfin, De Lucchini et al., 1991) (Fig. 1.2B).
Adjacent ZFs have been confirmed as having little or no interaction between them













Figure 1.2 The structure of some ZF DBDs.
A) The classical C2H2-type ZF depicted on the left (adapted from Klug and Schwabe, 1995) is from the
Drosophila protein, tramtrack (TTK). Two cysteine residues (C) at the amino end (N-) and two histidine
residues (H) at the carboxy end (C-) coordinate the Zn ion. The amino acids that contact DNA are
indicated. The last C residue and the first H residue arc separated by a region of 12 residues. The C2H2-
type ZF can be described as a "mini-globular"domain with a hydrophobic core and with polar side chains
on surface. The hydrophobic core can maintain the structure of the ZF as it binds into the major groove
of DNA. The 3-D structure of a C2H2 ZF is shown on the right. Helical regions are boxed. -strands
are enclosed in arrows and the amino and carboxyl-termini are marked. B) The 3-D structure of Zif268
bound to DNA. Left, The two strands of DNA are shades of green. Middle, DNA with bound recognition
helices (Fl, F2 and F3) and Zn ions. Righl, Entire protcin-DNA complex C) The RING finger (C3HC4)
has a single structural domain that binds twoZn ions in independent, but almost symmetrical binding
pockets (adapted from Barlow el al., 1994). There are examples of RINGs that have a cysteine or
histidinc substituted with other metal binding residues, such as aspartate or threonine (reviewed by Saurin
et al., 1996). Residues related by an approximate twofold symmetry are outlined with a dotted line.
The 3-D structure of the PML RING finger is depicted on the right (Borden el al., 1995).
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genes they can bind to. A target site selection model for ZFPs would benefit the
study of this large protein family, but remains a challenge for numerous reasons, one
of which is the way chromatin can affects target site selection. Chromatin structure
both facilitates and impedes binding of transcription factors. TBP (TATA box
binding protein) is an example of a transcription factor that cannot bind to
nucleosomal DNA even when the TATA box is exposed on the surface of the histone
octamer (Imbalzano et al., 1994). However, the winged helix transcription factor
HNF3, forms a much more stable complex with nucleosomes than with naked DNA
(Cirillo et al., 1998). 'Designer ZFPs' have been constructed and can bind to
specific target DNA sequences (Papworth et al., 2003). ZF peptides are also being
used as a useful tool to study the role of specific binding sites in the chromatin
environment (reviewed by Segal, 2002). In particular, some 'designer ZFs' are
being used as novel therapeutics and some can regulate therapeutically relevant
endogenous genes.
The vast majority of C2H2-type ZFs are classified as Kriippel-type on the basis of
the fact that they also share a conserved stretch of seven amino acids (the H/C link)
connecting multiple, tandem repeats of the ZF domain, as found in the Drosophila
protein, Kriippel (Rosenberg et al., 1986). DNA binding assays with artificial ZFPs
created from the Krtippel-family member, Spl, shows this linker sequence also has a
significant effect on DNA recognition (Nagaoka et al., 2001).
1.1.3.2 RING finger family
Another sub-family of ZFPs constitute those proteins containing a RING (really
interesting new gene) finger. The RING domain is the 9th most abundant motif in the
human protein and is found in species ranging from viruses to plants (Stone et al.,
2005). There are 36 known nuclear proteins with RING fingers (Nuclear Protein
database, NPD, section 2.11). The 3-D structure of the Vmwl 10 RING finger from
equine herpes virus IE110 was the first to be structurally characterised (Barlow et al.,
1994). It is a member of the C3HC4 sub-class, which tetrahedrally coordinate two
zinc atoms into an autonomously folded domain (Fig. 1.2C). The RING finger of
PML is also a member of this sub-class, but the spacing in the RING consensus
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sequence and structures around the second zinc-binding site indicate that this motif is
highly variable (Borden et ah, 1995).
Many unrelated proteins that form supramolecular complexes have RING domains
such as PML (promyelocytic leukaemia protein), BRCA1 (breast cancer associated
gene 1), BARD1 (BRCA1-associated RING domain) and KAP-1 (KRAB associated
protein-1), also known as TIF 1(3 (transcription initiation factor 1(3). Some RINGS
can self associate as well as bind to other RINGS, but they also have roles in other
protein-protein interactions, protein-DNA interactions and they also have catalytic
activity in ubiquitin conjugation (Lorick et ah, 1999; Seeler et ah, 2001). The RING
motif is often found in proteins in conjunction with other domains (see section
1.1.5.1). The E3-ubiquitin ligase activity of RING1A and RING IB has recently
been shown to ubiquitinate H2A on lysine residue 119 (section 1.2.2.3). Since
RinglA and RinglB are polycomb group proteins (PcG) (del Mar Lorente et ah,
2000; Voncken et al., 2003) and ubiquitinated H2A is found on the inactive X
chromosome (Xi) in female mammals (de Napoles et ah, 2004), this suggests they
are involved in chromatin-mediated heritable gene silencing.
1.1.4 The KRAB-ZFP transcription factor family
In 1991, the conserved KRAB (Krtippel-associated box) domain was identified in
human, mouse and Xenopus Kriippel-type ZFPs by sequence analysis (Bellefroid et
ah, 1991; De Lucchini et ah, 1991). It was reported that about one third of Kriippel -
type ZFPs contained this domain, and to date, the KRAB-ZFPs remain the largest
class of transcriptional regulators in the mammalian genome (reviewed by Urrutia,
2003). So far, they are restricted to the genomes of tetrapods (land-living
vertebrates), as members of this family have not been identified in yeast,
Arabidopsis, Drosophila or other vertebrates such as fish (Mark et ah, 1999; Urrutia,
2003). Considering there are 355 KRAB box containing C2FI2-type ZFPs in the
human genome (InterPro, proteome analysis, January 2005) and that the initial
characterisation of such proteins was carried out over a decade ago (Bellefroid et ah,
1991), comparatively little is still known of their specific biological functions. The
small number of biological roles already identified for KRAB-ZFPs is a result of
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their chance involvement in other biological pathways (Casademunt et al., 1999;
Zheng et al., 2000; Skapek et al., 2000; Li et al., 2003; Hennemann et al., 2003;
Nielsen et al., 2004). The deficit of KRAB-ZFP target DNA sequences contributes
to this lack of physiological knowledge.
The KRAB domain is a highly conserved 75 amino acid motif found almost
exclusively in the N terminus of C2H2 ZFPs (Bellefroid et al., 1991). The KRAB-
ZFPs can be sub-divided into four families based on the composition of the KRAB
box (Fig. 1.3A). All sub-families contain a KRAB A box which is encoded by a
single exon (Bellefroid et al., 1991). The remaining families contain a KRAB A box
in conjunction with either a classical B, highly divergent b, or the newly identified C
box (Mark et al., 1999; Looman et al., 2004). Each of these boxes is also encoded
by individual exons and they are predicted to fold into charged amphipathic helices
(Bellefroid et al., 1991; Looman et al., 2004). KRAB A family members often result
by alternative splicing out of the B exon (Bellefroid et al., 1993). Additional
families include those KRAB-ZFPs known to contain more than one KRAB box
(Looman et al., 2004). Still others are often found to contain a SCAN domain
(Pengue et al., 1994; Casademunt et al., 1999). The SCAN domain consists of at
least 87 residues known to mediate homo- and hetero-oligomerisation possibly with
other SCAN domain proteins (Collins et al., 2001; Honer et al., 2001). The ZF
repeats in all KRAB-ZFP families are located together at the C-terminus and are
encoded by one exon (Bellefroid et al., 1993; Villa et al., 1996), including ZNF91
and Xfin, which contain 35 and 37 contiguous repeats respectively.
1.1.5 KRAB-ZFP interaction with the KAP-1 co¬
mpressor
The KRAB domain was shown to function as a potent DNA binding dependent
transcriptional repressor, when fused to a heterologous DBD from the yeast GAL4
protein (Margolin et al., 1994; Witzgall et al., 1994). In this experiment the KRAB
A box was deemed necessary and sufficient for repression. The KRAB B box was
subsequently found to contribute to transcriptional repression but only to a lesser
extent (Margolin et al., 1994; Witzgall et al., 1994; Pengue et al., 1994), whilst the
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Figure 1.3 KRAB-ZFP sub-families
A schematic representation of the structures of the KRAB-ZFP sub-families found to date
(A) and KAP-1 (B). A, B and C are the KRAB A, B and C domains respectively. The
ZF (zinc finger) motif in each sub-family is represented as a group of six. The RING, BB
(B boxes) and CC (coiled coil) regions are collectively known as the RBCC motif. HP1BD,
HP1 binding domain; PHD, plant homeodomain; Br, bromodomain. Diagram not to scale.
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highly divergent b box was found to have no affect on transcriptional repression
(Vissing et al., 1995; Abrink et al., 2001). These experiments also showed that the
recently identified KRAB C box, like KRAB b, does not contribute to repression, but
it does appear to strengthen the interaction between the KRAB domain and KAP-1
(see below) (Looman et al., 2004).
To identify other proteins responsible for transcriptional repression by KRAB-ZFPs,
various routes were taken. Evidence for a titratable cellular factor required for
KRAB-domain mediated repression was obtained by squelching (inhibition of
transcriptional repression) of GAT4-KRAB-mediated repression with a non-DNA-
bound KRAB domain (Friedman et al., 1996). The cellular factor found to be
responsible, KAP-1 (TIFip), was then identified by affinity chromatography. The
same result was obtained with yeast two-hybrid experiments using the KRAB
domain (Moosmann et al., 1996).
1.1.5.1 The TIF family of proteins
Four mammalian TIFs have been characterised including TIF la, KAP-1, TIFl-y and
TIF 1-5 (Le Douarin et al., 1995; Ryan et al., 1999; Venturini et al., 1999;
Khetchoumian et al., 2004). All repress genes when tethered to a promoter and all
contain an RBCC motif at the N-terminus and a PHD (plant homeodomain) and
bromodomain at the C-terminus (Fig. 1.3B). The RBCC/TRIM (tripartite) motif is
composed of a C3HC4 RING finger (R), two additional Zn binding Cys/His-rich
clusters (the B-boxes) (Borden et al., 1993), and a putative a-helical coiled coil
region (CC). Other proteins containing this motif, or parts of, include Midi, which
exhibits E3-ligase activity and is the cause of Opitz syndrome (Trockenbacher et al.,
2001), HLS5, which is a candidate tumour suppressor (Lalonde et al., 2004) and
MuRF-1, which ubiquitinates troponin I (Kedar et al., 2004).
In addition to the domains mentioned above, TIF la, -P and -5 also contain a central
penta-peptide sequence (PXVXL, where X is any amino acid), responsible for HP1
binding to the HP1 binding domain (HP1BD). TIF la has been shown to associate
with a wide variety of ligand-bound nuclear hormone receptors and to function as a
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co-activator for retinoic acid receptors (Le Douarin et al., 1995). The nuclear
receptor interaction domain (NRBD) is adjacent to the HP1BD. Unlike TIF la and -
y, KAP-1 does not have a NRBD and does not interact with nuclear receptors, but
TIF la and KAP-1 can both bind to the KRAB box. TIFly and TIF 15 neither bind to
nuclear receptors, nor to KRAB-ZFPs (Venturini et al., 1999; Abrink et al., 2001;
Khetchoumian et al., 2004). Instead it is thought that these TIFs function via
oligomerisation and/or by interaction with other proteins. All homologues can
homodimerise but TIF la and -y have also been shown to heterodimerise (Peng et al.,
2002) and this heterodimerisation is functionally significant in childhood papillary
thyroid carcinomas (Klugbauer and Rabes, 1999). TIF 15 is unique among the TIF1
family in that its expression is largely restricted to the testes where it associates
preferentially with HPly (Khetchoumian et al., 2004). Gene targeting experiments
have only been reported for KAP-1 which was found to be embryonic lethal and
required for post-implantation embryogenesis and mesoderm induction (Cammas et
al., 2000). TIFly has recently been reported as an essential regulator of embryonic
and adult haematopoiesis in Zebrafish and whilst a TIF la orthologue has also been
identified, a KAP-1 orthologue has not (Ransom et al., 2004). Therefore, KAP-1 and
the KRAB domain still remain restricted to tetrapods. A single TIF1 homologue,
(Bonus) has been found in the Drosophila genome (Beckstead et al., 2001;
Beckstead et al., 2004) and shares with TIF la the ability to interact and negatively
regulate with nuclear receptor dependent transcription.
KAP-1 was also cloned as an interactor, along with TIF la, of the HP1
(heterochromatin protein 1) proteins (see section 1.3.1) demonstrating a potential
role in repressive chromatin structures (Le Douarin et al., 1996b). Similar to the
other TIFs, KAP-1 contains a Cys/His cluster termed the PHD domain (plant
homeodomain) and a bromodomain at its C-terminal. These domains are found in
many proteins implicated in chromatin-mediated transcriptional regulation (Aasland
et al., 1995; Syntichaki et al., 2000). KAP-1 interaction with chromatin remodelling
proteins is discussed in section 1.3 and the effect of the KRAB-KAP-1 interaction on
chromatin structure is discussed in more detail in section 1.3.4.
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1.1.5.2 Transcriptional repression by the KRAB-KAP-1
complex
KRAB-mediated silencing requires binding to the KAP-1 co-repressor (Agata et al.,
1999; Peng et al., 2000) and when tethered to DNA, KAP-1 and KRAB-ZFPs can
repress transcription from both proximal and remote promoter positions (Pengue et
al., 1994; Moosmann et al., 1996) (Fig. LIB, 3). Despite KAP-1 having the ability
to co-ordinate chromatin structure, KRAB-KAP-1 mediated regulation is also
reported to be by active repression (Fig. LIB, 3). Evidence for this is that KRAB-
KAP-1 mediated repression is efficient even in short-term transient transfection
assays before the bulk of reporter DNA templates would be fully assembled into
chromatin (Pengue et al., 1994; Agata et al., 1999). Active repression may be
achieved by inhibitory protein-protein interactions but evidence that the
bromodomain of TIF la (and KAP-1, Ryan et al., 1999) possesses intrinsic protein
kinase activity capable of autophoshorylation and phosphorylation of transcription
factors suggests that direct interaction may not be necessary (Fraser et al., 1998;
Ryan et al., 1999). The KRAB domain is able to repress transcription by Pol II and
Pol III, but not by Pol I, suggesting that KRAB exerts some of its repression activity
by interfering with components of the basal transcription machinery. However, it is
possible that Pol I could simply ignore any chromatin modifications.
Oligomerisation of KRAB-ZFPs has been shown to play a role in transcriptional
regulation (Li et al., 2003; Tan et al., 2004b). A KRAB and SCAN-only containing
protein (minus ZF domain), VHLaK, was recently shown to function as a
transcription repression module via homo-oligomerisation of the SCAN domain (Fig.
LIB, 4). KRAB-ZFPs are also likely to compete with other transcriptional
regulators for target sequences and so gene expression is also effected in this way
(Jheon et al., 2001; Tanaka et al., 2002; Jheon et al., 2003) (Fig. 1.B, 1).
Evidence that the KRAB-ZFP class of transcriptional repressors appears to mediate
repression via all of the mechanisms described in Figure LIB has been presented.
However, DNA in cells is assembled into chromatin, which imposes a very poorly
understood set of rules on the binding and action of transcriptional regulators. Thus,
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the fifth mechanism of repression utilised by transcription factors is the interaction
with co-repressor and co-activator proteins that mediate epigenetic re-organisation of
chromatin into an active/inactive form. The KRAB-KAP-1 interaction is a good
illustration of how a transcription factor and co-repressor initiates the specific
recruitment of chromatin-associated enzyme complexes for the subsequent
modification of chromatin structure. It is now clear that KAP-1 acts as a scaffold to
bring together various proteins that modify chromatin structure and so mediate
transcriptional repression (section 1.3.4). In order to understand this level of
regulation we must first understand the molecular basis of chromatin structure.
1.2 Chromatin structure
Chromatin is composite ofDNA, histones and non-histone proteins. Histones are the
most highly conserved proteins in the eukaryotic genome (Wolffe, 1995). They are
small (11-16 kDa) positively charged (lysine and arginine rich) proteins. 146 bp of
negatively charged DNA is wrapped around a core octameric complex formed by
dimers of histone proteins H2A, H2B, H3 and H4 to form a nucleosome (Luger et
al., 1997). The C-terminal histone fold domains of core histones are highly
structured and found on the inside of the nucleosome, but the N-termini are flexible,
and protrude from the nucleosome where they can make contacts with DNA,
nucleosomes, and other non-histone proteins. In this way, nucleosomes and
chromatin fibres are not structurally inert. Linker histones bind to DNA between
nucleosomes with a stoichiometry of one HI protein per nucleosome and interact
with the core H2A sub-units. DNA folds into a 30 nm chromatin fibre (Widom,
1998; Zlatanova et al., 1999) and other higher order structures based on modification
of the nucleosomes and of the DNA itself. It is now known that chromatin can fold
into a 30 nm fibre in the absence of HI and it is the core histone tails that are critical
for chromatin condensation (Carruthers et al., 1998). The compaction and
decompaction of chromatin fibres makes regions of chromatin refractory or
acquiescent to processes such as transcription, replication, recombination and repair.
15
1.2.1 DNA methylation
In animals, DNA is methylated on cytosine residues of CpG dinucleotides at the C5
position. This modification is essential for mammalian development and in control
of gene expression (Okano et al., 1999). In the adult vertebrate genome, 60-90% of
all CpG dinucleotides are methylated. The remaining non-methyated CpGs (-15%
in humans) are found in CpG islands, which usually include functional promoters
and are predominantly found in early replicating (R-bands) of the genome (Craig and
Bickmore, 1994).
DNA methylation is normally associated with gene silencing (Bird and Wolffe,
1999), X-inactivation and genomic imprinting (Ng and Bird, 1999). Three DNA
methyltransferases (DNMT1, -3a, and -3b) have been identified (Bestor et al., 1988;
Okano et al., 1998). This DNA mark plays a fundamental role in epigenetic gene
silencing as the methylation mark can be copied after replication, resulting in
heritable changes in chromatin structures. Imprinted genes are associated with
differentially methylated regions (DMRs) in which maternal and paternal copies of
the gene are methylated differently (Neumann et al., 1995) and mono-allelic
expression results as a consequence.
DNA methylation might influence gene expression in two ways. It might directly
repress transcription by blocking the binding of transcription factors. Secondly, it
can create a binding site for repressor proteins. A family of methyl-CpG binding
proteins (MBDs) have been identified on the basis of a conserved methyl-binding
domain (MBD) (Hendrich and Bird, 1998). The founder member, MeCP2, is a
transcriptional repressor that recruits repression complexes containing histone
deacetylases (section 1.2.2.1, Nan et al., 1998). MBD1 to -3 have also been shown
to be potent transcriptional repressors. MBD2 is a component of the MeCPl
repressor complex and interacts directly with Sin3A (Boeke et al., 2000). MBD4 is a
DNA glycosylase which repairs G:T mismatches at CpG sites (Hendrich et al.,
1999). MBD3 has been shown to be a member of the NuRD complex (Zhang et al.,
1999). More recently, MBD1 has been shown to recruit the histone
methyltransferase (HMT) SETDB1 to the large subunit of CAF-1 (chromatin
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assembly factor 1) to form an S-phase-specific complex that facilitates methylation
of H3-K9 during replication-coupled assembly (Sarraf and Stancheva, 2004).
SETDB1 also has a CpG DNA methyl-binding domain, which if functional, could
maintain H3-K9 methylation at a target locus (Schultz et al., 2002; Ayyanathan et
al., 2003). Dnmtl, which interacts with PCNA (an auxiliary component of the
replication machinery), is involved in the heritability of DNA methylation patterns
and this activity could supplement H3-K9 methylation by SETDB1.
Other experiments have suggested a close link between DNA methylation and
histone modifications. In Neurospora, DNA methylation is controlled by dim-5, the
EI3-K9 histone methyltransferase (HMT) protein (Tamaru and Selker, 2001). HMT
activity of the KRYPTONITE protein is also involved in maintenance of DNA
methylation in Arabidopsis (Jackson et al., 2002). MBD1 (methyl-CpG binding
domain 1) has been found to interact with the Suv39hl-HPl heterochromatic
complex (section 1.3.1) for DNA methylation-based transcriptional repression.
Furthermore, MBD1 links to histone deacetylases through Suv39hl and suggests the
presence of a pathway from DNA methylation to the modification of histones for
epigenetic gene-regulation (Fujita et al., 2003). This data presents the growing
relationships between DNA modifications, chromatin modifications and gene
expression.
1.2.2 Core histone modifications
Modifications of the core histones are associated with transcriptionally 'active' or
'silent' chromatin. The N-terminal tails are subject to post-translational
modifications including acetylation, methylation and phosphorylation whilst
ubiquitination occurs mainly at the C-terminus (Fig. 1.4). Such modifications
rework the chromatin fibre by altering the electrostatic charge of the histones and/or
through creating binding sites for non-histone proteins.
A "histone code hypothesis" was proposed by Strahl and Allis (2000) which
suggested that combinations or sequences of histone modifications results in the
signalling of specific downstream events by recruitment of transcriptional activators
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Figure 1.4 Histone modifications
Core histones consist of a central globular domain (oval) and N- and C- terminal tails that protrude
outwards from the globular core. Specific residues at the N- and C-terminal tails can be chemically
modified by methylation (Me), acetylation (Ac), phosphorylation (P) and ubiquitination (Ub) and a sub¬
set of these marks are illustrated. H, histone protein; K, lysine; S, serine; R, arginine.
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or repressors. This original hypothesis has been extended to include groups of
particular histone modifications that work in cohort to provide chromatin signals that
either permit or silence gene expression (Fischle et al., 2003b). It is proposed that
histone modifications primarily affect the interaction with other proteins that
concurrently influence chromatin structure and hence DNA accessibility, rather than
histone modifications altering the nucleosome or chromatin structure directly.
1.2.2.1 Histone acetylation
In 1964, Alfrey and colleagues proposed a link between acetylation of lysine residues
within the N-terminal domains of core histones (particularly H3 and H4) and the
regulation of transcription (see review by Peterson et al., 2002). It is unclear as to
how histone acetylation specifically alters or influences the biophysical properties of
chromatin. It could be that acetylation of N-terminal tails results in a weakened
interaction with the DNA backbone which would facilitate the interaction of
transcription factors with their target site (McGhee et al., 1983; Wolffe and Hayes,
1999) but there is evidence to suggest that this is not the case (Marmorstein, 2001).
Instead acetylation may be required for maintenance of an active chromatin state
rather than its establishment (Cavalli and Paro, 1999), which may be achieved by
acetylated histones creating a binding site for bromodomain-containing
transcriptional regulators (Fischle et al., 2003a). It should also be noted that many
transcriptional regulators, for example, p300/CBP and components of the basal
transcription machinery are also acetylated, thus acetylation has diverse affects on
gene regulation (Li et al., 1998; Li et al., 1999).
The discovery that co-activator complexes required for transcriptional activation also
contain histone acetyltransferase (HAT) activity was first observed in yeast
(Brownell et al., 1996; Grant et al., 1997). There is a high degree of sequence
similarity between members of each of the HAT families (reviewed by Kuo and
Allis, 1998) and they often encode two conserved domains, the acetyltransferase
domain and the bromodomain (Dhalluin et al., 1999; Mannorstein et al., 2001). The
bromodomain of the yeast Gcn5 HAT binds to acetylated lysines and is not required
for in vivo Gcn5-mediated histone acetylation but is required for subsequent Swi2-
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dependent nucleosomal remodelling (section 1.3.3) and subsequent transcriptional
activation, indicating that it may constitute a targeting step for events following
histone acetylation (Syntichaki et al., 2000). Many human HATs have been
described and they are components of multi-subunit complexes. These include
PCAF (the Gcn5 human homologue), p300/CBP and TAF250 that act locally at gene
promoters and modulate gene specific transcription (Owen et al., 2000; Jacobsen et
al., 2000).
There are three main classes of FIDACs identified. Class I and class II are based on
their similarity to the S. cerevisiae enzymes Rpd3p or Hdalp respectively, whilst
class III include the NAD+-dependent Sir2 family members (reviewed by Kraus and
Wong, 2002). In humans, HDAC 1, 2 and 3 are members of class I whilst HDACs 4,
5 and 6 are class II members. FIDACs 1 and 2 are found in the major chromatin
remodelling complexes, NuRD (for nucleosomal remodelling and histone
deacetylation, also known as Mi-2) and SIN3 (Bird and Wolffe, 1999; Knoepfler and
Eisenman, 1999). In addition to HDAC activity, NuRD contains ATP-dependent
nucleosomal remodelling activity, MBD3, and the histone binding proteins RbAp46
and RbAp48, the latter two of which are also found in the SIN3 complex (reviewed
by Ahringer, 2000). SIN3 has been extensively studied with respect to its
involvement in repression by nuclear hormone receptors. It physically links to the
co-repressors N-CoR and SMRT (Heinzel et al., 1997; Nagy et al., 1997) suggesting
that the repression by these co-repressors is linked to deacetylation of histones.
Consistent with this, transcriptional repression by nuclear hormone receptors is
blocked by TSA (Heinzel et al., 1997).
The distinction between histone hypoacetylation and hyperacetylation, is determined
by the number of acetylated lysine residues per H4 molecule (Zhang et al., 2002).
Three or more acetylated lysines is indicative of hyperacetylation and in general
hyperacetylation correlates with transcriptional activity while hypoacetylation
correlates with transcriptional repression (reviewed by Marmorstein, 2001). The
acetylation pattern for specific histone tails and their relation to gene activity has
been described for the human interferon-(3 locus (Agalioti et al., 2002), mouse P-
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globin (Bulger et al., 2003) and mouse insulin (Chakrabarti et al., 2003). The
inactive X is hypoacetylated (Plath et al., 2002).
Although it has been suggested that hyperacetylation of histones by inhibition of
histone deacetylases (HDACs) with TSA (Trichostatin A) causes gross remodelling
of nuclear structure (Taddei et al., 2001), recent evidence suggests otherwise
(Gilchrist et al., 2004).
KAP-1, may also mediate its repressive effects through deacetylation. Evidence for
this stems from the fact that TSA partially inhibits the silencing activity of KAP-1
(Nielsen et al., 1999) and KRAZ1 (Matsuda et al., 2001) when fused to the GAL4
DBD. However, although a small amount of KAP-1 is known to be complexed to
Mi-2a (section 1.3.3) (Schultz et al., 2001), TSA could still partially inhibit
deacetylation in C-terminal mutants that are devoid of the Mi-2a-KAP-l interaction
(Matsuda et al., 2001). In another in vitro study with stable or transiently transfected
reporter templates, HDAC inhibition did not alter KRAB-KAP-1 mediated
repression nor did they show KAP-1 to be in complex with SIN3 (Lorenz et al.,
2001), however the repression activity of TIF la was severely affected.
1.2.2.2 Histone methylation
Core histones can also be methylated at lysine and arginine residues (Fig. 1.4) and
the interplay between lysine methylation and acetylation influences transcription.
Each lysine residue can contain up to 3 methyl groups. Methylation does not alter
the overall charge of histone tails, but the addition of methyl groups does increase
their affinity for DNA, and also increases the resistance of DNA to trypsin digestion
(reviewed by Rice and Allis, 2001). Over the past four years there has been an
"explosion" of histone methyltransferases discovered.
Genes encoding mammalian homologues of Drosophila Su(var)3-9 (Suv39hl and
Suv39h2) were the first to be shown to encode proteins with lysine HMT activity
(Rea et al., 2000). Most HMTs contain the 130-amino acid SET domain (for
Su(var)3-9, Enhancer ofZeste, Trithorax). Suv39hl and -h2 display site-selectivity
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towards H3-K9 methylation at unmodified H3 amino termini (Rea et al., 2000).
SETDB1 is also H3-K9 specific and facilitates the conversion of di-methylation to
tri-methylation (Schultz et al., 2002; Wang et al., 2003). Other HMTs methylate H3
and H4 lysine residues specifically at other positions, for example, TRX (Beisel et
al., 2002) and ASH1 (Cao et al., 2002), whilst G9a is a dual HMT that methylates
lysines specifically at positions 9 and 27 ofH3 (Tachibana et al., 2001).
Both lysine and arginine histone methylation is involved in transcriptional regulation.
CARM1 (co-activator-associated arginine methyltransferase) specifically methylates
arginines 17 and 26 of histone H3 but also methylates non-histone proteins such as
p300/CBP. The intrinsic methyltransferase activity of CARM1 and interaction with
SRC protein stimulates nuclear hormone receptor activity in mammalian cell-based
reporter gene assays (Chen et al., 1999). SUV39H1, -H2. and G9a mediate
transcriptional silencing, since the H3-K9 mark serves as a binding site for
heterochromatin protein 1 (HP1) (section 1.3.2.1, Jacobs et al., 2001). The HMT
protein, Dotl (Disrupter of telomeric silencing-1) (van Leeuwen et al., 2002), is
involved in silencing at telomeres, the mating type locus and rDNA in budding yeast
by catalysing H3-K79 methylation. However, this protein does not contain a SET
domain. Drosophila ESC-E(Z) catalyses H3-K27 methylation and is associated with
transcriptional silencing of the HOX locus (Muller et al., 2002) and the human
homologue, EED-EZH2, is also associated with transcriptional silencing and X-
inactivation in human cells (Cao et al., 2002). The influence of histone methylation
on transcription may not only depend on the residue methylated but also on the
number of times it is methylated. For example, tri-methylated H3-K9 is enriched at
pericentromeric heterochromatin whilst mono and di-methylated forms localise
specifically to silent domains within euchromatin (Rice et al., 2003). Similarly, tri-
methylation of H3-K4 is specific for active transcription whilst di-methylation is
present in both active and repressed genes (Santos-Rosa et al., 2002). H3-K4 and
H3-K9 methylation have been proposed to be mutually exclusive (Heard et al., 2001;
Boggs et al., 2002). However, H3-K4 methylation has little affect on the ability of
SETDB1 to methylate H3-K9, in contrast to SUV39H1 whose enzymatic activity for
H3-K9 is significantly reduced by a methylated H3-K4 substrate (Schultz et al.,
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2002). This may help to prevent the spread of transcriptionally active or silent
chromatin. The co-ordination of histone methylation and acetylation on H3-K4, 9,
27 and H4-K20 suggests interplay between these epigenetic marks. H3-K9
acetylation and methylation are mutually exclusive suggesting histone deacetylation
precedes methylation at these residues (Nielsen et al., 2001b). Histone H4
hyperacetylation precludes H4 lysine 20 trimethylation but not mono or di-
methylation (Sarg et al., 2004). Recently, proteins capable of reversing the
methylation mark were discovered. For example, the transcriptional co-repressor,
TSD1, functions as a histone demethylase and specifically demethylates histone H3
lysine 4, which is linked to active transcription (Shi et al., 2004).
1.2.2.3 Other histone modifications
Histones can also be phosphorylated on serine and threonine residues of core
histones. Phosphorylation of histone H3 on serine 10 inhibits H3-K9 methylation so
that HP1 can no longer bind (Rea et al., 2000), but it is coupled with H3-K9 and -
K14 acetylation and transcriptional activation during mitogenic and hormonal
stimulation in mammalian cells (Cheung et al., 2000). Aberrant H3-K9 methylation
can antagonize serine 10 phosphorylation, leading to mitotic chromosome
dysfunction (Rea et al., 2000).
Other post-translational modifications of histones include ADP-ribosylation,
glycosylation (MBD4, section 1.2.1) and ubiquitination (section 1.1.3.2). Recently,
the rapid decondensation of chromatin was found to be associated with polyADP-
ribosylation and important for long-term memory (Cohen-Armon et al., 2004).
Histone H2B was found to be ubiquitinated in S. cerevisiae (Robzyk et al., 2000),
and although polyubiquitylation has a role in protein turnover, histones are generally
monoubiquitylated, a form of the modification that is not associated with protein
degradation (reviewed by Osley, 2004). Ubiquitination of H2B plays an important
role in the trans-histone methylation of histone H3, a modification with close ties to
the regulation of gene expression.
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Histone modifications provide an interface between DNA and non-histone chromatin
proteins that can then affect gene transcription but there are several core histone
variants that confer specialised properties to nucleosomes and are differentially
expressed during development (Romano, 1992; Wolffe, 1995). A number of H2A
variants are non-randomly distributed on the active and inactive X chromosome
(Chadwick et al., 2001). H2A.Z has been associated with transcriptional control as
deletion mutants in yeast exhibit slower growth patterns (Santisteban et al., 2000).
The histone variant H3.3 has a conserved N-terminal tail and can replace histone H3
at sites of active transcription adding a new layer of complexity and possibilities to
the regulation of transcription through changes in chromatin structure (McKittrick et
al., 2004).
1.3 Euchromatin and heterochromatin proteins
Cytological studies distinguished two types of chromatin based on their microscopic
structural characteristics. DNA dyes, such as DAPI, highlight portions of the
interphase genome that stain more intensely than the surrounding euchromatin. This
constitutive heterochromatin is generally associated with regions of tandem repeats,
such as at centromeres (reviewed by Richards and Elgin, 2002). Facultative
heterochromatin is euchromatin that will adopt specific heterochromatic properties in
a spatially and temporally controlled manner. In nucleated erythrocytes, mouse and
chicken have different mechanisms of facultative heterochromatin formation. Mouse
embryonic erythrocytes require HP1 proteins unlike chicken, Xenopus and zebrafish
erythrocytes (Gilbert et al., 2003). In chicken, differentiation of erythrocytes
coincides with the appearance of the variant linker histone H5. The female inactive
X-chromosome is another example of facultative heterochromatin formation.
Histone modifications associated with constitutive heterochromatin are
hypoacetylation of histones, H3-K9 methylation, DNA methylation (reviewed by
Richards and Elgin, 2002), mono-methylation of H3-K27 (Peters et al., 2003) and
H3-K20 tri-methylation (Schotta et al., 2004). Facultative heterochromatin is not
characterised by repetitive sequences but can be defined as euchromatic regions that
become packaged into a heterochromatic-like form with many of the same molecular
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signatures as constitutive heterochromatin at the nucleosomal level. Histone
hypoacetylation and H3-K9 methylation occur on the inactive X chromosome (Peters
et al., 2002) but it is not depleted in acetylated H4 within the XY body during
spermatogenesis (Armstrong et al., 1997).
The biochemical and structural differences between eu- and heterochromatin directly
influence transcriptional regulation. When the expression of a gene variegates with
respect to heterochromatin, the phenomenon is called position effect variegation
(PEV) (Csink and Henikoff, 1996). A euchromatic transgene can become integrated
adjacent to a block of heterochromatin, and transcription may be silenced in only a
subset of cells, and this state is stably inherited by their progeny leading to variegated
or mosaic patterns of gene expression (Wakimoto, 1998). Many proteins that
function at heterochromatin and help to establish repressive chromatin structures
were identified as modifiers of PEV Su(var)s in Drosophila genetic screens.
Homologues of these were then identified in mammals. Examples include, Su(var)2-
5 (HP1) and the Su(var)3-9 HMTs. A new group of PEV mutants (Su(var)3-1) have
recently been identified that reflect a gain-of-fiinction and antagonize the expansion
of heterochromatin (Ebert et al., 2004).
The dependency of epigenetic modification of heterochromatin structure by proteins
is reflected by the fact that mutations in the human DNMT3b gene cause ICF
syndrome (Immunodeficiency-centromeric instability-facial anomalies syndrome)
and patient cells show destabilisation of centromeric heterochromatin (Xu et al.,
1999). Similarly, loss ofDNMT1 in human cancer cells affects nuclear organisation
of pericentromeric heterochromatin by decreasing H3 methylation and increasing H3
acetylation (Espada et al., 2004). However, the erasure of CpG methylation in
Arabidopsis alters patterns of histone H3 methylation in heterochromatin without
substantially changing the structural properties of heterochromatin and there was no
detectable activation of transcription (Tariq et al., 2003).
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1.3.1 HP1 and the propagation of heterochromatin
Mammals have three homologues of Drosophila Su(var)2-5, termed HPla, -p and -
8 (Singh et ah, 2002; Saunders et ah, 1993; Ye and Worman, 1996). Each isoform
contains a chromodomain, which binds to H3-K9 and is essential for
heterochromatin-mediated gene silencing (Bannister et ah, 2001; Lachner et ah,
2001), and a chromoshadow domain, which is involved in homo and
heterodimerisation and a number of different protein interactions with transcriptional
regulators such as KAP-1 and TIF la (Le Douarin et ah, 1996a), SUV39H1 (Aagaard
et ah, 1999) and lamin B receptor (Ye et ah, 1997). KAP-1 and SUV39H1 are often
situated at heterochromatin (Ryan et ah, 1999; Agaard et al., 1999), however TIF la
and the lamin B receptor are associated with the nucleoplasm and the nuclear
periphery respectively (Remboutsika et ah, 1999; Stuurman et ah, 1998).
The dose-dependent effects of HP1 on heterochromatin-mediated gene silencing in
both flies and mammals has been well documented (Eissenberg et ah, 1992;
Festenstein et ah, 1999; Festenstein et ah, 2003). PEV is stochastic in nature due to
the role FTP 1 plays in the variable spreading of heterochromatin and thus
transcriptional silencing. The link between H3-K9 tri-methylation and HP1 directly
links stable epigenetic gene silencing with heterochromatin structure. A recent
model for the proposed propagation of heterochromatin initiates with methylation of
FI3-K27 and H3-K9 by currently unknown H3-K27 and H3-K9 mono-methylases
(Fig. 1.5). Methylation of mono-methylated H3-K9 by Suv39h would then ensue
with the subsequent binding of HPla and -P to tri-methylated H3-K9. The HP1
molecules are then predicted to recruit the novel Suv4-20h enzymes, which in turn
would tri-methylate H4-K20 (Schotta et ah, 2004). The role of RNA in this model
will be discussed in section 1.3.2.
Recently HP1 dosage was shown to participate in the silencing of mammalian,
constitutively expressed, euchromatic genes, that is, genes that are not physically
linked to large blocks of heterochromatin (Festenstein et ah, 1999). A murine CD2





Figure 1.5 Current model of constitutive heterochromatin formation
Heterochromatic tandem repeats give rise to ds RNA that is cleaved by a ds RNA ribonuclease termed
Dicer into 21-25 nt siRNAs. In S. pombe siRNAs, along with a nucleoprotein complex called RITS
(RNAi-induced transcriptional silencing), are recruited to centromeres and guide Suv39h to the region.
H3-K9 methylation then recruits HPl/Swi6 deposition, which in turn recruits Suv4-20 to tri-methylate
H3-K20 residues (section 1.3.2.1).
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variegation was either enhanced or repressed by HP1 dose depending on the
integration site. However, the coordination of processes such as histone
deacetylation, H3-K9 methylation, HP1 deposition and chromatin compaction in
facultative heterochromatin are less well studied.
1.3.2 The role of RNA in transcriptional regulation and
heterochromatin formation
Transcription of non-coding RNAs is now known to have a significant role in the
epigenetic regulation of gene expression and in the initiation of heterochromatin
formation (Richards and Elgin, 2002). Initial clues that an epigenetic regulatory
RNA component existed were obtained by the identification of untranslated
transcripts of Xist and Tsix that are involved in the initiation of X-inactivation in
female cells by coating of the inactivated X-chromosome (Clemson et al., 1998).
Non-coding transcripts appear to be involved in genomic imprinting, for example,
Air is involved in imprinting at the Igf2r cluster (Sleutels et al., 2002)
In 1999, Hamilton and Baulcombe identified short RNAs, 21-25 nucleotides (nt) in
length, which were responsible for specifically targeting endogenous plant genes for
transcriptional repression. The idea that RNA might interfere with protein
expression indicated an RNA interference model (RNAi) where double stranded
RNA (ds RNA) molecules could target specific mRNA molecules for degradation
(Elbashir et al., 2001). Unexpectedly, the proteins responsible for RNAi (the RNAi
machinery) have also been found to have a central role in assembly of silent,
condensed heterochromatin (reviewed by Lippman and Martienssen, 2004). Repeat
RNA transcripts are processed into short interfering RNAs (siRNAs) that direct
chromatin modification at centromeric and telomeric regions in fission yeast,
Tetrahymena, Drosophila and Arabidopsis (Hall et al., 2002; Volpe et al., 2002;
Tavema et al., 2002; Pal-Bhadra et al., 2002; Zilberman et al., 2003). In yeast,
RNAi mutants defective in vital components of the RNAi machinery exhibit reduced
H3-K9 methylation and both HP1 and H3-K9 methylation are lost from centromeric
reporter genes (Volpe et al., 2002). This ultimately disrupts chromosome
segregation during mitosis because HP1 cannot recruit cohesin (Bernard et al.,
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2001). In S. pombe, an RNAi-induced transcriptional gene-silencing complex
(RITS) has been purified which contains RNA-binding protein (Ago) and a
chromodomain protein (Chpl), which can bind to centromeres (Verdel et ah, 2004).
There is no evidence for the recruitment of such a complex in mammals. In
mammals, very few siRNAs have been cloned, however, pericentromeric localisation
of H3-K9 methylation and HP1 is abolished by RNase treatment (Maison et ah,
2002). Therefore an RNA signal may provide an entree in the formation of
heterochromatin whereby Suv39h enzymes would be subsequently targeted to repeat-
rich sequences and components of the RNAi machinery at heterochromatin (Fig.
1.5).
1.3.3 ATP dependent chromatin remodelling
Nucleosomes can also undergo ATP hydrolysis, and to date there are four classes of
nuclear proteins that can remodel chromatin in this way, based on the nature of their
ATPase subunits (reviewed by Tsukiyama, 2002).
The first class constitutes the SWI-SNF (mating type switching/sucrose non-
fermenting) complex, and is the prototypical chromatin-remodelling complex,
originally identified in budding yeast (Stem et al., 1984). This complex has been
found to disrupt chromatin structure and facilitate the binding of transcriptional
regulators to promoters (Hirschhorn et al., 1992; Krebs et ah, 1999) but SWI/SNF is
also involved in transcriptional repression (Sudarsanam et al., 2000). SWI/SNF has
an extensive repertoire of biochemical activities in vitro. It can reposition
nucleosomes in an ATP-dependent pattern by sliding histone octamers to other sites
on the same DNA molecule (cA-displacement) (Whitehouse et al., 1999) or by
transfering histone octamers to other DNA molecules (/ram-displacement) (Lorch et
al., 1999). In mammalian cells, there are two characterised Swi2/Snf2-like ATP-
ases, BRM and BRG1. Both of these associate with tumour suppressor proteins such
as Rb and BRCA1. BRG'"knockout mice also indicate susceptibility to tumour
growth and are embryonic lethal (Bultman et al., 2000). Mutations in the human
ATRX gene (X-linked a-thalassemia/mental retardation syndrome) implicate SWI-
SNF remodelling in differentiation and development because ATRX is an ATP-
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dependent type II class SNF2 helicase (Picketts et al., 1996). Recently, mass
spectrometry and western blotting identified BRM, BRG1 and KAP-1, in addition to
HDAC3, as members of N-CoR-1 (nuclear receptor-1) complex (Underhill et al.,
2000). This would allow coupling of gene specific regulation by KRAB-ZFPs with
chromatin remodelling proteins via KAP-1 and N-CoR-1.
The other class of ATP-dependent chromatin remodelling proteins are the ISWI
(imitation switch) family, originally identified in Drosophila, the CFID
(chromodomain ATPase) and IN080 classes. ISWI homologues in yeast (Iswl and
Isw2) and human (hSNFL and SNF2H) have been identified. Initial studies on Isw2
mutants have shown that this complex is involved in control ofmeiotic growth genes
and the formation of nuclease resistant chromatin structures (Goldmark et al., 2000).
Mouse Snf2h is required for early pre-implantation development (Stopka et al.,
2003) and recently SNF2H was found to target the Williams syndrome transcription
factor (WSTF) to replication foci through direct interaction with PCNA (Poot et al.,
2004). The CHD class is generally thought to be involved in transcriptional
repression since Mi-2 is a characterised member of this family, and is found in
conjunction with HDACs and MBD proteins in the NuRD complex (Zhang et al.,
1998; Wade et al., 1999). The PHD and bromodomains of KAP-1 form a co¬
operative unit that interacts with Mi-2 a (Schultz et al., 2001). This discovery
showed that the KRAB-KAP-1 interaction represses transcription by employing the
activities of chromatin associated enzymes such as HDACs and NuRD and outlined a
mechanism of repression in which the largest transcription factor family in the
genome are members.
1.3.4 KRAB-KAP-1 mediated effects on chromatin
structure
KAP-1 coordinates all the machinery required for repression of an integrated
luciferase transgene, recruited via an inducible KRAB-domain containing protein
(Ayyanathen et al., 2003). The KRAB box, is required for localised compaction of
the promoter region (assayed by nuclease accessibility assays) and the enrichment of
H3-K9 methylation, KAP-1, HPl and SETDB1 proteins at the promoter (Schultz et
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al., 2002; Ayyanathen et al., 2003). Repression of KRAB-ZFP target genes is now
known to involve a cascade of events starting with the recruitment of KAP-1 to
specific genes via the KRAB domain (Fig. 1.6). Deacetylation of histones and ATP-
dependent chromatin remodelling then occurs as a consequence of KAP-1 interaction
with NuRD, followed by recruitment of SETDB1 for methylation of H3-K9 in
euchromatic regions. Interaction and phosphorylation of HP1 proteins by KAP-1 is
thought to bring about localised heterochromatinisation of the loci specified by
KRAB-ZFPs or the locus itself may be re-located to heterochromatin.
Multimerisation and higher order chromatin structure may add further complexity to
this model because KAP-1 is a homotrimer in vivo and two molecules of HP1 can
bind per KAP-1 monomer (Peng et al., 2000; Peng et al., 2002). KAP-1 does not
hetero-oligomerise with other members of the TIF1 family. A potential role for
KAP-1 modification by sumolyation has been observed but its function is not yet
assessed (Seeler et al., 2001).
1.4 Nuclear compartments and their role in
chromatin organisation and gene regulation
Another mechanism of epigenetic regulation involves the 3-D organisation of
chromatin, and therefore individual genes and their cognitive transcriptional
regulators, in the nucleus. Figure 1.7 depicts some of the sub-structures
compartmentalised in the mammalian nucleus, many of which are outlined below.
1.4.1 The nuclear periphery and gene silencing
The nuclear periphery of mammalian cells consists of the nuclear membrane, a lipid
bi-layer adjacent to the nucleoplasm, and the nuclear lamina, a filamentous network
of proteins that is located adjacent to the inner nuclear membrane (INM). It is
proposed that the lamina acts to bridge chromatin to the nuclear envelope. The INM
contains LEM domain proteins that can bind DNA and chromatin in vitro (Dechat et
al., 2000). The lamina associated proteins LAP-2P and HA95 also contain LEM






















Figure 1.6 Proposed model for KRAB-KAP-1 mediated repression
KRAB-ZFPs target specific genes for repression mediated by the co-repressor KAP-
1. KAP-1 recruits histone deacetylases (HDACs) and ATP-dependent chromatin
remodeling factors (Mi-2a) to establish repression. SETDB1 can bind to KAP-1 and
methylate H3-K9 in euchromatic regions. Interaction of HP1 proteins with KAP-1
and/or methylated H3-K9 may bring about localised heterochromatinisation of the target
loci (I) or the loci may be re-located to heterochromatin (II). The kinase activity
associated with KAP-1 may also affect gene regulation by interaction with the transcription
machinery. RBCC, Ring, BB, coiled coli; PHD, plant homeodomain; Br, bromodomain;
HP1BD, HP1 binding domain.
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Lamins and the INM protein emerin are mutated in the laminopathy disorders, and it
has been proposed that a consequent dysregulation of gene expression could underlie
some of the disease pathologies (Mounkes et al., 2003).
The nuclear periphery is characteristically associated with gene silencing. In S.
cerevisiae, heritable inactivation of telomeric genes and the silent mating type locus
cluster near the nuclear periphery (Gravel et al., 1998). Sir proteins are maintained
at high concentrations in this compartment and the proteins yKu, Mips and Esc have
been shown to function in tethering of silent loci to the nuclear membrane
(Gartenberg et al., 2000; Galy et al., 2000; Andrulis et al., 2002). However, there is
no evidence that homologues of these proteins play a similar role in mammals. FISH
studies suggest that relatively gene poor chromosomes (HSA4, 13 and 18) are
situated around the periphery of the nucleus (Croft et al., 1999; Boyle et al., 2001).
1.4.2 The nuclear interior and transcription
Early-replicating DNA is preferentially located in the nuclear interior (Sadoni et al.,
1999) consistent with clustering of gene rich chromosomes there (Boyle et al., 2001).
Sub-nuclear positioning represents a way of regulating transcription and
recombination of endogenous IgK loci during lymphocyte development (Kosak et al.,
2002). FISH shows that IgK loci are preferentially positioned at the nuclear
periphery in haematopoietic progenitors and pro-T cells but are centrally configured
in pro-B nuclei. Moreover, in pre-B cells, one allele of IgK is preferentially
packaged into active chromatin characterised by H3-K4 methylation and histone
deacetylation, whilst the other allele is recruited to heterochromatin, where it is
associated with HPl-y and Ikaros (Goldmit et al., 2004). Other genes when active
have been observed at more internal sites (Chambeyron et al., 2004; Zink et al.,
2004).
Arguing against such preferential positioning of transcription, sites of transcription
have been visualised throughout the entire nucleus (Szentirmay and Swadogo, 2000).
Labelled nascent RNAs are distributed throughout the nucleoplasm; they are not
limited to the interior of the nucleus (Verschure et al., 1999). Antibodies against
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hyperphosphorylated forms of RNA polymerase II (Zeng et al., 1997), and detection
of BrUTP incorporation (Jackson et al., 1993) showed transcription foci to be
randomly positioned.
1.4.3 Transcription and the chromosome territory
Initial studies showing active gene transcription on the surface of chromosome
territories were based on FISH analyses of single selected loci and they suggested
that inactive loci are positioned towards the interior of chromosome territories, while
active genes are found on the surface (Volpi et al., 2000). The positions of
contiguous genes spread along the length of a segment of HSA11 were mapped with
respect to their position within the chromosome territory (Mahy et al., 2002b). In
this study, active genes were not always on the territory surface, but were found
located within chromosome territories. Inhibition of transcription by Actinomycin-D
(Act-D), reduced the percentage of loci visualised outside the territory, suggesting
that chromatin looping/movement is influenced but not driven by transcription
(Mahy et al., 2002a).
More recently, the co-linearity of genes in the HoxB cluster was studied in the
context of chromatin structure and nuclear re-organisation upon induction of HoxB
expression by retinoic acid (Chambeyron et al., 2004). ChIP was used to identify
changes in histone modification, and chromatin decondensation was observed upon
transcription. However, the progressive looping out of genes from the chromosome
territory towards the nuclear centre, is proposed to be necessary for the activation of
high levels of transcription since decondensation and histone modification is not
restricted to the most 3' gene, Hoxbl.
Gene dense regions of HSA11, the MHC (major histocompatibility complex) locus
and the EDC (epidermal differentiation complex) locus are excluded from
chromosome territories in FISH studies (Mahy et al., 2002a; Volpi et al., 2000;
Williams et al., 2002). Moreover, a novel approach combining chromatin
sedimentation analysis with FISH was used to identify 'open' chromatin fibres that
correlate with regions of high gene density (Gilbert el al., 2004) but not with gene
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expression. In this way, inactive genes are found in domains of 'open' chromatin
and active genes in regions of 'closed' chromatin. The fact that chromatin fibre
structure impacts on levels of decondensation suggests that domains of 'open'
chromatin may create a nuclear environment that facilitates transcriptional activation.
1.4.4 Centromeric heterochromatin
When a block of heterochromatin was placed adjacent to the euchromatic Drosophila
Brown gene, bwD, gene expression was trans-inactivated, along with the normal
bwD allele and silencing correlated with relocation of both bwD copies to
eenlromeric heterochromatin (Platero et al., 1998). This suggested that
transcriptional repression could be accompanied by relocation of genes to
heterochromatic compartments of the nucleus. A similar scenario was reported in
mammalian cells where inactive genes were found to co-localise with Ikaros protein
and centromeric heterochromatin during lymphocyte proliferation (Brown et al.,
1997; Brown et al., 1999). Rag and TdT alleles reposition to centromeric domains in
primary CD4DT thymocytes (Brown, et al., 1999). Ikaros is found complexed to
NuRD and so may function in the remodelling of chromatin, similar to KAP-1
(O'Neil et al., 2000). It has been suggested that Ikaros-binding influences gene
expression in B-lymphocytes by the recruitment of chromatin remodelling factors,
rather than centromeric localisation per se (Sabbattini et al., 2001) as silencing is
exerted through a direct effect on the promoter. In the KRAB-KAP-1 system,
centromeric localisation of KRAB-ZFPs does not occur when the interaction with
KAP-1 is disrupted and this correlates with lack of repression activity (Matsuda et
al., 2001).
Topological constraints would prevent all silenced genes within a cell from being
localised at pericentromeric heterochromatin, and in some cases the association with
heterochromatin is not enough to silence transcription (Nagaki et al., 2004; reviewed
by Dillon and Festenstein, 2002). Translocation of proteins and genes may be a
consequence of silencing, rather than causative. For example, on recruitment of
C/EBPp (CAAT/enhancer proteins) and -5 to pericentromeric heterochromatin,
histone acetylation and TBP binding is potentiated consistent with non-silencing
36
(Zhang et ah, 2001; Schaufele et al., 2001). Interestingly, KAP-1 physically
interacts with C/EBP(3 and functions as a co-activator in myeloid differentiation
(Rooney et al., 2001).
1.4.5 The nucleolus
The most obvious nuclear sub-structure is the nucleolus. It is composed of the
fibrillar centre, a dense fibrillar component and the granular component (reviewed by
Carmo-Fonseca et al, 2000). Transcription and processing of rDNA takes place in
the nucleolus, and the nucleolus forms around acrocentric rDNA clusters in humans
(Sullivan et ah, 2001). The nucleolus is therefore linked to chromosome territory
organisation through these acrocentric associations but transcription of rDNA does
not appear to direct association of human acrocentric chromosomes to form the
nucleolus. The nucleolus is also responsible for pre-ribosomal assembly,
sequestration of proteins and cell-cycle control (Carmo-Fonseca, 2000) and the
satellite sequences of HSA1 and the Y chromosome are adjacent to the nucleolus
during G1 (Bridger et ah, 1998).
1.4.6 Positioning relative to other nuclear bodies
Genes and protein complexes specifically co -localise with a number of other
nuclear bodies. These include PML nuclear bodies, Cajal (coiled bodies), and
nuclear speckles (reviewed by Dundr and Misteli, 2001).
PML nuclear bodies are seen as dense fibrillar ring structures by microscopy. The
MHC locus associates with PML bodies (Wang et ah, 2004) but the relationship
between them is poorly understood. In PML"'" transgenic lines, MHC I protein is
down-regulated (Zheng et ah, 1998). However, in RNAi knockdown experiments of
PML, MHC I expression has been shown to be unaffected (Bruno et ah, 2003; Wang
et ah, 2004). Cajal bodies are also associated with specific gene loci that include the
histone gene clusters, U1 and U2 small nuclear RNA genes, and the U3 small
nucleolar RNA genes (Frey et ah, 1999). |3-actin and collagen lal, are actively
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transcribed genes that also associate with splicing speckles (Xing et al., 1995;
Shopland et al., 2003).
Transcriptionally active genes have been proposed to associate with 'transcription
factories'. These are discrete nuclear sites of nascent RNA production and
concentrated transcriptional components, such as RNA polymerase (Iborra et al.,
1996; Jackson et al., 1998; Verschure et al., 1999; Zaidi et al., 2002). Several active
genes are dynamically organised into shared, pre-assembled, nuclear sub-
compartments/transcription factories, rather than the specific recruitment of these
transcription complexes to individual genes (Osborne et al., 2004). It is not yet
known whether a similar mechanism of transcriptional control occurs for the
repression of euchromatic genes.
1.5 Proposed Research
1.5.1 Background to proposal
Prior to my PhD, a visual gene-trap screen in mouse ES and F9 cells had been
performed for the large-scale identification of nuclear proteins and the sub-nuclear
compartments in which they reside (Tate et al., 1998; Sutherland et al., 2001). The
importance of this kind of study is revealed firstly by the fact that mis-localised
nuclear proteins are involved in human genetic disease, cancers and in virally
infected cells (Marsh et al., 1998; Koken et al., 1997; Bell et al., 2000; Chen et al.,
2004). Secondly, determination of sub-nuclear localisation can give important clues
as to the function of novel proteins (McDowell et al., 1999). Also, because common
protein signatures are often found in proteins from a given nuclear compartment, this
allows for the possible prediction of biological pathways in which novel proteins
could function (Bickmore and Sutherland, 2002).
Seven KRAB domain-containing proteins were identified in this gene-trap screen.
Prior to 2001, the specific functions of some KRAB-ZFPs, and a few target
sequences in humans, had recently become known (Casademunt et al., 1999; Skapek
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et al., 2000; Zheng et al., 2000). Apart from this, very little was known about the
specific biological functions, and mechanisms of repression, employed by this
protein family.
The trapping of these genes therefore provided a way in which to study this protein
family that had not previously been utilised. Initial characterisation of some of these
trapped proteins revealed that the majority were novel (Sutherland et al., 2001) and
that some were found to localise to pericentromeric heterochromatin, in a sub-
population of mouse ES cells (Sutherland et al., 2001). This variable localisation
pattern of KRAB-ZFPs had only been published by two other groups (Payen et al.,
1998 and Matsuda et al., 2001) with the suggestion that there may be a common
function at pericentromeric heterochromatin for KRAB-domain containing proteins.
The interaction between KAP-1 and HP1 supported this proposal, suggesting a
mutual role for KRAB-ZFPs in the sequence-specific targeting of genes to
heterochromatin, where they could undergo gene silencing (Ryan et al., 1999;
Nielsen et al., 1999). Fuelled by these observations, I believed that the function of
KRAB-ZFPs at pericentromeric heterochromatin might be rooted in their common
mechanism of repression of target genes but in vivo evidence for such a model
remained elusive. The gene-trap screen hence paved way for a study, which could
involve the use of both functional and descriptive methods, to contribute to a better
understanding of this protein family and individual KRAB-ZFPs.
1.5.2 Initial proposal
In light of the above, my project was roughly divided into two parts. Firstly, since
knockout mice existed for only one KRAB-ZFP at that time (Casademunt et al.,
1999), an initial aim of the project was to establish a mutant (gene-trapped) KRAB-
ZFP mouse line, as a first step towards the functional analysis of a specific KRAB-
ZFP (Chapter 6). Likewise, in mice, no target genes were known for any KRAB-
ZFPs at this time so it was thought that the establishment of mouse lines, as well as
giving specific clues as to the function and expression pattern of a particular KRAB-
ZFP, would also prove to be useful for target gene assessment. Secondly, the fact
that only one study actually describes the localisation of an endogenous KRAB-ZFP
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to pericentromeric heterochromatin (Payen et. al., in 1998), and the fact that the
majority of the literature describes the localisation of many epitope-tagged KRAB-
ZFPs to the cytoplasm, the nucleus and other non-heterochromatic sub-structures
within the nucleus (De Lucchini et al., 1991; Grondin et al., 1997; Payen et al., 1998;
Huang et al., 1999; Yano et al., 2000; Cote et al., 2001), suggested that more in vivo
localisation studies were needed. I therefore proposed to make a specific antibody to
a gene-trapped KRAB-containing protein to check that gene-trapped versions behave
in the same way as their endogenous counterpart (Chapter 4). In addition, no
research had yet been published on how, or why, the association of KAP-1 and/or
KRAB-ZFPs with centromeric heterochromatin could be induced and how this may
in turn result in heterochromatin-mediated gene silencing. Hence, I decided to
broach this question by examining how the different stages of the cell cycle and the
effects of cell differentiation may affect the sub-nuclear localisation of the gene-






All chemicals named throughout this chapter were analytical grade and supplied by
Sigma or Roche unless otherwise stated. Technical staff prepared, autoclaved and
stored general solutions at the required temperature. Nucleic acid manipulations
were performed in l .5 ml or 0.5 ml microcentrifuge tubes. All centrifugations were
carried out at RT unless otherwise stated.
2.1.1 Growth of bacterial strains
Competent Escherichia coli (E. coli) XL 1-blue or DH5-a were grown with vigorous
shaking or on inverted L-agar plates at 37°C o/n in Luria-Bertani (LB) medium
containing the appropriate antibiotic and used in the preparation of plasmid DNA for
all cloning procedures.
2.1.2 Generation of competent bacteria
Competent DH5a cells were purchased from Invitrogen™ (sub-cloning or library
efficient). Competent cells for all other strains were prepared as follows: A 300 ml
E. coli culture was grown to an optical density of approximately 0.3 at 550 nm with
inoculation from an o/n 5 ml starter culture. After pelleting the cells at 6000 g in a
Sorval GSA rotor for 10 min at 4°C, they were resuspended in 5 ml 10 mM CaC^
and incubated on ice for 15 min. Cells were pelleted once more and resuspended in
10 ml freezing mix (15% glycerol [v/v], 75 mM CaCL, 10 mM KC1, 10 mM MOPs
(3-[N-Morpholino] propanesulfonic acid; 4-Morpholinopropanesulfonic acid, pH 7).
300 pi aliquots were snap frozen on dry ice and stored at -80°C until required.
2.1.3 Bacterial transformations
Competent cells were incubated on ice with -10-100 ng DNA for 30 min. Heat
shock treatment at 42°C for 45 sec enabled bacterial transformation. Bacteria where
then grown with shaking at 37°C in 500 pi of LB medium for at least 45 min to
recover, before being plated on L-agar plates containing the selection antibiotic
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(ampicillin [50 pg/ml], kanamycin [50 pg/ml], carbenicillin [50 pg/ml] or
chloramphenicol [34 pg/ml]). Plates with transformed bacteria were grown o/n at
37°C.
2.2 Preparation and manipulation of DNA
2.2.1 Plasmid DNA isolation
Single bacterial colonies were picked from agar plates and used to inoculate 5 ml or
100 ml of LB medium with antibiotic for o/n growth at 37°C. Plasmid DNA was
then extracted in one of two ways. Either commercial mini- or maxiprep kits
(QIAGEN® Plasmid Mini/Maxi Kits) were used according to the manufacturer's
instructions; or when clean, supercoiled plasmid DNA was required, by alkaline lysis
of bacteria and isolation of the DNA on caesium chloride (CsCl) gradients as
described by Sambrook et al, (2001). Briefly, bacteria were incubated in
resuspension buffer (50 mM Tris-HCl [pH 8], 10 mM EDTA [pH 8], 100 pg/ml
RNase A [ribonuclease A]) before lysis under alkaline conditions (0.2 M NaOH, 1%
SDS [sodium dodecyl sulfate] [w/v]). Chromosomal DNA was precipitated by
addition of 3 M potassium acetate and 2 M acetic acid, pH 5.2. After centrifugation
at 4°C for 15 min at 20,000 g, the supernatant was passed through muslin. 0.6 vol of
propan-2-ol was added to precipitate the DNA in the supernatant before pelleting and
drying. The pellet was resuspended in TE (Tris-EDTA) buffer (10 mM Tris-HCl, 1
mM EDTA [ethylenediaminotetra-acetic acid], pH 8) and 1 g of CsCl was allowed to
dissolve per ml of solution before addition of 10 mg/ml ethidium bromide (EtBr, 2,7-
diamino-10-ethyl-9-phenyl-phenathridium bromide). After centrifugation at 12,000
g, suspended DNA was loaded into 2.4 ml tubes (Beckman) and spun at 16°C in a
Beckman Til00.3 rotor at 80,000 rpm overnight (acceleration programme 2,
deceleration programme 9). Supercoiled DNA was obtained by puncturing the side
of the tube with a 21 gauge needle and drawing out the appropriate DNA band
(Sambrook et al., 2001). EtBr is removed from the DNA by repetitive extractions
with equal volumes of water-saturated butan-l-ol. DNA was precipitated with 3 vol
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70% ethanol (v/v with dfbO) before resuspension in TE (typical yield, ~l-2 mg/ml
plasmid DNA).
2.2.2 Phenol/chloroform extractions of DNA
An equal volume of phenol/chloroform (50% buffered phenol/48% chloroform [v/v],
0.5% 3-methyl-l-butanol [v/v], pH > 7.8) was added to the DNA preparation and
vortexed. This was microcentrifuged at 12,000 g for 10 min. The top aqueous layer
was decanted into a fresh tube and the chloroform step repeated if the DNA was to
be used for cloning. Ethanol precipitation was then performed to concentrate the
DNA (section 2.2.3).
2.2.3 Ethanoi precipitation
0.1 vol 3 M sodium acetate, pH 5.2 and 2 vol 100% ice cold ethanol were added to
the DNA sample. After vortexing, the sample was microcentrifuged at 12,000 g for
10 min. The supernatant was discarded and the pellet washed in 70% ethanol.
Centrifugation was repeated and the supernatant discarded. Once the pellet had dried
at RT, it was resuspended in an appropriate volume of dtEO.
2.2.4 Mouse genomic DNA extraction
Tissue samples (mainly ~2 mm mouse tail biopsies) were allowed to dissolve in 600
pi of DNA lysis buffer (100 mM EDTA [pH 8], 50 mM Tris-HCl [pH 8], 100 mM
NaCl, 1% SDS [w/v]). Protein was digested by addition of 30pl 10 mg/ml proteinase
K (Roche) and incubation at 55°C o/n. The DNA was extracted by addition of 420
pi phenol/chloroform and gentle mixing on a rotor for at least 2 hr. Samples were
microcentrifuged at 12,000 g for 10 min. Approximately 500 pi of the top aqueous
layer was decanted to a fresh tube and the DNA precipitated out of this layer upon
addition of 500 pi of propan-2-ol (no additional salt required since DNA lysis buffer
has an adequate amount). After gentle inversion of tubes, blunt ended glass rods
were used to collect the precipitated DNA for drying at RT. Genomic DNA was
resuspended in an appropriate volume of TE buffer (-300 pi for a tail biopsy.
Typical yield, ~ 300 pg/pl genomic DNA) and 1 pi and 20 pi of this solution were
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used for PCR genotyping reactions (section 2.2.12) and for Southern blotting (section
2.2.14) respectively.
2.2.5 DNA digestion
DNA was digested with restriction enzymes (New England Biolabs, NEB) in the
required reaction buffer according to the manufacturer's instructions. Enzyme was
added at a concentration of 5-10 U/pg DNA with the total volume of the enzyme
never exceeding 10% of the total reaction volume so as to prevent the inhibition of
digestion by glycerol. Double digests were performed where enzyme buffer
requirements and temperature were compatible. When incompatible, they were
perfonned sequentially after a phenol/chloroform extraction and ethanol precipitation
(section 2.2.2 and 2.2.3).
2.2.6 Filling in 3' recessed ends of DNA
When cohesive ends needed to be made blunt for subsequent ligations (section
2.2.11), the 3' to 5' exonuclease activity of Klenow fragment (Roche) at a
concentration of 0.5 U/pg DNA template was utilised to fill in 3' recessed ends with
100 pM of the relevant dNTPs (deoxynucleotide triphosphates) (Abgene).
2.2.7 Agarose gel electrophoresis
1-2% horizontal agarose ('HiPure' Low EEO agarose, Biogene UK) gels (w/v) were
used in conjunction with lx TAE (90 mM Tris-HCl [pH 8], 90 mM glacial acetic
acid, 2 mM EDTA [pH 8]) electrophoresis buffer to resolve DNA samples. EtBr was
added to the molten agarose to a final concentration of 0.5 pg/ml before pouring to
allow visualisation of the DNA under ultraviolet light (UV). 6x loading buffer (15%
. -t TM
Ficoll 400 [Amersham Biosciences], 0.25% Orange G [Sigma] both w/v in dEEO)
stored at RT was added to all DNA samples before loading. 500 ng of the DNA size
markers <))Xl74 UNAJHaelll (Promega) or A, DNA/Hindlll (Invitrogen™) were
loaded into a well on each gel to enable the sizing and quantification of DNA
fragments. Stained DNA was photographed using the EagleEye II system
(Stratagene®) and a thermal printer (Mitsubushi).
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2.2.8 Gel purification of DNA fragments
Clean razor blades were used to dissect agarose gel slices containing the required
DNA fragments and a commercial kit (Hybaid Recovery " DNA Purification Kit II,
Hybaid or QIAquick® Gel Extraction Kit, Oiagen) was used to extract this DNA
from the slices. In brief, gel slices are melted in equilibration buffer and this solution
is then passed over a silica-gel matrix that selectively binds DNA. Washing this
membrane removes EtBr and residual agarose and the DNA is eluted into the
required volume of dH20.
2.2.9 Analysis of DNA quantity and quality
Quantification ofDNA was measured either by comparison of the unknown quantity
of DNA with a known quantity on an agarose gel, or by measuring its absorbance in
a spectrophotometer (Ultrospec 3000pro, Amersham Biosciences) at 260 nm (A26o)
(Sambrook et al., 2001).
2.2.10 Dephosphorylation of DNA fragments
Prior to ligation, vector DNA was treated with calf intestinal alkaline phosphatase
(CIP) (Roche) in accordance with manufacturer's instructions to dephosphorylate the
5' termini of vector DNA. This prevents self ligation of the empty plasmid DNA
consequently increasing the yield of positive ligation products since successful
ligation should only be achieved when phosphates are donated to the 5' plasmid ends
by untreated DNA fragments with compatible digested ends. The reaction was
terminated by phenol/chloroform extraction and ethanol precipitation of DNA
(section 2.2.2).
2.2.11 Ligation of DNA fragments
Fragments with cohesive complementary ends were ligated o/n at 16°C, using 1 U of
T4 DNA ligase (NEB), 1% NP-40 (Nonidet P-40) (v/v) and the appropriate volume
of lOx reaction buffer in a 20 pi ligation reaction. Ligations were usually set up with
a 1:3 and 1:10 vector to insert molar ratio using 20-50 ng of both digested vector and
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DNA insert. 10 jj.1 of ligation product was subsequently used for bacterial
transformation (section 2.1.3).
2.2.12 Polymerase Chain Reaction
2.2.12.1 Reagents
2.2.12.1.1 dNTPs
dNTPs (Abgene) were purchased as 100 mM stocks of each of the dNTPs. Working
stock concentrations of 2.5 mM and 10 mM were prepared for use in genotyping and
non-genotyping polymerase chain reactions (PCRs) respectively and used at final
concentrations of 0.2 mM (genotyping) and 0.5 mM (non-genotyping). Stocks were
stored at -20°C.
2.2.12.1.2 Oligonucleotide primers
PGR primers were designed by selecting a sequence between 17 and 25 nucleotides
in length for which the [G+C]:[A+T] ratio was approximately equal. OligoAnalyser
(v. 3) at http://www.idtdna.com was used to analyse these primers to reduce the
likelihood of choosing primer sets that anneal with each other or self anneal. Primers
were purchased from MWG Biotech and Invitrogen'M as lyophilised desalted
compounds and a stock concentration of 1 pg/pl made with dH20. Working stock
concentrations were prepared at 25 ng/pl. Oligonucleotides (oligos) were used at
final concentrations of 1 ng/pl and 0.5 ng/pl for genotyping and non-genotyping
PCRs, respectively.
2.2.12.1.3 Additional PCR reagents
Plasmid DNA to be amplified during non-genotyping PCRs was used at a
concentration of 10 ng/pl. For non-genotyping PCRs, Amplify® DNA polymerase
(Roche, 5 U/pl) was used at 0.5 pi per 50 pi reaction or when high fidelity PCR
• • . . (r)
products were required (e.g. for subsequent cloning applications), PfuTurbo DNA
polymerase (Stratagene®, 2.5 U/pl) was used at the same concentration as above.
(r)
For amplification of genomic DNA template (section 2.2.4), AmpliJag' DNA
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polymerase was used at 0.2 pi per 25 pi reactions. lOx PCR buffer and 2.5 mM
MgCl2, supplied with their respective polymerase, were used at 1:10 and at 1.5 mM
respectively. Reaction mixes were made up to 25, 50 or 100 pi total vol with dFEO.
2.3.12.2 PCR amplification programmes
PCRs were performed in 0.5 ml centrifuge tubes or 96 well PCR plates in a MJ
Research DNA Engine Tetrad. The formula below represents a PCR thermal cycle
that includes an initial v min DNA denaturation step at 94°C followed by 30 cycles
of a w min denaturation step, a x sec annealing step at a temperature specific to the
primers in use (usually between 50-60°C), a y min elongation step at 72°C, and a
final elongation step for z min to complete the cycle:
lx(94[vm]) 30x(94[wm]50[xs]72[ym]) lx(72[zm])
Formulas resembling the above will be used to describe PCR thermal cycles
throughout this thesis. Primer sequences and amplification programmes used in
genotyping and non-genotyping PCRs are tabulated below.
Table 2.1 Primers and amplification programmes used for genotyping PCRs
LacZ primers (section
6.2.2)
5' LacZ forward GTTGCGCAGCCTGAATGGCG









5' wt 492 forward CACAGACTTGAATGTGC





Table 2.2 Primers and amplification programmes used for non-genotyping
PCRs





































3' 492plN 1 AGATGGGAGCTCCGACCAAAG
Programme









1 x(94[3m])30x(94[30s]52[ 1 m]72[2.5m])
lx(72[10m])
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All cloning products were sequenced in order to monitor the integrity of recombinant
plasmids and inserts. BigDye Terminator v. 3.1 (ABI Prism) was used as follows:
200 ng of plasmid DNA or PCR product, 0.8 pM sequencing primer and 4 pi BigDye
were diluted in dfBO in accordance with the manufacturer's instructions to a final
volume of 10 pi. Reactions were run on a DNA Engine Tetrad (MJ Research) for
25x(96[30s]50[15s]60[4m], Reactions were cleaned by addition of 0.2 vol 3 M
sodium acetate (pH 5.2) and 5x vol 95% ethanol, incubated on ice for 10 min and
pelleted at 12,000 g, 4°C for 30 min. Pellets were washed once in 70% ethanol and
centrifuged as above for 15 min before being left to air dry. Resuspended reactions
were run through 50 cm capillaries on POP6 polmer gels (3100 Genetic Analyser,
Applied Biosystems) and data collection was performed using v. 3.7 of the supplied
software.
2.2.14 Analysis of genomic DNA by Southern blotting
and hybridisation
2.2.14.1 The Southern Blotting protocol
Up to 10 pg of genomic DNA was digested in 50 pi reactions o/n using 20-30 U of
restriction enzyme in the buffers supplied and under the conditions specified by the
manufacturer. The digested DNA was separated by electrophoresis in 0.8% agarose
gels containing EtBr (section 2.2.7). The DNA was depurinated by UV nicking in a
GS Gene Tinker " UV Chamber (Bio-Rad) and capillary blotted to Hybond-N^
membrane (Amersham Biosciences) using 0.4 M NaOH as the transfer solution
(Reed and Mann, 1985). The membrane was then briefly neutralised at RT in
neutralisation solution (0.2 M Tris-HCl [pH 7.4], 2x SSC made from a 20x stock [3
M NaCl, 0.3 M tri-sodium citrate, pH7.4]) and rinsed in 2x SSC for 5 min at RT.
Membranes were firstly prehybridised in 20 ml of hybridisation solution (5x
Denhardt's reagent made from 50x stock [1% BSA (bovine serum albumin) (w/v),
1% Ficoll®400 (v/v), 1% polyvinylpyrrolidone (w/v)], 0.5% SDS [w/v], 6x SSC),
supplemented with 100 pg/ml of fragmented salmon sperm DNA (Sigma) in
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cylindrical glass bottles (Amershara Biosciences) at 65°C with continuous rotation.
Membranes were prehybridised for 5 hr before addition of freshly boiled probe DNA
(section 2.2.14.2) to the prehybridisation solution. After an o/n hybridisation with
the probe, membranes were washed in 0.2% SDS (w/v) in 2x SSC at RT for 15 min,
then in 0.5% SDS (w/v) in O.lx SSC at 37°C and 65°C for 1 hr each, rinsed in PBS
and allowed to air dry. Membranes were exposed to a storage phosphor screen (BSA
cassette, Fuji Film) for 1-3 days and visualised using Fuji Film FLA-5100 v. 2
phosphor imager hardware and Aida Image Analyser v. 3.44 software (both Raytek
Scientific Ltd)
2.2.14.2 Probe preparation and radio-labelling of probes
DNA fragments to be radio-labelled for use as radio-active probes in Southern and
northern blot analyses were prepared by PCR amplification of cDNA. 25 ng of
purified DNA was made up to 11 pi with dFFO and denatured by boiling for at least
10 min and immediately placed on ice. Denatured DNA was labelled using random
priming with the commercial kit, Fligh Prime (Roche) and [a-J"P] dCTP. Briefly, 4
pi of High Prime reagent was added to the probe along with 5 pi (50 pCi) [a-32P]
dCTP and mixed to a total volume of 20 pi. The reaction mix was incubated at 37°C
for 1 to 5 hr, after which it was placed on a G-50 Sephadex Quick Spin column
(Roche) and eluted with 80 pi TE (pH 8) to separate the labelled DNA fragments
from unincorporated nucleotides. Labelled probe was then denatured by boiling for
10 min, before being added to prehybridised membranes in hybridisation solution.
2.3 Preparation and manipulation of RNA
2.3.1 RNA isolation and purification
A commercial kit (Bio/RNA-Xcell '' from Bio/Gene) with a single step method for
the isolation and purification of total RNA from tissues and cells was used according
to the manufacturer's instructions. Cells were homogenised in the Bio/RNA-Xcell"'
solution by passage firstly through a 21 gauge needle then subsequently a 23 gauge
needle, before chloroform addition and centrifugation of the homogenate in a
microcentrifuge at 12,000 g. The RNA found in the upper aqueous phase of the
homogenate is then mixed with propan-2-ol and an RNA binding resin provided in
the kit. The RNA bound resin is pelleted by microcentrifugation and washed in 75%
ethanol twice before being eluted in dFFO. A final round of centrifugation allowed
the RNA in solution to be eluted from the resin. RNA was quantified by measuring
the A260 and calculated as described in Sambrook et al. (2001).
2.3.2 5' Rapid amplification of cDNA ends (5' RACE)
5' RACE products were generated as previously described (Tate et al., 1998 and
Sutherland et al., 2001) using primers purchased from MWG Biotech and
Invitrogen'". The sequences of primers described in this section are in table 2.3.
RNA is reverse transcribed into first strand cDNA by annealing 10 ng P456 primer
specific for LacZ to 5 pg total RNA at 70°C (see Fig. 3.IB). Incubation with 10 mM
DTT (dithiothreitol), 10 mM dNTPs and 200 U of Superscript II reverse transcriptase
(Invitrogen' ) at 37°C for 1 hr in a total volume of 20 pi completes first strand
synthesis. RNA is hydrolysed at 65°C for 20 min by addition of freshly prepared
NaOH to 0.1 M before neutralising with 0.1 M FIC1. DNA was microdialysed for 4
hr on 0.025 pm nitrocellulose discs against TE (pH 8) to remove dNTPs and
exchange buffer. The volume was made back up to 20 pi with dfEO. A poly A tail
was added to first strand cDNA by incubation at 37°C for 10 min with 2 mM dATP
and 30 U of recombinant terminal deoxynucleotidyl transferase (TdT) (Invitrogen'").
TdT can catalyse the template-independent addition of dNTPs to the 3' hydroxyl
terminus of single stranded (ss) DNA. This tailed DNA was used as a template to
synthesise second strand cDNA using primer 56 (Fig. 3.IB). Two consecutive
rounds of PCR reaction with nested LacZ primers (59, 80, and 79) followed by
microdialysis steps on 0.1 pm nitrocellulose disks to size select larger PCR products,
were used to amplify the specific 5' DNA sequences of genes. These RACE
products were directly sequenced with a -40 LacZ sequencing primer (section
2.2.13).
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Table 2.3 Primers used for 5' RACE
Primer no. Sequence
p456 5 '-ccgtgcatctgccagtttgagggga




-40 LacZ sequencing primer 5,-gttttcccagtcacgac
2.3.3 Analysis of RNA by northern blotting
A mouse Multiple Tissue Northern (MTN®) Blot kit was purchased from BD
Biosciences (# 7762-1) and used according to the manufacturer's instructions.
Briefly, ExpressHyb Solution was heated to 68°C and stirred to dissolve any
precipitate. Membranes were prehybridised in 10 ml of ExpressHyb Solution in
cylindrical glass bottles (Amersham Biosciences) with continuous rotation for at
least 30 min at 68°C. Freshly boiled, radio labelled probe was prepared as described
in section 2.2.14.2, added to the prehybridisation mix and left to incubate with
continuous rotation at 68°C o/n. The blot was rinsed the following day in 0.05%
SDS (w/v) in 2x SSC for 40 min at RT with several changes of the wash solution.
The blot was then washed twice in 0.1% SDS (w/v) in O.lx SSC with continuous
rotation for 40 min each at 50°C. Excess wash solution wash removed and the blot
immediately covered in plastic wrap and exposed using a storage phosphor screen as
previously described (section 2.2.14.1).
Membranes were reused after stripping previous probe from the blot as described
below. Sterile dH20 containing 0.5% SDS was heated to ~90-100°C. The
membrane was placed in the heated solution for 10 min. The dH20 was allowed to
cool for 10 min before removing the blot and allowing it to either air-dry for long
term storage, or placed in 2x SSC for a subsequent hybridisation.
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2.4 Protein preparation and analysis
2.4.1 Total, soluble and insoluble protein extractions
from bacterial cells
A 20-40 ml culture (OD6oo=0.75) containing appropriate antibiotic was induced with
1 mM IPTG (Isopropyl bD-thiogalactopyranoside) (Melford Laboratories Ltd).
Cultures were left to grow for 3-4 hr until OD600 ~1.6. 1 ml aliquots of cultures
were removed before induction and after induction at 1 hr intervals. The pellet was
centrifuged for 1 min at 12,000 g and resuspended in an appropriate volume of lysis
solution (50 mM Tri-HCl [pH 8], 2 mM EDTA [pH 8]) as determined by the OD6oo
reading of the sample. (It is known that when -160 pi of lysis solution is added to a
culture of OD6oo ~ 2, protein can be easily visualised by SDS-PAGE [SDS-
polyacrylamide gel electrophoresis][2.4.4]). 1 pi of 10 mg/ml lysozyme and 1 pi 1%
NP-40 (v/v) were added and the sample was incubated at 37°C for 15 min. 1 pi of
1M MgSCL and 1 pi of DNase at 1 U/pl (Invitrogen , 10 U/pl) was then added and
incubated as above. The sample was centrifuged at 12,000 g for 2 min and the
supernatant containing soluble protein removed to a fresh tube. An equal volume of
2x SDS protein loading buffer (125 mM Tris [pH 6.5], 4% SDS [w/v], 10% 2-p-
mercaptoethanol [[3-ME] [v/v], 20% glycerol [v/v], 0.1% bromophenol blue [w/v])
was added to the supernatant. Boiling the sample for 5 min and sonication on ice for
15 sec at 10 pm produces the soluble protein fraction. Resuspension of the pellet in
an appropriate volume of lysis solution as before, with addition of 2x SDS protein
loading buffer, boiling and sonication results in the insoluble protein fraction. A
total cell protein sample (TPS) was obtained by resuspension of the unlysed cell
pellet in an appropriate volume of PBS (phosphate buffered saline) and 2x SDS
protein loading buffer, which was boiled and sonicated as above.
2.4.2 Total cell protein extracts from mammalian cells
Cells grown in T25 cm2 culture flasks were rinsed in PBS, lysed in 300 pi of PBS
and 300pl of 2x SDS protein loading buffer, and scraped from the surface of the
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flasks. Total protein samples were boiled for 5 min and sonicated on ice at 5 pA for
10 sec before being stored at -20°C until required.
2.4.3 Nuclear protein extracts from mammalian cells
Cells were grown in T75 cm2 culture flasks until confluent, trypsinized and harvested
by centrifugation at 1000 g for 3 min. Cells were then washed in PBS and
resuspended in 2.5 ml of NBA (Nuclei Extraction Buffer A, 5.5% sucrose [w/v in
dfEO], 10 mM Tris-HCl [pH 8], 85 mM KC1, 0.5 mM spermidine, 250 pM PMSF
[phenyl methyl sulfonyl fluoride], 0.2 mM EDTA). 2.5 ml NBB (Nuclei Extraction
Buffer B, NBA and 0.1% NP-40 [v/v]) was next added and incubated on ice for 3
min. Nuclei were centrifuged at 500 g for 3 min at 4°C, washed in 5 ml ofNBA and
recentrifuged before resuspension in 200 pi NBA.
To measure the concentration of suspended nuclei, the nuclei were incubated with
0.1 U/pl of DNase I and A260 reading taken. Since the concentration of DNA in the
pellet equals the concentration of nuclei in the pellet, this OD reading can be used to
prepare a nuclear protein extract of known concentration i.e. 1 mg/ml. An equal
volume of 2x SDS protein loading buffer was added to the sample and boiled before
loading 10 pi (5 pg) on an SDS-PAGE gel (section 2.4.4).
2.4.4 Resolution of proteins by SDS-PAGE
Cell or nuclear protein extracts were harvested and prepared as above (section 2.4.2)
and 10 or 15 pi loaded for analysis. Resolution was achieved on denaturing
polyacrylamide mini gels (10-12% acrylamide [v/v], 0.39 M Tris-HCl [pH 8.8],
0.1% SDS [w/v], 0.1% ammonium persulfate [w/v], 0.04% TEMED [N, N, N', N-
tetramethylethylene diamine] [v/v] in dH20) with stacking gels (5% acrylamide
[v/v], 0.13 M Tris-HCl [pH 6.8], 0.1% SDS [w/v], 0.1% ammonium persulfate [w/v],
1% TEMED [v/v] in dH20) using 30% or 40% acrylamide (29:1 and 37:1
acrylamide: bis-acrylamide [v/v] respectively) (Severn Biotech). Gels were run in
electrophoresis tanks (Mighty Small, Hoefer) in Tris-glycine running buffer (25 mM
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Tris base, 250 mM glycine, [pH 8.3], 0.1% SDS [w/v]) at 110 V for 2 hr. Pre-stained
protein standards (Bio-Rad) were loaded along side samples to aid with analysis.
2.4.5 Visualisation of cellular proteins
After SDS-PAGE, stacking gels were removed and the remaining gel was rinsed in
dFEO. Gels were submerged in coomassie stain (0.25% coomassie brilliant blue R-
250 [w/v], 45% methanol [v/v], 10% glacial acetic acid [v/v] in dlRO) for 1 hr with
gentle agitation. The stain was discarded and the gels were incubated o/n in destain
(30% methanol, 10% glacial acetic acid in dH?0).
2.4.6 Western Blotting
After SDS-PAGE (section 2.4.4), the stacking gel was removed and protein samples
were transferred to polyvinylidene difluoride (PVDF) membrane (Hybond-P,
Amersham Biosciences) for further analysis by wet western blotting. In brief, PVDF
membrane was soaked in methanol for 10 sec, rinsed in dFEO then equilibrated in
protein transfer buffer (20% methanol [v/v], 24 mM Tris base, 192 mM glycine [pH
>8]). Transfer apparatus (GENIE* blotter, Idea Scientific) was assembled according
to the manufacturer's instructions and run for 1 hr at 12 V with the gel and
membrane sandwiched by 4 pieces of 3MM paper (Whatman) equilibrated in transfer
buffer.
Membranes were then blocked for either 1 hr with agitation or o/n without agitation,
in 1% western blocking reagent [v/v] (Roche) in lx TBS (150 mM NaCl, 10 mM
Tris-HCl [pH 7.5]). Primary antibodies (Table 2.4) were diluted in 0.5% western
blotting reagent (v/v in lx TBS) and incubated with the membranes for 1 hr at RT
with rotation. Membranes were washed for 3 x 5 min in lx TBST (lx TBS, 0.05%
Tween-20 [v/v]) and incubated with the appropriate secondary antibody (Table 2.5)
for 1 hr. Membranes were rewashed for 2x 10 min in lx TBST, before detection by
chemiluminescence (SuperSignaR West Pico Chemiluminescent, Pierce). Signals
were exposed on Kodak Biomax film.
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Table 2.4 Primary antibody dilutions for western Blots
Antibody Species Source Dilution Factor
Anti-KAP-1 (Ab3) Rabbit polyclonal





(Tanaka et al., 2002)
1:1250
Anti-492Ab IgG Rabbit polyclonal This thesis 1:1500
Anti-492Ab AP Rabbit polyclonal 1:1000
Anti-HP la
(MAB3584)
Mouse monoclonal Chemicon Int. 1:2000
Anti-HP ip
(MAB3448)
Mouse monoclonal Chemicon Int. 1:2000
Anti-HP ly
(MAB3450)
Mouse monoclonal Chemicon Int. 1:2000
Anti-fibrillarin
Nop 1 p (mAb D77)
Mouse monoclonal
Gift, J. Aris, (Florida,
USA)
1:5000
Table 2.5 Secondary antibody dilutions for western Blots













Donkey Sigma, A-3415 1:5000
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2.5 Generation of Antibodies
2.5.1 Glutathione-S-transferase purification of fusion
proteins
DNA sequence of the antigen was ligated into the expression vector, pGex-4T-l
(Amersham Biosciences) in frame with the glutathione-S-transferase (GST) coding
sequence. The expression vector was transformed into E. coli BL21-
CodonPlus®(DE3)RP cells (Stratagene®) to allow purification of the fusion protein
on a glutathione-agarose column. This E. coli strain contains the T7 RNA
polymerase under control of the lacUV5 promoter and was used for protein over-
expression by induction with the galactose analogue IPTG. This strain is designed
for high-level expression of mammalian proteins since the cells are protease deficient
and contain extra copies of the rare E. coli tRNA genes. Cells were grown in
chloramphenicol (34 pg/ml) containing media and the fusion protein was purified as
follows:
Small-scale cultures were used to determine at what temperature and length of
induction maximal soluble fusion protein was produced. A 300 ml culture was then
induced at an OD6oo of 0.75 with 1 mM IPTG and were left to grow for 3~4 hr until
OD6oo ~1.6. Cells were then harvested at 6000 g at 4°C for 10 min and resuspended
in 20 mM Tris-HCl (pH 8), 1 mM EDTA, 1 mM EGTA, 100 mM NaCl, 10%
glycerol (v/v), 1 mM DTT, 1 mM PMSF, 1 tablet/100 ml of protease inhibitor
cocktail (Roche). Cell pellets were sometimes frozen before resuspension at -20°C
until ready for use. After resuspension, cells were incubated on ice for 30 min after
addition of 1 mg/ml lysozyme. Sonication of the cells on ice at 10 pm for 5 min and
extraction with 0.1% Triton X-100 (v/v) in dE^O ensured most of the fusion protein
was released from the cells. After 20 min of centrifugation, 12,000 g, 4°C, 15 ml of
supernatant containing the expressed fusion protein was removed and added to 2 ml
of 50% slurry of glutathione-agarose (Sigma) in PBS, 150 mM NaCl. This was
incubated at 4°C for 1 hr on a roller mixer before loading into a column (Econo, Bio-
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Rad). The supernatant was allowed to either drip through or be pumped through
using a peristaltic pump (Gilson). The column was washed with 10 ml PBS-T (PBS,
1% Triton X-100 (v/v) and protease inhibitors as before (but no DTT). The GST
fusion protein was eluted with 5 ml elution buffer (10 mM reduced glutathione [3
mg/ml] in 50 mM Tris-HCl [pH 8]) and protease inhibitors as before. Eluate was
collected in 1 Ox 0.5 ml fractions. A sample of each aliquot was mixed with an equal
volume of 2x SDS loading buffer for protein analysis by SDS-PAGE (section 2.4.4)
and visualised by coomassie staining (section 2.4.5). The yield of fusion protein was
quantified against known BSA standards (10 mg/ml, NEB). Fractions containing the
GST fusion protein were pooled and concentrated in centricon-10 columns
(Amicon/Millipore) following manufacturer's instructions.
2.5.2 Immunisation
Host animals were tested for antibody manufacture suitability by western blotting
(section 2.4.4) and immunofluorescence of their pre-immune serum on NIH 3T3 and
HeLa cells (section 2.8.1). An animal from each species was subsequently chosen
for immunisation with antigen, based on minimal cross-reacting proteins detected by
the pre-immune on a western blot and low background fluorescence by
immunofluorescence.
After ethical approval of the immunisation protocol by the Home Office, antigen was
sent to Diagnostic Scotland (unconjugated peptide and 1 mg/ml of GST-fusion
protein) for immunisation of the designated animals. Designated animals were firstly
injected with a mix of synthetic peptide (0.5 mg/ml) and fusion protein (0.125
mg/ml). A subsequent booster four weeks later and two further booster injections
were given and bleeds collected two weeks after each. A total of 2 mg/ml of peptide
and 0.5 mg/ml of fusion protein were injected into each animal. The immune
responses were checked both by western blotting (section 2.4.6) and
immunofluorescence (section 2.8.1) with immunised serum on NIH 3T3 and HeLa
cells.
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2.5.3 Purification of antibodies
2.5.3.1 Immunoglobulin G purification of peptide and GST-
fusion protein
Serum from bleed 3 was diluted 1:10 in 20 mM phosphate buffer, pH 7. 20 mM
phosphate buffer was also passed through an Immunoglobulin G (IgG) HiTrap
column (HiTrap Protein G HP, Amersham Biosciences), linked up to a peristaltic
pump (Gilson) with the flow rate at 1 ml/min. 20 ml of diluted antibody was passed
through the column and the column washed with 10 volumes of phosphate buffer to
remove non-specifically bound proteins. Antibody was eluted with 3 ml of 100 mM
glycine (pH 2.7) and 0.5 ml fractions collected into 1.5 M Tris-HCl (pH 8.8) to
neutralise the eluate. 10 pi of each sample was mixed with 10 pi of 2x SDS loading
buffer, boiled for 5 min and analysed by SDS-PAGE (section 2.4.4). 5 pi of each
fraction was diluted in 500 pi PBS and the absorbance at A280 measured to estimate
protein concentration given that an A280 of 1 equals 0.75 mg/ml of pure IgG. The
peak fractions were pooled and antibody was stored at 4°C or -20°C in a final
volume of 30% glycerol (v/v) with 1 mg/ml of BSA if the antibody concentration
was less than 1 mg/ml.
2.5.3.2 Preparation of affinity columns for purification of GST-
fusion antibodies
2.5.3.2.1 Binding of histidine-tagged fusion proteins on a nickel-agarose
column
DNA sequence of the antigen was ligated into expression vector pET-32-a
(Novagen), which produces a TRX (thioredoxin) fusion protein with a histidine (his)-
tag to enable purification on a Ni-agarose column (HIS-Select ' Nickel Affinity Gel,
Sigma). The plasmid was transformed into BL21-CodonPlusii(DE3)RP. A 300 ml
culture at an OD600 of 0.75 was induced with 1 mM IPTG and incubated at 37°C for
3~5 hr (OD60o -1.6). Cells were pelleted at 6000 g at 4°C for 10 min and
resuspended in 15 ml of binding buffer (0.3 M NaCl, 5 mM imidazole, 50 mm
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NaH^PC^, 10% glycerol [v/v] and freshly added 10 mM (3-ME and 0.1 mM PMSF).
Cells were lysed by incubation with 1 mg/ml lysozyme for 30 min on ice, followed
by sonication at 10 (am for 5 minutes on ice. Triton X-100 was added to 0.1% (v/v).
After centrifugation at 20,000 g for 20 min at 4°C to remove bacterial debris, the
supernatant containing the soluble fusion protein was removed for purification on a
Ni-agarose column.
2 ml of 50% slurry of Ni-agarose in PBS was equilibrated by rotation with 10 ml of
binding buffer for a minimum of 2 hr at 4°C. Centrifugation at 400 g for 5 min
released the supernatant, which was removed and replaced with 15 ml of bacterial
cell supernatant containing the his-tagged fusion protein. This mixture was rotated at
4°C for a minimum of 24 hr before being transferred into a small Bio-Rad column
where the supernatant was allowed to drip through. The column was washed twice
with 20 mM imidazole wash solution (20 mM imidazole, 0.3 M NaCl, 50 mM
NaH?P04, 0.1% Triton X-100 [v/v], 10% glycerol [v/v], 10 mM |3-ME, 0.1 mM
PMSF) and the fusion protein eluted in 1 ml fractions with 5 ml of 250 mM
imidazole buffer (250 mM imidazole, 0.3 M NaCl, 50 mM NaFEPO/j. 0.1% Triton X-
100 [v/v], 10% glycerol [v/v], 10 mM (3-ME and 0.1 mM PMSF). Samples were
analysed as in 2.5.1 and concentrated in a centricon-10 column.
2.5.3.2.2 Desalting and buffer exchange of his-tagged fusion protein on
a PD-10 column
Equilibration buffer supplied with the PD-10 column (Amersham Biosciences) was
allowed to run into the column by removal of the end caps. His-tagged fusion
protein was added to the column bed in a sample volume made up to 2.5 ml with
coupling buffer (0.1 M NaHC03, 0.5 M NaCl at pH 8.3). When the sample had run
into the bed, high molecular weight proteins (>5 kDa) were separated from low
molecular weight substances (<1 kDa) by molecular exclusion chromatography and
eluted off the column in 7x 0.5 ml fractions with 3.5 ml of coupling buffer. The
exchange into coupling buffer allows fusion protein to be coupled to CNBr-activated
Sepharose™ 4B via its amino groups, which are now predominantly in the
unprotonated (desalted) form (section 2.5.3.2.3). 10 pi of each fraction was
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analysed by boiling for 5 min with 10 pi of 2x SDS loading buffer and analysed by
SDS-PAGE (section 2.4.4).
2.5.3.2.3 Making a CNBr-activated Sepharose 4B affinity column
The column was prepared by resuspending 1 g of CNBr-activated Sepharose™ 4B
(Amersham Biosciences) in 15 ml of 1 mM HC1. for 15 min on a mixing rotor. 200
ml of 1 mM HCl/g of gel matrix was passed through the sepharose 4B matrix whilst
linked up to the peristaltic pump and constantly mixed to allow complete washing of
the matrix. The matrix was centrifuged in 1 mM HC1 at 12,000 g and its vol
measured in a 15 ml falcon tube. 50% (w/v) slurry of matrix and 1 mM HC1 was
stored at 4°C until required.
To make a 1 ml column, 2 ml of slurry was resuspended in a 15 ml falcon with 10 ml
coupling buffer, mixed by gentle inversion and centrifuged at 400 g for 1 min. The
coupling buffer was aspirated and the matrix resuspended with approximately 5 mg
(1.5 ml) of desalted fusion protein from the PD-10 column and 1.5 ml coupling
buffer (total volume added to matrix was 3 ml). The column was mixed by gentle
inversion at room temperature for 1 hr per 1 ml of gel. After centrifugation, the
matrix was washed for a further 5 min in 14 ml of coupling buffer. A 2 hr wash at
RT with 14 ml of 100 mM Tris-HCl (pH 8) deactivates the remaining active groups
on the column. Subsequent alternate washing with 0.1 M NaCOOH3 (pH 4)
containing 0.5 M NaCl, followed by 0.1 M Tris-HCl (pH 8) containing 0.5 M NaCl,
ensures removal of excess fusion protein so that no protein remains ionically bound
to the immobilised 492 fusion protein. The matrix was poured into a Bio-Rad
disposable column and held upright with support to produce the affinity column.
The column was stored in storage buffer (0.05% NaN3 in PBS [w/v]) until required.
2.5.3.3 Affinity purification of GST-fusion antibody
For a 1 ml column, 2.5 ml of serum was diluted up to 25 ml in PBS (1:10 dilution)
and filtered through a 0.45 pm filter. 10 bed volumes (i.e. 10 ml) of PBS were run
through the affinity column before loading the column with diluted serum. Flow
through was collected to check for non-specific binding of proteins. Another 10 ml
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of PBS was used to wash the column followed by 20 bed volumes of High Salt wash
buffer (10 mM Tris-HCl [pH7.5], 500 mM NaCl). The column was washed with 20-
50 bed volumes of PBS until ready to elute antibody. 35 pi of 1 M Tris-HCl (pH
8.8) was measured into 12-15 1 ml collection tubes and upon addition of elution
buffer (100 mM glycine [pH 2.7], 150 mM NaCl, 10% glycerol [w/v]), 0.5 ml
fractions were collected, mixed and placed on ice. 5 pi of each fraction was diluted
in 500 pi PBS and the absorbance at A280 measured to estimate protein concentration
(section 2.5.3.1). The peak fractions were pooled after analysis on an acrylamide
gel. Antibody was stored at 4°C or -20°C in a final volume of 30% glycerol [w/v]
with 1 mg/ml of BSA if the antibody concentration is less than 1 mg/ml.
2.5.3.4. Preparation of affinity column for purification of
peptide antibody
2.5.3.4.1 Reduction of unconjugated peptide
A Reduce-Imm Immobilised Reductant Column and Reducing Kit (Pierce) were
used according to manufacturer's instructions to reduce any disulphide bonds present
in the unconjugated peptide (KLH free). This ensured that any sulfhydryl (-SH)
groups occurring in the side chain of cysteine (cys) residues were free for
conjugation and immobilisation of the peptide on a gel support. A Reduce-Imm'"
Immobilized Reductant Column was equilibrated at RT with 5 ml of the supplied
equilibration buffer. The column was activated by addition of 10 ml of 10 mM DTT.
Non-immobilised DTT was removed from the column after washing with 10 ml of
equilibration buffer. 2.4 ml (10 mg) of unconjugated peptide was added to the
column and incubated for 1 hr. The reduced peptide was recovered from the column
by applying 9 ml of equilibration buffer and collecting 1 ml fractions. Fractions
containing the reduced peptide were determined using 10 mM Ellman's Reagent
supplied with the kit. Briefly, 20 pi of each fraction was added to 1 ml of
equilibration buffer and 100 pi of Ellman's Reagent added upon which, fractions
containing reduced peptide turned yellow. After incubation for 15 min, an Azn2
reading was taken and fractions containing the peak absorbance were pooled.
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The Reduce-Imm"' Immobilized Reductant Column was regenerated by repeating the
activation step with 10 mM DTT and subsequently stored at 4°C after a 10 ml wash
in PBS containing 0.05% NaN3 (w/v).
2.5.3.4.2. Immobilisation of reduced peptide on SulfoLink® Coupling Gel
5 ml of SulfoLink® Coupling Gel slurry was placed into a disposable Bio-Rad
column and equilibrated at RT with 4 column volumes of coupling buffer (50 mM
Tris-HCl, 5 mM EDTA-Na [pH 8.5]). 3 ml of sulfhydryl-containing peptide
(2.5.3.4.1) diluted with 2 ml of coupling buffer (total volume = 5 ml) were added to
the column and the column mixed at RT for 15 min. The column was then incubated
for 30 min without mixing whilst the gel bed settled. The column was washed with 3
column volumes of coupling buffer after which the non-specific binding sites on the
column were blocked by addition of 5 ml of 50 mM L-cysteine*HCl in coupling
buffer with gentle mixing for 15 min at RT followed by an incubation for 30 min
without mixing. 6 column volumes of 1 M NaCl was used to wash the column
followed by washing with 2 column volumes of storage buffer (0.05% NaN.3 in PBS
[w/v]) before storage of the affinity column in a further 2 ml of storage buffer.
2.5.3.5 Affinity purification of peptide antibody
For a 5 ml column, 10 ml of serum were diluted up to 50 ml in PBS (1:5 dilution)
and filtered through a 0.45 pm filter. 6 ml of PBS were run through the affinity
column (2.5.3.4.2) before loading the column with diluted serum. The serum was
passed over the column 4 times before washing with 3 bed volumes of PBS. 100 pi
of 1M Tris-HCl (pH 7.5) was measured into 8 x 1.5 ml collection tubes and upon
addition of 8 ml of elution buffer (100 mM glycine [pH 2.7]), 1 ml fractions were
collected, mixed and placed on ice. 10 pi of each fraction was mixed with 10 pi of
2x SDS loading buffer, boiled for 5 min and analysed by SDS-PAGE (section 2.4.4).
The peak fractions were pooled after analysis on an acrylamide gel. Antibody was
stored at 4°C or -20°C in a final volume of 30% glycerol (w/v) with 1 mg/ml of BSA
if the antibody concentration is less than 1 mg/ml.
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2.6 Transgenic animal production
2.6.1 Animal husbandry
All animals were maintained in a specific pathogen free (SPF) environment and
experiments were carried out under home office licence. Wild-type (wt) mice
(C57BL6 [Charles River, UK] or MFI [Harlan]) were bred in-house with mice
heterozygous for the transgene to establishment gene-trap knockout lines. Embryos
for all experiments were generated from timed matings with females from the
outbred mouse line CD1 (Charles River, UK) or transgenic females with the morning
of vaginal plug detection being counted as embryonic day 0.5 (E0.5).
2.6.2 Blastocyst injection of embryonic stem cells and
establishment of transgenic mouse lines
The gene-trap screen by Sutherland et al. in 2001 was performed with passage 19
(pgl9) E14 embryonic stem (ES) cells, which are derived from the 129/Ola mouse
strain. Between 10-50 cells from cell lines ESI 13 at pg6 and ES492 at pg5 were
injected into 2 different female C57BL6 blastocyst recipients at 2.5 days post coitum
(dpc) by Shelia Webb of the MRC Human Genetics Unit in Edinburgh and these
blastocysts were placed into pseudopregnant C57BL6 females by uterine transfer.
Chimeras among the offspring were identified by a mottled coat colour and these
were bred with both outbred MFI or inbred C57BL6 mice to determine if the mutant
ES cell lines were transmitting through the germ line to establish mutant lines.
Resulting progeny were tested for the presence of the pGTl-3 transgene by PCR
amplification using primers that amplify a 413 bp (base pairs) fragment within the
LacZ gene (section 2.2.12). Heterozygous lines for both mice were established by
repeatedly backcrossing LacZ positive mice with either wt MFI or C57BL6 mice.
LacZ positive mice were bred for congenic inbred and outbred lines.
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2.6.3 Harvesting of post-implantation embryos
Post-implantation embryos were harvested for wholemount X-Gal (5-bromo-4-
chloro-3-indolyl-P-D-galactoside) (Melford) staining and/or paraffin wax sectioning.
The plugged females were sacrificed by cervical dislocation at the appropriate time
point and embryos removed from their uteri into PBS. Embryos were freed from the
extra-embryonic membranes and yolk sac using scissors and forceps, and rinsed in
fresh PBS prior to subsequent fixation (section 2.8.4.1).
2.7 Mammalian Cell Culture
2.7.1 General methodology
2.7.1.1 Freezing and thawing cells stored in liquid nitrogen
All cell suspensions were frozen in 0.5 ml aliquots of 7% DMSO (v/v) in foetal calf
serum (FCS) (except mouse ES cells which were frozen in 10% DMSO/FCS) before
being stored in cryotubes in frozen liquid N2. To retrieve cell lines from liquid N2,
cells were thawed at 37°C for 5 min in a water bath and were spun down in culture
medium to remove the DMSO before seeding into T25 cm" culture flasks. Mouse ES
and F9 embryonic carcinoma (EC) cells were seeded into T25 cm2 culture flasks
coated with 0.1% gelatin (Sigma, G-1890), prepared by firstly layering a solution of
0.1% gelatin in PBS over the bottom of the flask and aspirating off before adding
cells and media.
2.7.1.2 Routine cell culture and harvesting
All cells were incubated at 37°C with 5% CO2 and tissue culture medium as
described in Table 2.3. Cells other than mouse ES cells were cultured in Dulbecco's
Modified Eagle Medium (DMEM, Invitrogen ") and 10% FCS (v/v) containing
penicillin (1000 U/ml) and streptomycin (650 pg/ml). ES cells were grown in
Glasgow Modified Eagle Medium (GMEM, Invitrogen'M) with supplements (Table
2.6) as described by Smith et al. in 1988. Cells were grown to near confluence before
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splitting into fresh tissue culture flasks coated in gelatin if required. To split the
cells, medium was poured off, flasks were rinsed with PBS and monolayers were
then covered with 1.5 ml of trypsin-EDTA and incubated at 37°C for 5 min. Gentle
agitation dislodged the cells, fresh medium was added, and the cells pelleted at 1000
g for 5 min before being replated or harvested for experiments.
Cells were counted (section 2.7.1.3) before being seeded at the relevant density onto
microscope slides for immunofluorescence (ES cells, 10° cells per slide). Slides were
prepared by soaking in 100% ethanol before being left to dry in QuadriPerm slide
chambers (VIVASCIENCE, Satorius) inside a laminar flow sterile fume hood
(Heraeus). The slides were coated with gelatin for growth of ES or EC cells.
2.7.1.3 Cell counting
For cell counting, cells were resuspended in PBS after harvesting and a drop placed
on a haemocytometer (Weber Scientific International Ltd.) with a weighted coverslip
sealed on top. The total volume defined by the grid was 1x104 ml and cell
concentrations per ml were obtained by multiplying the total number of cells over the
grid by 104.
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2.7.2 In vitro differentiation of ES cells (Strickland and
Mahdavi, 1978) and F9 cells
Cells were passaged as described (section 2.7.1.2), seeded (104 cells/cm") onto
gelatin-coated flasks and were grown overnight in normal media. The next day, cells
were rinsed with PBS and the media changed to LIF free media (ES cells) or normal
media (F9 cells) supplemented with 5x 10_<> M retinoic acid (all-trara-retinoic acid,
stock solution 3.3x 10"3 M in DMSO, stored in the dark at -20°C). The retinoic acid,
containing medium was renewed every 24 hr for a period of two (F9 cells) or four
days (ES cells) following induction.
2.7.3 In vitro differentiation of ATDC5 cells
To culture undifferentiated ATDC5 cells, cells were seeded at 6xl04 cells per 6 well
plate in maintenance media (Table 2.6). Cells proliferate rapidly until confluent
5 2 ••••fit*
(1.4x10' cells/cm") where they remain undifferentiated with a fibroblastic
morphology (Shukunami et al., 1996). To differentiate ATDC5 cells, cells were
seeded at the same density per 6 well plate but this time cultured in maintenance
medium supplemented with 10 mg/ml bovine insulin (Shukunami et al., 1996). By
day 3 of differentiation cells stop growing by contact inhibition and by day 6-10,
cells have condensed into an elongated spindle-like morphology with a decreased
growth rate. Day 14-21 sees the formation of nodules by proliferating cells with a
round morphology. Cells around the nodules remain fibroblastic and by day 24
cartilage nodules have stopped growing.
2.7.4 In vitro differentiation of OS25 cells (Billon et al.,
2002)
Undifferentiated OS25 cells were cultured in normal LIF containing ES cell culture
medium in the presence of 100 pM G418 to select for undifferentiated cells. To
differentiate OS25 cells, the differentiation protocol as described by Billon et al.,
2002, was modified as described by Chambeyron and Bickmore, 2004. Cells were
grown for 1 day in a T25 cm2 flask without LIF and then grown for 2 days with
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retinoic acid (5x 10"°M) present in the LIF free media. Cells were then harvested in
4 ml of media before being seeded onto microscope slides at 1 ml of cell suspension
per slide. Cells were left to grow on the slides for two days with gancyclovir (2.5
pM) to select against undifferentiated cells. The cells were left to grow on the slides
for a further four days in gancyclovir alone with the media being renewed every
other day.
2.7.5 Transfections
2.7.5.1 NIH 3T3 cells
5 22.4x10' cells were seeded onto coverslips in 6 cm dishes and grown to 70%
confluence. For each transfection, 5 pi Lipofectamine 2000 (Invitrogen ) was added
to 200 pi of Opti-MEM (Invitrogen'M), vortexed and incubated for 5 min. A further
200 pi of Opti-MEM was incubated with 2 pg DNA for 5 min. Both incubation
mixtures were added together and left to incubate for a further 20 min. Media was
removed from the cells and 3 ml of fresh media added with drop-wise addition of the
transfection mix. Cells were incubated for 24 hr and then fixed for
immunofluorescence (section 2.8.1) or visualised directly under a fluorescent
microscope for GFP (green fluorescent protein) expression.
2.7.5.2 ES cells
ES cells were seeded in the morning onto gelatinised coverslips at 3.6x10^ cells per 6
cm2 dish ready to transfect that afternoon or alternatively they were seeded at 7.8xl04
cells per dish ready to transfect the following day. 2 pg of DNA was added to 76 pi
Opti-MEM and mixed for 5 min during which time 2 pi of Lipofectamine2000
(Invitrogen ") was mixed with 76 pi Opti-MEM and incubated for 5 min. The above
solutions were mixed and left to incubate for 20 min before being adding drop-wise
to the cells. Cells were left to transfect overnight and analysed the following
morning by fluorescent microscopy.
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2.8 Immunohistochemistry
2.8.1 Immunofluorescence on fixed cells
Mammalian cells were grown on slides as described (section 2.7.1.2) and all
subsequent incubations performed at RT. Slides were rinsed in PBS containing 1.5
mM MgCb and 1 mM CaCf and fixed for either 10 or 20 min in 4% or 3%
paraformaldehyde (pFa) (w/v) in PBS respectively. All subsequent steps were
performed with PBS containing Mg and Ca. After a further 3 washes in PBS, the
slides were quenched in 50 mM NH4CI in PBS for 10 min and permeabilised for 12
min in 0.1% Triton X-100 (v/v) in PBS. Slides were washed a further 3 times in PBS
before blocking in 5% donkey serum (v/v) in PBS for 20 min. Slides were then
incubated o/n in moistened chambers with primary antibody (diluted in 5% block)
under a parafilm coverslip (Table 2.7). After washing, slides were incubated in
secondary antibody (Table 2.8) diluted in the same way but this time for 1 hr. All
secondary antibodies were species-specific fluorescein isothiocyanate (FITC) or
Texas Red (TR) conjugates obtained from the Jackson Laboratories or Vector Lab.
Secondary antibody was washed as above and all slides were mounted with 0.5
pg/ml 4,6-diamidino-2-phenylindole (DAPI) in Vectashield (Vector). Coverslips
were sealed with rubber solution (PANG) and slides were stored in the dark at 4°C
until imaged (section 2.10.3). For dual epitope IF with primary antibodies that had
been raised in the same species (i.e. rabbit), the Zenon Rabbit IgG labelling kit
(Molecular Probes) was used to label one of the two antibodies according to the
manufacturer's instructions. After primary antibody incubation with the first
antibody was performed as for normal IF, the secondary antibody incubation then
followed. Instead of proceeding to mount the slides, 1 pg of the second primary
antibody was labelled with 5 pi of Zenon rabbit labelling reagent (FITC labelled Fab
fragments) and the volume made up to 10 pi with PBS. After incubation for 5 min, 5
pi of blocking reagent (non-specific IgG) was subsequently added to bind any
remaining unbound Fab fragments. The total reaction volume was not allowed to
exceed 20 pi and the labelled antibody was applied to the slide within 30 min, after
removing the secondary antibody by washing in PBS as before. A second fixation
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step of 10 min in 4% pFa (w/v) followed, and after a PBS wash, slides were mounted
as for normal IF.
Table 2.7 Primary antibody used for immunofluorescence
Antibody Species Source Dilution Factor
Anti-KAP-1 Mouse monoclonal David Schultz neat





Anti-492Ab IgG Rabbit polyclonal This thesis 1:1000
Anti-492Ab AP Rabbit polyclonal 1:100
Anti-BrdU Rat monoclonal Harlan Seralab 1:100
Anti-SSEA-1 Mouse polyclonal DSHB 1:200






Anti-HP la Mouse monoclonal Chemicon Int. 1:500
Anti-HP 1(3 Mouse monoclonal Chemicon Int. 1:500
Anti-HP ly Mouse monoclonal Chemicon Int. 1:500
CREST (Campbell) Human anti-sera B. Sullivan 1:300
Anti-2b-MetiH3-K9
(rabbit no. 4861)
Rabbit polyclonal Peters et ail., 2001 1:500
PML Mouse monoclonal Chemicon 1:100
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Table 2.8 Secondary antibodies used for immunofluorescence
Antibody Species Source Dilution Factor
Anti-rabbit FITC
conjugate (IgG,































Donkey Jackson Labs, 313-
096-047
1:75
2.8.2 Immunofluorescence on fixed cells with
bromodeoxyuridine incorporation
For immunofluorescence of bromodeoxyuridine (BrdU) incorporation into DNA
synthesising cells, BrdU was added 30 min before 3% pFa (w/v) fixation at a
concentration of 0.01 M (Boehringer). Cells were fixed in 10% formalin (v/v) for 10
min and lysed with 0.1% Triton X-100 (w/v) for 12 min. A 30 min 2 M F1C1
treatment denatures the DNA in the cells for antibody accessibility. Cells were
washed in PBS, blocked for 10 min in 5% BSA (w/v) before incubating in anti-Brd-
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U antibody (Table 2.7) for lhr. Secondary antibody incubation and mounting of the
slides in DAPI/Vectashield was performed as described above.
2.8.3 Detection of the differentiation state of cells
2.8.3.1 Alkaline phosphatase staining of ES cells
The differentiation state of ES cells were detected using an alkaline phosphatase
assay performed using a kit (Sigma, 86-R) containing a fixative and stain. Culture
medium from the cells grown in 6-well plates was replaced with 1.5 ml fix and left
for 30 sec. The fix was removed and the cells rinsed gently with dH20 for 45 sec.
Cells were rinsed again and enough stain (prepared fresh) was gently poured into
each well. Cells were incubated in the dark for 15 min at RT. Undifferentiated ES
cell colonies stain intensely pink. Stain was removed and the wells rinsed with water
and air-dried.
2.8.3.2 Alcian blue staining of ATDC5 cells
Mouse ATDC5 cells were grown on slides or coverslips as described (section 2.5.5)
and rinsed with PBS. Cells were fixed for 20 min in 95% methanol (v/v in dH20)
and stained o/n with 0.1% alcian blue 8GS (w/v) in 0.1M HC1 (pH 1). Stain was
rinsed off in PBS and the slides photographed (section 2.10.2).
2.8.4 Wholemount expression analysis of mouse
embryos and tissues
2.8.4.1 Tissue fixation
1 M phosphate buffer (pH 7.3) was prepared by mixing 1M NaH2P04 and 1 M
Na2HPC>4, in a ratio of 21:6. Mouse embryos or tissues were fixed for 1 hr in either
10 ml of gluteraldehyde fixative (5 mM EGTA [pH 8], 0.2% gluteraldehyde [v/v]
and 2 mM MgCl? in 0.1 M phosphate buffer) or 4% pFa (w/v) immediately after
dissection (section 2.4.3). Embryos were washed twice at RT for 15 min in wash
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solution (0.05% BSA [w/v], 2 mM MgCf, 0.02% NP-40 (v/v), 0.1% sodium
desoxycholate [w/v] in 0.1 M phosphate buffer) before staining.
2.8.4.2 X-Gal staining
X-Gal staining solution was prepared by fully dissolving 250 mg X-Gal in 5 ml
dimethylformamide (DMF) before adding to the rest of the X-Gal reaction buffer (5
mM potassium ferricyanide [K3Fe(CN)6], 5 mM potassium ferrocyanide
[K4Fe(CN)6], 0.25 mg/ml spermidine, 2 mM MgCh and made up to 500 ml in wash
solution [2.8.4.1]). This solution was filtered before use. 50 ml aliquots were stored
at -20°C for later use. After fixation and washing, embryos were stained o/n in X-
Gal staining solution (maximum 15 hr) at RT whilst protected from the light.
Staining solution was removed the following morning and the samples stored in fix
until required. Embryos were visualised with microscopy (section 2.10.1).
2.8.5 Mouse histology
2.8.5.1 Tissue processing for paraffin wax sectioning
For histochemistry, embryos were processed for paraffin wax embedding and
microtome sectioned. Tissue processing was automated through 11 stages of equal
duration (usually 30-40 min depending on the sample size) using a Tissue-Tek " VIP,
at the settings presented in table 2.9.
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Table 2.9 Settings used for wax processing of embrvos/tissues
Stage Temperature (°C)











For fragile tissues, the pressure vacuum was switched on at the second 100% ethanol
stage to maintain the integrity of the tissue during the embedding stages. Smaller
embryos less than 9 dpc, were hand embedded in wax to minimise damage to the
embryos. A procedure similar to the above was followed but the duration of each
stage was 15 min. Following the final wax stage, samples were transferred into a
suitable mould, orientated and allowed to solidify in the wax bed. The wax block
was trimmed to the desired size and the edges angled to improve sectioning on the
microtome.
2.8.5.2 Microtome sectioning, dewaxing and tissue staining
Wax embedded embryos were sectioned at 7-10 pm on a microtome and ribbons of
sections floated out in a 42°C water bath. Sections were transferred to Superfrost
Plus slides (BDH) and the slides incubated overnight at 55°C to allow sections to
dry. Slides were dewaxed by washing for 3x 10 min in fresh xylene, followed by 3x
10 min washes in 100% ethanol. Slides were then passed through a graded ethanol
series, washed in dFFO and counterstained with nuclear fast red (nfr) according to a
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standard protocol. Typically, slides were immersed in nfr for 1 min before being
brought back up the alcohol series into 3 final washes in Histoclear " (national
diagnostics, US). Sections were mounted in Histomount (national diagnostics, US)
to preserve X-Gal staining.
2.9 Fluorescence in situ hybridisation
2.9.1 Fixing of cells in 3:1 methanol: acetic acid
Cells for two-dimensional (2-D) fluorescence in situ hybridisation (FISH) were
prepared as follows: cells were harvested and resuspended in 10 ml hypotonic
solution (0.033 M KC1, 0.017 M tri-sodium citrate), which was added drop-wise with
constant agitation (the concentration of cells in hypotonic should be <2x 107/ml).
The cells were left to swell for 10 min at RT before centrifugation at 400 g for 5 min.
Cells were then fixed in fresh 3:1 methanokglacial acetic acid (MAA), again added
drop-wise with constant agitation before incubating on ice for 20 min. After
centrifugation, the cells were resuspended in 8 ml of fix and the cells placed at 4°C
o/n. Cells were fixed twice more and stored indefinitely at -20°C.
2.9.2 Preparation of probes for FISH
2.9.2.1 Nick translation
DNA was labelled using biotin-16-dUTP or digoxigenin-11-dUTP incorporation by
nick translation. 1-1.5 pg of DNA was added to 4 pi lOx nick translation salts (0.5
M Tris-HCl [pH7.5], 0.1 M MgS04, 1 mM DTT, 500 pg/ml BSA), 4 pi each of 2
mM dATP, dGTP and dCTP, 2 pi of 0.5 mM dTTP and 4 pi biotin-16-dUTP or
digoxigenin-11-dUTP (Roche). DNase I was added to a final concentration of 1
U/ml along with 1 pi of T4 DNA polymerase I (Invitrogen", 10 U/pl). The total
volume was made up to 40 pi with dH20 and mixed thoroughly before being
incubated at 16°C for 90 min. The reaction was terminated by placing at -20°C or
immediately processed for the removal of unincorporated label (section 2.9.2.2).
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2.9.2.2 Removal of unincorporated label
Quick Spin columns (Roche) containing G-50 Sephadex beads were used in
accordance with the manufacturer's instructions to remove any free biotin-16-dUTP,
digoxigenin-11-dUTP or dNTPs remaining in the solution. Cleaned probes were
eluted in 40 pi TE (pH 8).
2.9.2.3 Quantification of label incorporation
Gridded nitrocellulose membranes were prepared by brief soaking in dPEO followed
by 20x SSC for 10 min. Labelled DNA probes were diluted to lxlO"3 and lxl0"4 in
TE (pH 8) and 1 and 2 pi of each were spotted onto the gridded membrane. On the
same membrane 20, 10, 2 and 1 pg of labelled lambda DNA standards (Roche) were
also spotted. DNA was cross-linked onto the membrane by exposure to 30 mJ ofUV
irradiation.
The membrane was immersed in buffer 1 (0.1 M Tris-ElCl [pH7.5], 0.15 M NaCl) for
5 min at RT, then blocked in 5% Marvel (w/v) in buffer 1 at 37°C for 30 min. 10 pi
streptavidin-alkaline phosphatase (Boehringer) and/or anti-digoxigenin-alkaline
phosphatase (Boehringer) were added to 10 ml of buffer 1 and placed in a sealed
polythene bag with the membrane for 30 min at RT. The membrane was washed
twice in buffer 1 then equilibrated for 5 min in 0.1 M Tris-HCl (pEl 9.5). The colour
reaction was developed by incubation of the membrane in a sealed polythene bag,
with 5 ml of 0.1 M Tris-HCl (pH 9.5) and two drops from bottles 1-3 from the
alkaline phosphatase substrate kit IV (Vector). The substrates in this colour reaction
are 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium, which produce
a blue reaction product. A complete colour reaction was observed within a few hours
of incubation at RT in the dark and an estimate of the concentration ofDNA labelled
probe was made by comparison with known lambda standards.
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2.9.3 The FISH protocol for MAA fixed nuclei
2.9.3.1 Slide preparation
Glass slides were stored in a dilute solution of HCl in ethanol and were dried and
polished with muslin before use. MAA fixed cells (section 2.6.1) were removed
from storage at -20°C and centrifuged at 400 g for 5 min. Fresh MAA fix was added
until the cell suspension reached a 'milky' appearance. One drop of suspension from
a fine tipped pastette was dropped onto a horizontal microscope slide from a 30 cm
height (the best chromosomal spreads were achieved when the air humidity was
-50% and by breathing on the slides initially). The quality of the spread was
monitored by phase contrast microscopy. Slides were stored for 2-6 days prior to
hybridisation.
2.9.3.2 Hybridisation
Slides were treated with 100 pg/ml RNaseA in 2x SSC for 1 hr at 37°C, washed
briefly in 2x SSC and dehydrated through an ethanol series (2 min each in 70%, 90%
and 100% ethanol). Slides were dried under a vacuum for 10 min before being
heated in a 70°C oven for 5 min and immediately denatured in 70% formamide (v/v)
in 2x SSC (pH 7.8) at 70°C for 1-2 min. Slides were plunged in 70% ethanol at 4°C
for 2 min before dehydration through 90% and 100% ethanol.
Labelled probes (section 2.9.2) were prepared by precipitation of -75 ng probe (200
ng BAC probe) with 5 pg salmon sperm DNA and mouse Cot 1 DNA (Invitrogen M,
2.5-10 pg depending on repeat content of probe). After the addition of 2x vol of
ethanol, probes were spun down under a vacuum before resuspension in 10 pi
hybridisation mix (50% deionised formamide [v/v], 10% dextran sulphate [v/v], 1%
Tween 20 [v/v], in 2x SSC) or 13 pi of commercial mouse chromosome paints
supplied in hybridisation buffer (Cambio). All probes were denatured at 70°C for 5
min and reannealed at 37°C for 15 min before being spotted onto coverslips and
picked up by the slides. Slides were sealed with aibber solution (TipTop) before
incubation o/n in a covered tray in a 37°C water bath.
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2.9.3.3 Washing and detection of FISH signal
Rubber solution was removed from the slides and they were immersed in 2x SSC at
45°C for 4x 3 min. The coverslips fall off naturally. Slides were washed a further
4x 3 min in O.lx SSC at 60°C before transfer to 0.1% Tween 20 [v/v] in 4x SSC.
Detection was carried out in a moist chamber pre-heated to 37°C. Biotin was
detected with sequential layers of fluorochrome-conjugated avidin (FITC- or TR-
avidin), biotinylated anti-avidin, and a further layer of fluorochrome-conjugated
avidin. Digoxigenin was detected with sequential layers of Rhodamine (R)-
conjugated anti-digoxigenin and TR-conjugated anti-sheep IgG. Detection reagents
were diluted in SSCM (4x SSC, 5% Marvel milk powder [w/v]) to the appropriate
concentration (Table 2.10). After blocking with 40 pi of SSCM for 5 min at RT, 40
pi of the appropriate detection layer was applied to each slide. Slides were incubated
in the same way at 37°C for 60 min followed by 3x 2 min washes of 0.1% Tween 20
[v/v] in 4x SSC at 37°C. All slides were mounted in 0.5 pg/ml of DAPI in
Vectashield. Coverslips were sealed with rubber solution (PANG) and slides were
stored in the dark at 4°C until imaged.













FITC-avidin Goat Vector 2.0 1:500
TR-avidin Goat Vector 2.0 1:500
Biotinylated anti-
avidin
Goat Vector 0.5 1:100
R-anti-
digoxigenin
Sheep Roche 0.2 1:20
TR-anti-sheep
(IgG, H&L)
Rabbit Vector 0.5 1:100
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2.10 Fluorescence and brightfield imaging and
processing
2.10.1 Wholemount microscopy
Dissections of post implantation embryos were imaged with the aid of a Leica Stereo
MZFLIII stereofluorescence microscope (Leica Microsystems, Milton Keynes, UK)
fitted with a fibre optic cold light source and illuminated base for
incident/transmission illumination. Images of whole embryos under PBS were
captured with a Photometries CoolSnap colour CCD camera (Roper Scientific,
Arizona) controlled scripts written for IPLab Spectrum (Scanalytics Inc., VA).
2.10.2 Brightfield analysis of cells or tissue sections
Embryo sections and cells were analysed with brightfield (using differential interface
contrast [DIC] optics) and images taken with a Photometries CoolSnap HQ
monochrome CCD camera (Roper Scientific, Arizona). IPLAB Spectrum
(Scanalytics Inc., VA) wrote the image capture scripts that controlled camera
capture.
2.10.3 Fluorescence imaging of cells or nuclei
2-D FISH slides or immunofluorescence experiments were examined in a methodical
manner using either a Zeiss Axioplan II or Zeiss Axioplan fluorescence microscope
both with 100 watt mercury bulbs and equipped with a triple band-pass filter
(Chroma # 83000). Grey scale images for each fluorochrome were collected with a
cooled CCD camera depending on the model ofmicroscope (Pentamax with a Kodak
KAF 1400 sensor or Micromax with Kodak KAF 1400e sensor respectively,
Princeton Instruments) using IPLAB software v. 3.6 (Scanlytics, USA).
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2.11 Computational methods
The Bioinformatics programmes and resources referred to in this thesis are listed




InterPro (proteome analysis) http://www.ebi.ac.uk/integr8/ProteomeAnalysisAction
NCBI (BLASTN/P, TBLASTN) http://www.ncbi.nih.gov/BLAST/
NCBI (Entrez) http://www.ncbi.nlm.nih.gov/Entrez/index.html
NPD (nuclear protein database) http://npd.hgu.mrc.ac.uk/
PIX analyses (HGMP) http://www.hgmp.mrc.ac.uk/Bioinformatics/








Despite the abundance of KRAB-ZFPs in the mouse and human proteomes,
comparatively little is known about the specific biological functions and mechanism
of repression employed by this protein family. Whilst at the start of this thesis, the
precise functions of a number of KRAB-ZFPs and their target sequences had recently
become known (Casademunt et al., 1999; Skapek et al., 2000; Zheng et al., 2000),
they were mainly thought of as a group of proteins involved in aspects of cell
differentiation and proliferation that harboured a potent repressor activity. In
humans, the target sequence of ZNF202 (a SCAN domain-containing KRAB-ZFP)
suggested that this KRAB-ZFP is involved in regulating lipid metabolism (Wagner et
al., 2000). Similarly, ZBRK1 was known to repress GADD45, a gene involved in
cell cycle regulation, by binding to a specific sequence within intron 3 (Zheng et al.,
2000). In rat, only one KRAB-ZFP (AJ18) target gene was known and was found to
modulate the activity of Runx2, a master gene of osteogenic differentiation (Jheon et
al., 2001). In mice however, no KRAB-ZFP target genes had yet been discovered.
Although comparative sequencing studies ofKRAB-ZFP genes and the proteins they
encode do exist (Mark et al., 1999; Looman et al., 2002; Shannon et al., 2003),
comprehensive functional studies are limited due to a lack of target genes and modes
of analysis that incorporate the study ofmore than one protein. The gene-trap screen
isolated 7 KRAB-ZFPs, which could be used as a starting point for such a
comprehensive study. As a first step, I decided to identify and structurally
characterise each gene-trapped KRAB protein. By doing so, I hoped to outline any
similarities and differences within the candidate group in preparation for choosing
group representatives for further functional studies.
The gene-trap approach employs a P-galactosidase-neomycin phosphotransferase (fi-
geo) reporter gene (lacking its own promoter and start codon), which more often
integrates into the introns, rather than the exons of expressed genes. If the reporter
gene is spliced in frame into the gene transcripts (Fig. 3.1A), translation results in a
fusion protein that is expressed from the trapped genes endogenous
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Figure 3.1 Gene-trap screening and sequencing strategy
A) pGT(l-3) containing the p-geo reporter gene is integrated into the intron of an expressed gene
downstream of coding exons (grey boxes). The fusion gene is spliced in frame into the gene transcript
via its splice acceptor (SA), taken from the mouse engrailed 2 gene (En2). The polyadenylation (pA)
signal ensures that the gene transcript terminates after p-geo. The transcript encodes a fusion protein
possessing both neomycin phosphotransferase and P-galactosidase activities. Drug selection (G418)
identifies cells that have integrated the vector into the introns of expressed genes in the correct orientation.
X-Gal and immunofluorescence assesses the sub-cellular and sub-nuclear distribution. B) The sequence
of trapped genes is established by 5' RACE. Products of the second PCR reaction are sequenced directly.
Primers used are the same as those used by Sutherland et al., 2001, and are described in section 2.3.2.
promoter, where the N-terminal amino acids are derived from the endogenous gene
and the C-terminal amino acids derived from the amino acids are derived from the
endogenous gene and the C-terminal amino acids derived from the (5-geo cassette.
X-Gal staining and immunofluorescence with an anti-P-gal (a-P-gal) antibody was
used to identify ES or F9 cell clones with nuclear fusion proteins that may
recapitulate the sub-nuclear localisation of the endogenous protein, if sequences that
determine sub-nuclear compartmentalisation are N-terminal to the site of gene-trap
integration (Sutherland et al., 2001). 5' rapid amplification of cDNA ends (5'
RACE), and sequencing of the products allowed a comparison of the sequences to
genomic databases to be identified as known or novel (Fig. 3.IB). The 5' RACE
protocol and the primers used were the same as those previously reported
(Sutherland et al., 2001) and are described in Table 2.3.
3.2 Characterisation of gene-trapped loci by
FISH
Initial characterisation of trapped genes required their chromosomal locations to be
identified because at the start of my PhD less KRAB-ZFP gene sequences and/or
expressed sequence tags (ESTs) were available in the databases, and their assembly
within the genome was either non-existent or in regions not yet sequenced. I took
advantage of the fi-geo cassette situated 3' to the endogenous gene sequence within
the gene-trap lines, to determine the chromosomal locations of gene-trap integration
sites by 2-D FISH analyses of metaphase spreads (section 2.9). Some KRAB-ZFPs
are very similar to each other, and a single gene on one chromosome can often be
related to multiple genes on different chromosomes (Bellefroid et al., 1993).
Therefore identification of chromosome location may also help to differentiate
between highly similar gene/protein sequences, which would otherwise be difficult to
distinguish. FISH can also rule out the possibility of more than one gene-trap
integration per gene-trap cell line.
Probe DNA (pGTl-3) was labelled with biotin and hybridised to metaphase spreads
from each gene-trap line (section 2.9). More than 20 metaphases from each gene-trap
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line were analysed by Muriel Lee and karyotyped from the DAPI banding pattern of
the chromosome on which the gene-trap signal was found. I then confirmed the
chromosomal location of the gene-trap in each cell line by co-hybridisation ofpGTl-
3 probe with the relevant commercial mouse chromosome paint labelled with FITC
(Fig. 3.2 and Table 3.1).
As expected, signal was detected on both chromatids of only one chromosome per
gene-trap line, accounting for integration of the gene-traps at single genomic
locations. Signal was sometimes detected on mouse chromosome 5 (MMU5) at the
endogenous mouse En2 locus (the only place in the mouse genome with sequence
homology to part of the pGTl-3 vector, i.e. the splice acceptor was derived from the
En2 gene). The analyses suggest that for cell lines ES9 and F9/30A6, the gene-trap
is on an abnormal chromosome in some of the cells. Although ES9 and F9/30A6 are
situated on MMU13 and MMU9 respectively, most of the cells in these cell lines
have abnormalities on these chromosomes, which may involve fusions with other
chromosomes. These abnormalities may be a consequence of the gene-trap
insertions or unrelated, but ultimately exclude the prospect of chimeric mice
generation with the ES cell line. Strikingly, 5 of the trapped genes (ESKN205,
ES261, ES492, ES510 and F9/30A6) appeared to map close to telomeres or
centromeres, in agreement with the literature as human KRAB-ZFPs are known to
have a biased distribution to telomeric, centromeric and/or fragile sites within the
genome, which also seems to be the case in other tetrapods (Lichter et al., 1992;
Eichler et al., 1998; Meiboom et al., 2004).
3.3 Sequence identification of trapped genes
I repeated 5' RACE and direct sequencing for each KRAB containing gene-trap line
previously reported (Sutherland et al., 2001), plus one additional but as yet
unpublished gene trapped in the same screen (ES cell line 492) in order to confirm
previous RACE attempts and to obtain better quality sequence data (Table 3.1).
Between 300-800 base pairs (bp) of 5' RACE sequence were obtained for all gene-
trap lines (Fig. 3.3) and were compared with other sequences in the GenBank and
Ensembl databases using the BLAST algorithm. The websites used for all
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Figure 3.3 Alignments of 5' RACE sequences
Nucleotide alignments of each RACE sequence with their nearest BLAST/Ensembl hit were performed
using the bl2seq algorithm at NCBI. Capital letters represent RACE sequence with no significant
similarity to other sequences in the GenBank and Ensembl databases. Numbers represent nucleotide
positions within the matching cDNA sequence and flank contiguous sections of similarity. Nucleotide
matches with En2 are boxed. Corresponding protein sequences of either the translated RACE sequence
and/or the matching cDNA are shown in italics and the KRAB box is underlined. The translated protein
sequence is reversed, but in the correct orientation. For ESKN205, the circled number designates the
end of the match between ESKN205 RACE sequence and AF051348.
Es9
cttgtatgtcttcgagaactttgacatggttcttcaatgtgatggtcttggnatttgtaacctat race





111 111 I I Til I II ITI I 11 I I II I I II I I I II I I I I I 111 II 111 I I I I I I I Til I I IT I II II
agaagtaaggttccagtaggtctccaacataacatctttgtagagattcatctgggaaggatcca
S T L N W Y T ELM V DKYLNMQS PPL
gcaaattccattcttctttagtgaagttcacatgcacatcgtcaaaagtcactgcatccatgtct




1111111iTiTi1111iTiTTi11ii1111iTi111 nii ill ill1111iliTiiTTi 111 ill
aaatctcagagcttcctgaggtcccctcaatgcacccgacagcagatctcagagcaggacacaga
gaaccattcaaccctgcacagccacagcgatcttctNAAAAAAAAAAAAAAAAAANNNTTNTANG











III I I I I I I I II I Mill II I II II 111 II I I I I ITI I I III I I I I I I III ITTI I I
agcattgaggttcctgtaggtctccaccatgacatctttgtagagcttcttctgggaaggatcca
A N L N R YTEVMVDKYLKKQS PPL
ncaacagcgccacacctcttgagtgaagttcacatgcaggtcctcataagtcactngcattcatq
I Mill II I I I II II II 111 11 I 11 I I II I ITllTTI II II II I I II II I I 1 II I I I I IT
gc-agagc-ccactcctcttgagtgaagttcacatgcaggtcctcataagtcact-gcattcatg
LA WEEQTF NVHLDEYTV A N M
tcgaacacgccgtagatcgctggcnaattccntaaggcccctggcaccaganattaaaacaaaan
111 I I IT I II III I III Mil II II II II I Till II Mill I III II II II II III
tcg-ccacgtcgtagatcgctggc-aattccctaaggcccctggcagcagagattaaaac-aaat
cagaccaagcttCGCAGGNCTGCTCCGAAACGGGANAGGGACACANANCACCGGNACTAANCNNA
















III II I I I I I I I I I I I I I I I I I I II I III II I I I I III II I I I I I II II
tgagcaaaattgag-acattcccattcttctga-tgag-aagtccaaaaacacatccttgaaggt
£_ N W K
taatatacactgtncaggtgttttccagnagaagnactcattcttttaattgttcttctcncana
I I I I I I I I I I I I III I I I I I I I I I I I I I I I I II I I I I I I II I I I I I I I I I I I II II I
taatagacactgtgcag-tgttttccag-agaagcactcattcttttagttgttcttctcccaga
_LLCQATNEL S A S M
ttcntnnnnnnnatcaaacattcaagttcntctggntccttggtnatagtctccttgacctttaa




















I I I I I I I I I II I I I I III II I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II
ccacagcatccaaccgcaggaaacggagcacggcacacagaaccattcaagcactcaaccaggaa
gcgaaacNCGA












iTTtiIIITTT Mil TTTII IITTIIITTTTI III I I I I ITTI I I IT lllTllIlT II
cgggacct ggggccaatgggctttggactggggcagaccttcggttctgt-tttgtaacgttctt
PGIPKPSPCVKPET K Y R E E
705 572
cagcaaccttcctcagcggtgtttccgtcagcgtcgctgatgcttcntctganattaatggtggc








II I I I I I I I II I I I I I I II I I II I I I I I I I I I I I II I I I I
ctggctcagctcggttccctgtccatccag-gacccacgggtcttctcctc














I II I I I I I II I I II I I I I I II II I I I I I II I II I I I II I I I I I I I I I I I I II II I II I I I
tccagcaaagcccattcttcctgagtaaagctcaccaggacatcatagtacgtcactgcgttctc
DLLAWEEQTFSVLVDY Y T V A N E
tgtgggaagtgacaatatcctcatcatgtcgcactttcagaacttgcctgagtttccttcacagt





















II I II II I I II II II II I II I II II II II II I I II I III
catgtctcagctgcggagc-tgcccgagcgcacgtcacagcgtca
M D - S R L QGLAR-LT
13
ATCACAGAAAAACGTTAAAGCCATCTAGATNANCNNACNACCCTGGNCT
computational methods in this chapter and throughout the rest of the thesis can be
mouse found in section 2.11. I also used the SSAHA (Sequence Search and
Alignment by Hashing Algorithm) at Ensembl with pre-defined optimised parameter
sets, to look for exact or 'almost exact' matches between the RACE sequences and
the genomic assembly. SSAHA is a faster tool than BLASTN for matching and
aligning DNA sequences with genomic assemblies. Predicted protein sequences for
each trapped gene were assessed for conserved protein domains and motifs using
InterProScan at EBI (European Bioinformatics Institute) and SMART (Simple
Modular Architecture Research Tool). For gene-trap sequences with known gene
and therefore protein sequences I used PSORT II to confirm that the nuclear
localisation observed in the gene-trap lines is the same as predicted for the
endogenous protein. PSORT II was also used to find the location of any nuclear
localisation signals (NLSs) or other signal peptides. However, since all trapped
genes were selected on the basis of their nuclear localisation, their NLSs must be
present either before the site of gene-trap insertion (and therefore contained in the
RACE sequence) or otherwise their localisation is achieved via transport along the
endoplasmic reticulum (ER) and nuclear envelope (NE) and/or complexed to other
NLS-containing proteins. The results of these searches are presented in Table 3.1
and as of the 25th October 2004, all data resulting from these searches is deemed to
be correct. A more detailed description of each gene-trap loci follows.
3.3.1 ES9
BLASTN analysis indicates that the ES9 RACE sequence has 97% identity over 296
nucleotides to Riken cDNA, AK082760, which encodes a peptide with a KRAB
domain (Fig. 3.3). Its protein sequence is only 95% identical to that encoded by the
RACE sequence because of unknown nucleotides (Ns) in the RACE sequence that
cannot be translated into amino acids (Fig. 3.3). ES9 and AK082760 are both 98%
identical over 265 nucleotides to AY 149175, a partial cDNA clone encoding known
mouse KRAB-ZFP, MZF6D (Fig. 3.4A). The match is in the region encoding the
KRAB domain and a portion of the 5' UTR. MZF6D has at least 7 ZF motifs and
was originally isolated from a mouse testes cDNA library (Abrink et aL, 2001) but
has only recently been deposited in GenBank and published as a member of the
92
newly identified KRAB A+C family (Looman et al., 2003). Despite various
attempts, a full-length cDNA clone for this gene has not yet been isolated (Looman
et aL, 2003). PSORT II predicts MZF6D to have a nuclear localisation and three
NLS can be found in the ZF region (two of which overlap) (Fig. 3.4A). All three of
the above sequences match to two overlapping Ensembl predicted genes within the
same contig (AC101221.11.45569.258193) located at -63.8 Mb on MMU13 in band
B3 (Fig. 3.4B). This mapping data is consistent with that obtained by FISH analysis
(section 3.2), although the ES9 cell line appears to be abnormal (data not shown).
The match is in the KRAB encoding region of MZF6D/ES9, however of the two
predicted genes (which share 95% nucleotide identity over this same region) only
one encodes an identical KRAB domain (ENSMUSG00000058671, NM_183119),
because an additional nucleotide in the remaining gene (ENSMUSG00000053212,
Q8BKS1) after the start codon shifts the translational reading frame. Since the
predicted genomic structures of neither gene seem to encode a full-length KRAB-
ZFP (the KRAB domain ofNM183119 is immediately followed by a STOP codon),
1 used the two-sequence alignment algorithm at NCB1 (bl2seq) to BLAST the
corresponding genomic sequence of this contig (AC101221.11.45569.258193) with
the exon sequences encoding MZF6D (5' UTR, KRAB A, KRAB C and ZF
domains) (data not shown). The results indicate that the 5' UTR, KRAB A and
KRAB C exons all match with 100% nucleotide identity to the genomic contig.
Moreover, this genomic clone contains a duplication of each of these exons which
share only -96% nucleotide identity over the same length of sequence.
Unfortunately, only 95% nucleotide identity is observed with the MZF6D ZF exon,
suggesting that this exon is either not contained within this contig or that there are
sequence discrepancies within either MZF6D and/or Ensembl. In fact, the ZF exon
has over 20 hits within this contig and all have greater than 75% nucleotide identity.
Collectively, this data implies that the DNA sequence contained in this genomic
contig is highly repetitive. The orientation of MZF6D within the contig suggests
that the ZF exon could be located in a contig upstream of this genomic clone, and
this is not the case. Unorientated upstream contigs are also separated by gaps in the
sequence and so the full genomic structure of this gene cannot be correctly identified.
This analysis confirms that MZF6D is composed of at least three exons, the first of
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which contains the 5' UTR and the start codon (ATG), the second and third encode
the KRAB A and KRAB C domains respectively.
Within the 1 Mb region surrounding this locus I can find ~10 different ZFP genes,
four of which also have a KRAB domain. The repetitive nature of ZF motifs and the
fact that many ZFPs are duplicated in this region expose the problem of sequence
assemblage in such regions and means that gene prediction programmes perform
badly here. These other KRAB-ZFPs have very different KRAB domains compared
to ES9/MZF6D and show only 40% to 50% protein homology over the full-length
sequence (data not shown). Therefore, these other KRAB-ZFPs belong to a different
subfamily of KRAB-ZFP genes in this region.
To identify if putative homologues in other species could help to decipher the
genomic structure of ES9/MZF6D I searched for syntenic regions in human and rat.
There is very little DNA sequence conservation between the mouse and human
genome over a 1 Mb region surrounding ENSMUSG00000053212 at 63.8 Mb on
MMU13 (data not shown) so I performed a SSAHA/BLASTN search of the human
genome with the MZF6D nucleotide and protein sequence. 1 could not find an
orthologous KRAB-ZFP gene or gene cluster in the human genome. The closest
matching protein has -48% identity over 269 amino acids confirming that some
genes very distantly related to MZF6D/ES9 may exist in humans, as postulated by
Looman et al. (2003). According to Ensembl, a break in synteny with the rat
genome exists at -63.9 Mb. MZF6D/ES9 lies -100 kb upstream and is one of the
last genes before the break. Although there are areas of sequence conservation
between MMU13 at -63.8 Mb with the telomere on the short arm of rat chromosome
14 (RN014p22), no homologous MZF6D gene appears to exist in this region and
neither does it contain any ZFPs of the Kruppel type (Fig. 3.4B). Post 63.9 Mb,
synteny is observed with RN07q22 and many genes are conserved in this region. A
SSAHA/BLAST search using both the nucleotide and protein sequences of MZF6D
indicates that MZF6D/ES9 is distantly related to numerous KRAB-ZFPs found on
different rat chromosomes, supporting previous northern blot data by Looman et al.
(2003). Most nucleotide and/or protein similarities (-61-68%) are found close to the
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telomeres ofRN012ql6, RN03q43 and RN01pl3 (data not shown). However only
RN01pl3 is a known ZFP cluster containing KRAB-ZFPs. Whether these genes
are true orthologues remains to be proven.
3.3.2 ES113
By BLASTN, ESI 13 RACE sequence matched a RIKEN cDNA clone (BC047396)
with 90% identity over 272 nucleotides (Fig. 3.3). BC047396 encodes a KRAB-ZFP
with 7 ZFs but the match is in the 5' UTR and KRAB domain portion of the cDNA.
-60% of the mis-matching nucleotides in the RACE sequence are unknown
nucleotides (Ns) therefore less amino acid identity is observed over this region
(71%). A SSAHA search at Ensembl confirms that both the RACE sequence and
BC047396 probably match genomic DNA fragments on MMU13 at around band B
or C, consistent with FISH mapping of ESI 13 to MMU13 band C. However, the
highest matches for both are in unorientated contigs that have not yet been assembled
into the genome. There are many large gaps between the sequenced contigs in this
region, probably due to assembly problems based on the repetitive nature of the
genome here, since clusters of ZFP and KRAB-ZFP genes are interspersed
throughout bands B3 to C2 on MMU13 (data not shown). Assigning a gene to
ESI 13 is therefore not possible based on the RACE sequence alone. To determine
whether rat and human orthologues of ESI 13 exist I performed BLAST/SSAHA
searches on the respective genomes with ESI 13 RACE sequence and BC047396
cDNA. Ensembl does not detect a human orthologue with either the RACE sequence
or BC047396, however MMEH3 (B3-C2) does appear to have a highly conserved
syntenic region in rat. A SSAHA search with ESI 13 RACE sequence shows hits
over a 39 bp region to the short arm of rat chromosome 17 (RN017pl4).
RN017pl4 is highly conserved with MMU13 band B3 and is also littered with
KRAB-ZFP genes (I detected at least 9 different KRAB-ZFP genes over a 1 Mb
region here). However, there are still many gaps in the rat sequence and some
contigs are unorientated suggesting that a genuine rat orthologue may be mis-
positioned. An SSAHA/BLASTN search with BC047396 reveals an 87% match to
RNOXq35 over -300 bp in the region of encoding the KRAB box. This match
precedes subsequent hits (>6) to RNO!7pl4 over a similar region of the KRAB box
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(data not shown). Whilst no portions of MMU13 between bands B and C are
syntenic to RNOX, it may be that ESI 13 is orthologous to more than one rat gene as
previously reported for other KRAB-ZFPs (Shannon et al., 2003) or that this contig
has been mis-assembled on RNOX. RNOXq35 is not associated with a KRAB-ZFP
cluster in this region but rather a single, isolated KRAB-ZFP seems to exist here. In
conclusion, the exact genomic location of an ESI 13 orthologue in rat cannot be
determined on RN017pl4 since the genomic location of ESI 13 is unknown,
however it is likely that one or more exists.
3.3.3 ESKN205
ESKN205 shares 80% (over 293 bp) and 81% (over 219 bp) nucleotide identity to
full-length mouse cDNA, BC058858 and mRNA, AF051348 respectively (putative
Rex2 mRNA) (Fig. 3.3). Both of these genes encode KRAB domains only and are
93% identical to each other at the nucleotide level but differ at individual bases
throughout the length of the sequence. Their KRAB boxes (also encoded in part by
the RACE sequence) are 86% identical at the protein level. However the RACE
sequence shows 83% nucleotide identity with the 5' UTR of BC058858 and this
sequence is not contained in AF051348 (Fig. 3.3). Therefore BC058858 and
AF051348 could be separate genes with a very similar KRAB domain. To verify
this, I used the BLASTN algorithm at Ensembl to find out which part of the mouse
genome the clones and RACE sequence map to. As expected, both of these
sequences and the RACE map with the highest percentage identity and lowest e-
value, to genomic DNA in band El on MMU4 consistent with FISH mapping of
ESKN205. However BC058858 and AF051348 map on opposite strands of adjacent
contigs (Fig. 3.5A). AF051348 matches to Ensembl predicted gene,
ENSMUSG00000061969 at —145.2 Mb. This gene is associated with -10
transcripts, 8 ofwhich encode a KRAB box in association with -13 ZFs. The RACE
sequence shows 73% protein identity to ENSMUSG00000061969 in the KRAB box
region. BC058858 matches to Ensemble predicted gene, NM145078, located on the
opposite strand of the adjacent contig at -145.5 Mb on MMU4 (Fig. 3.5A).
Translation from the predicted start codon (ATG) in NMJ 45078 results in a
putative protein, BAB27959.1 (putative Rex2) that contains the latter part of the
96
A) gaattccggggttctctgtgtcctgctctgagatctgctgttgggtgcattgaggggacctcaggaagctctgagatttagacatQaatacaataacttttaacaatatacatataaacttcactaaaaaaaaataaaatttQctaaatccttcccaaataaatct
M D A "]VT FD D v h M N F Tk E E W N l l D P s Q M N l]
ctacaaagdtqttatqtrqqaga..'L-tactgjaacct tact tatataqqttacaaa t qgqa a qa c ca t. ca ca c l gaagaa cc at.
I Y K D V M L E T Y W N L T S I i G Y K WED h h I E E P |
qtcaaaattctcaaaaacatacabaqcatgtaaqaaqtcataqttqqaaqaaactctatqaatqtaatcaatqtqqtaaaqcct
^QSSRRHT^R H Vl RSHSw'KKL YECNQCGKA
tttcctctcacagtagtctcagatatcataaaagaacccatactggagagaaaccttatgaatgtaatcattgtggtaaagcct
FSSHSSLRYHKRTH T G E K P YECNHCGKA
ttgcaacacccagtcatctccaaagacataaaagaacccatactggagagaaaccttatgaatgtaatcaatgtggtaaagcct
FATPSHLQRHKRTH T G E K P Y'ECKQCGKA
tttcctctcacagtaatctcaaatatcataaaagaaaccatactggagtaaaaccttatgaatgtaatcaatgtggtaaagtct
P :■ H G N K Y H K H N H T G V K P YECNQCGK'
ttgtagcaactactactctccgaagacataaaagaacccatactggagagaaaccttatgaatgtaatcaatgtggtaaagcct
FVATTTLRRHKRTH T G E K P YECNQCGK
tttcctgtcacagtagtctcatatatcataaaagaacccatactggagagaaaccttatgaatgtaatcaatgtggtaaagcct
FSCHSSLIYHKRTH T G E K P YECNQCGKA
tttcctgtcacagtagtctcagatgtcatgaaagaacccatactggagagaaaccttatgaatgtaatcaatgtggtaaaacct
ttgacatccagtcatctacaatgtcataaaagaacccataccggagcccggaattc
fatsshlqchkrth t g a r n
B ) d Top level
'■■■■■ '■■■■ 1 u a [i r:-. i■. ■ I•.I
ut. ill-, if- —
3 Overview
Hi. Ml'. 11! Lull I
HJ. iIatFI ~








ENSHUSTO 0 0 0 0 082 0* 0 ENSHUS TO 0 0 0 0 069694
Vi T
I NH_183119 I
63.86 Mb 63.87 Hb
HI
Rat 160.00 Kb 170.00 Kb 180.00 Kb 190.00 Kb 200.00 Kb 210.00 Kb 220.00 Kb 230.00 Kb 240.00 Kb 250.00 h





160.00 Kb 170.00 Kb 180.00 Kb 190.00 Kb 200. 00 Kb 210.00 Kb 220.00 Kb 230.00 Kb 240.00 Kb 250.00 Kb
ni
Figure 3.4 The sequence, genomic location and orthology of MZF6D/ES9
A) MZF6D partial cDNA sequence (lower case) with corresponding protein sequence (upper case).
Bold text represents the start codon. The KRAB A and C domains (open and shaded boxes) are indicated
and the ZF motifs are underlined. The gene-trap integration is located after arrowhead. A portion of the
5' UTR is shown preceding the start ATG and the potential NLSx3 in the ZF domain are shown in bold
italics (the latter two overlap). B) Ensembl predicted genes (NM183119 and Q8BKS1) are shown in
their genomic region on MMU13 in band B3 (open boxes). Other KRAB-ZFPs in the surrounding region
are circled. A multi-contig view of the rat syntenic region (RN014p22) is shown and the amount of
sequence conservation is indicated (pink/purple blocks).
KRAB domain and 5 ZF motifs. However this putative start codon does not have an
identical match to the Kozak consensus sequence (A/GNNATGGG) (Kozak, 1986).
On further inspection, I found that an ATG codon immediately upstream of the
predicted start ATG results in a transcript that exactly matches BC058858. The
standard genomic structure of a KRAB-ZFP gene normally spans 4 exons depending
on the KRAB domain family to which it belongs (Shannon et ah, 1998 and
references therein). The first exon generally contains the 5' UTR and/or the start
ATG. The second and third usually contains the KRAB box (depending on whether
an A, B/b or C box is present) while the last exon contains the ZFs. The Ensembl
predicted transcript does not conform to this standard whilst the genomic structure of
BC058858 does. 1 therefore conclude that the gene trapped by ESKN205 is
NM_145087, and although this transcript encodes a KRAB only protein, the use of a
second ATG codon further downstream can change the reading frame and result in a
Kriippel type ZFP protein with truncated KRAB box. Hence, it is plausible to
speculate that cryptic splices sites within this transcript could operate to join together
these two separate functional domains. KRAB-only containing proteins have
recently been identified as functional proteins with roles in transcriptional repression
(Li et al., 2003; Oh et ah, 2005). PSORTII predicts BC058858 to be localised to the
nucleus and it has an NLS (KRHK) in the C-terminus that may be responsible for
this. Gene-trap localisation data confirms this prediction (Chapter 4).
I counted ~5 other ZFPs in a 1 Mb region surrounding NM 145078, and checked for
the presence of other KRAB-ZFP genes which may harbour a similar KRAB domain.
Apart from the two genes above, a third gene, NM198619 also contains a KRAB
box. However it has only 36% amino acid identity with the RACE sequence and is
clearly a different gene (data not shown). Although 100% nucleotide identity is not
shared between the ESKN205 RACE sequence and NM_145087 (because of the
quality of the RACE sequence), ESKN205 does share sequence identity with the 5'
UTR of NMJ45087 and not with ENSMUSG00000061969 (AF051348). The
assembly in this region contains no unorientated contigs or gaps, therefore it is
unlikely that ESKN205 is another gene very similar to the two described above. I
therefore postulate that NM_145087 is likely to be ESKN205, which is a paralogous
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gene to the AF051348 transcript (Rex2) and both belong to a larger sub-family of
KRAB-ZFP genes within this 1 Mb region. NM_145087 is likely to be the result of
a duplication and subsequent inversion of the full-length KRAB-ZFP gene,
ENSMUSG00000061969, which is associated with many Rex2 type transcripts
including AF051348.
According to Ensemble, there is little sequence conservation between MME14 at
-145 Mb and the human syntenic region. However, there is strong sequence
conservation with RN05q36 (Fig. 3.5A). A predicted rat KRAB-ZFP gene
(ENSRNOG000000247078) shares -70% amino acid identity with the KRAB
domain of both ENSMUSG00000061969 and NM 145087 whilst -48% identity is
observed over the entire coding region. Consequently, an orthologous rat gene does
exist but it is predicted to encode up 16 ZF motifs depending on the transcript. This
suggests that it is an orthologue of ENSMUSG00000061969 since different
transcripts of this gene also encode many ZF motifs. In support of this hypothesis,
both of these genes seem to be of a proportionate length and span the same length of
genomic sequence in either genome. In light of these observations I could not find a
duplicated copy of the rat orthologue in its immediate vicinity, supporting the
hypothesis that the duplication of NM 145087 is mouse specific, although the rat
assembly does contain gaps in this region.
3.3.4 ES261
ES261 RACE sequence matches with 83% (over 91 bp) and 87% (over 79 bp)
nucleotide identity to partial cDNAs AK045713 and AK021061 respectively, which
are both 100% identical to each other over a 91 bp region and described as being
similar to the KRAB-ZFP Kriippel-ZFP F80-L (Fig. 3.3). Most mis-matches in the
aligned region can be explained by Ns in the RACE sequence and the aligned
sections are separated by -300 bp of sequence for which the RACE sequence quality
is extremely poor. According to Ensembl, the matching portions of AK045713 and
AK021061 map to exactly the same genomic location at the very tip of MMU16 in
band C4 at -98.8 Mb, although recently the full AK045713 cDNA was found in an
unassembled contig. The RACE sequence also BLASTS to this region and FISH
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analyses confirm gene-trap integration into the telomeric region of MMU16. The
RACE sequence matches both of these cDNAs in the region upstream of the KRAB-
domain corresponding to the 5' UTR. However, the ES261 RACE sequence is of
poor quality in the likely KRAB encoding region because it contains -21% unknown
nucleotides. A frameshift mutation also occurs in the RACE sequence thus direct
translation results in protein sequence, which does not match the putative protein
encoded by AK045713 with any similarity. Since matching sequence is in the 5'
EfTR, one cannot compare the amino acid similarity. The start codon of AK045713
is after the match with the RACE sequence. Moreover, the product of translated
AK045713 appears to be a truncated KRAB-ZFP, containing the KRAB domain only
but no ZF motifs. An in frame stop codon after the first 64 amino acids of
AK045713 suggests that this cDNA could be an example of a KRAB domain-only
containing protein rather than an alternatively spliced isoform. PSORTII predicts
AK045713 to be a nuclear protein in agreement with the gene-trap localisation data
(Chapter 4).
Only three ZFP genes (none of which contain a KRAB domain) are found within a 1
Mb from the telomere of MMU16, all of which have orthologues on RNOHql2.
Orthologous genes are also observed in the human (HSA21q22.3) and chicken
genomes (GGA1, -102.8 Mb) (data not shown). However, gaps in the mouse
genome at this location and unassembled contigs are preventing the ES261
orthologous gene from being identified and I could find no KRAB-ZFP genes in the
same region in either of the other genomes.
3.3.5 ES492
I compared the ES492 RACE sequence with all sequences available at NCBI
GenBank and Ensemble. This revealed 94% nucleotide identity with hypothetical
mouse mRNA, NM 172817 (Fig. 3.3), which encodes the KRAB-ZFP, ZFP647
(6030449J21). The translated RACE sequence has only 65% identity with Zfp647,
because of the number of Ns in the sequence but no other KRAB-ZFP in the mouse
genome showed similarity with the RACE sequence in a TBLASTN search (data not
shown). A genomic clone (AY 187287) located in band El on MMU15 was found
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to contain NM_172817, which spans -7.69 kb of genomic DNA (between 78.13 and
78.14 Mb) on MMU15 (Fig. 3.5B) consistent with FISH mapping. Its predicted
protein coding sequence constitutes 4 exons separated by 3 introns, as expected of a
KRAB-ZFP with more than one KRAB box (Fig. 3.5B). An exon containing only 5'
UTR is found upstream. There are two ZFPs -200-300 kb either side of this gene,
neither of which contains a KRAB domain although a KRAB-ZFP is found -500 kb
downstream. This region of MMU15 is highly conserved on RN07q34 and an
orthologous gene exists (ENSRNOG0000004523). In humans, the orthologous gene
(.ZNF647, NM_021061) is at the telomere of HSA8q24.3, just before a break in
synteny with the mouse genome (gene search, NCBI). The most recent version of
Ensembl does not recognise this homology although previous releases have and have
annotated the human orthologous gene (data not shown). Orthologous genes in all
species above encode a highly conserved KRAB-ZFP with a KRAB box and 13 ZF
motifs. 81% and 96% amino acid identity is found between the human and mouse,
and rat and mouse proteins respectively (Fig. 3.6). This conservation in amino acid
sequence highlights a possible important function for this protein. Such high levels
of similarity are often seen between orthologous KRAB-ZFPs (Jheon et al., 2002).
In the case of ES492, the KRAB and ZF domains of mouse and rat are 100%
identical. In humans 89% and 98% identity is found between the KRAB and ZF
domains respectively. The linker regions are less conserved with 86% identity
between mouse and rat orthologues whilst an additional 21 amino acids are found in
the human protein. The similarity in the ZF region implies that this protein in all 3
species regulates the same genes.
3.3.6 ES510
ES510 has 90% nucleotide identity (Fig. 3.3) and 76% amino acid identity with
known gene L20450 (MUSDNABPZ/Zfp97), as previously confirmed (Sutherland et
al., 2001). Zfp97 is a KRAB-ZFP with 13 ZFs and was first identified as a novel
cDNA expressed in neuroblastoma cells (Wick et al., 1995). Ensembl identifies
L20450 to be located in a currently unknown contig, which is not yet sequenced, but
is probably located somewhere on MMU17. The RACE sequence is situated in a
contig known to be located on MMU17 on the boundary between band A2 and A3 (a
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Figure 3.5 Genomic location and ortholology of ESKN205 and ES492
A) Ensembl predicted genes (NM_145087 and ENSMUSG00000061969) are shown
on MMU4, band El (open boxes). A multi-contig view of the rat syntenic region
(RN05q36) is shown and the orthologous rat gene is circled. B) Ensembl predicted
gene, NM 1 72817, is located on MMEf 15, band El at —78.14 Mb (open box). The
transcript encodes 4 exons (numbered 1-4), with the largest containing the ZFs (4).
The syntenic region and orthologous gene in rat is indicated by a corresponding black
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region just below the centromere), in accordance FISH mapping. However, although
the assembly in this region is very poor and contains many gaps, a 4 kb region with
high sequence conservation to RN01ql2 can be found (data not shown). At this
same region there is a break in synteny with the human genome, where a syntenic
boundary between HSA5 and HSA19 meets. I BLASTed L20450 at Ensembl and
searched for possible orthologous genes in the rat and human genomes. However,
since the genomic location of L20450 is unknown, no direct orthologues could be
identified in either species. The best protein match in humans is ZNF442 and is
found on HSA19pl3.2. ZNF442 (NM152601) has 52% amino acid identity with
Zfp97 and is a KRAB-ZFP with 16 ZFs. ZNF422 is situated in a ZFP cluster on
HSA19pl3.2, a chromosome that contains a disproportionately large fraction (—1/3)
of human KRAB-ZFPs, and this region is proposed to be rapidly expanding
(Shannon et al., 2003). The mouse syntenic region is unknown, because this part of
the human genome is associated with a break in synteny with the mouse genome.
Therefore ES510/Zfp97 appears to be mouse specific. PSORTII also predicts
L20450 to be a nuclear protein.
3.3.7 F9/30A6
BLASTN identified that F9/30A6 is 93% identical at the nucleotide level to an
mRNA expressed in brain, BC050776, but this identity is within the KRAB encoding
region only (Fig. 3.3). The sequence upstream of the KRAB box lacks any identity
with the RACE sequence. At the protein level, the KRAB box of BC050776 is 92%
identical to the translated RACE sequence enforcing that these two genes may at
least share the same KRAB encoding exon. A BLASTN search at Ensembl
demonstrates that both the RACE sequence and BC050776 show similar alignments
to regions scattered on at least 10 different chromosomes (data not shown).
Although none of these regions map to the telomere ofMMU9, which is the site of
gene-trap integration determined by FISH mapping (section 3.2); it is worth noting
that the highest scoring hits are Ensembl predicted transcripts, which are located in
contigs that have not yet been assembled in the mouse genomic database. Therefore,
Ensembl cannot predict the genomic location of F9/30A6. Sequences with unknown
genomic locations are often associated with portions of the genome that contain
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highly repetitive sequences, making individual genomic fragments difficult to
consign. This may be the case for the above, suggesting that F9/30A6 may be a
member of a KRAB-ZFP cluster and/or be paralogous to other mouse KRAB-ZFP
genes. BC050776 encodes a KRAB containing protein with no ZF motifs due to an
in frame termination codon after the KRAB domain. It is therefore possible that
F9/30A6 also lacks ZFs. I searched for orthologous sequences within the rat and
human genomes and in contrast with the human genome; at least 10 different rat
chromosomes produced nucleotide alignments with both BC050776 and the RACE
sequence. The best-hit rat protein is an Ensembl predicted protein that has 67%
identity to BC050776, but this is based solely on the KRAB domain, a region which
often shows high levels of protein similarity even though they are not orthologous
(Bellefroid et al., 1991). In human, the highest scoring nucleotide matches were on
HSA19pl3.2 but these hits are only found when the filters are removed. No
nucleotide matches are obtained with the standard Ensembl filter sets. A BLASTP
search of the human genome at Ensembl using the standard filter sets shows the best
protein match is also present on EISA 19p 13.2 but is only -58% identical to translated
BC050776. Taken together I conclude that no orthologous gene exists in humans
and since I do not know the precise genomic location of F9/30A6 in mouse, a
specific rat homologue can neither be assigned, although it is likely one exists.
In summary, I have described the identification of 2 previously identified (ES9 and
ES510) and 5 novel KRAB domain-containing genes. Of these novel genes, 3 are
located in known genomic locations (ESKN205, ES261, ES492). Surprisingly, 3
genes are found to be most similar to KRAB-only containing proteins. So far, only 2
KRAB-only genes have been published and have functional roles. Although the
ESI 13 and F9/30A6 genes could not be identified during the course of this thesis,
significant improvements in the genomic databases over three years has made their
initial study possible. The gene-trap has not preferentially integrated into any
particular chromosome since out of 7 gene-trap lines, 6 locate to different
chromosomes. However, although the actual genomic structure of most genes is
unknown, there does seem to be a preference as to where the gene-trap integrates
within the gene. In all cases, integration is after the KRAB domain, as each RACE
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sequence contains either the 5' UTR and/or the KRAB box. Presumably the vector
inserts into the intron separating the KRAB and the linker region/ZF coding exons.
This might be expected since the ZF are encoded in a single exon and this intron is
generally the largest in size when compared to the introns separating the 5' UTR and
KRAB containing exons (Phillipe Gautier, Pers. Com.). Less likely is the possibility
that the DNA in this region has a particular conformation that allows better access
for the gene-trap vector. There is no preference for integration into sites of
individual or clustered KRAB-ZFP genes and both are represented in this analysis,
but the preferred distribution of KRAB-ZFPs in particular genomic regions (Lichter
et al., 1992) is demonstrated by the fact that 5 of the trapped genes are close to either
telomeric or centromeric regions. It is interesting to note that some of the murine
KRAB-ZFP genes in this study are orthologous to either rat genes alone (ES9,
ESI 13, ESKN205) or both human and rat genes (ES261, ES492), suggesting that
some of the gene-trap KRAB proteins are conserved between species and may
therefore have fundamental functions.
3.4 Characterisation of KRAB sub-famiiies
KRAB-ZFPs are divided into 4 sub-families on the basis of their KRAB domain.
The newly identified KRAB C domain, once thought to be part of the linker region,
has recently been described and is always found in conjunction with a KRAB A box.
The 21 amino acid KRAB C domain is encoded by a separate exon and appears to
strengthen the interaction between the KRAB domain and KAP-1 as indicated by
yeast two-hybrid experiments (Abrink et al., 2001; Looman et al., 2003), although it
does not seem to affect the potency of transcriptional repression as indicated by
repression assays with GAL4 DBD-KRAB fusion proteins in mammalian cells
(Abrink et al., 2001). Therefore, the KRAB C domain may have physiological
implications for transcriptional repression by KRAB-ZFPs (Looman et al., 2003).
1 used the CLUSTALW algorithm at EBI to produce alignments of the KRAB
domains found in the gene-trap screen. I firstly aligned all the KRAB A domains
encoded by either the translated gene-trap sequence or its closest matching gene,
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mouse ILGLPGSKPVVT SOT.ERGEDPWvUdGOGTELSOS LGS DH S 94
rat LGL PGS KPVVI SQLE RGEDPWVLDGQET E LSQGLGS DHS 94
human LGLPGSKPDIISQLERGEDPWVLDRKGAKKSQGLWSDY SDNLKY DHTTACTQQDSLSCPW 120
mouse ECKAKEENQNTDLNVPPLI£>DBASATLTETPLRKVAEERY KTEPKVCPSPKPIGPQNAHG 154
rat ECKAKEENQNTDSNAQPLISDEASAMLAETPLRKVDEH-Y KTEPNFCPS PKSVGPQNAHV 153
human ECETKGESQNTDLSPKPLIS-EQTVILGKTPLGRIDQENNETKQSFCLSPNSVDHREVQV 179
mouse LNPSVPVARPOTAPSVERP I CIECGKCFGRSSHLLQHQRIHTGEKPYVCHVCGKAFSQS 214
rat LNPSVPVARPQMAPSGERPYI CIECGKCFGRSSHLLQHQRIHTGEKPYVCHVCGKAFSQS 213
human LSQSMPLTPHQAVPSGERPYMCVECGKCFGRSSHLLQHQRIHTGEKPYVCSVCGKAFSQS 239
mouse SVLSKHRR I HTGEKPY ECNECGKAFRVS S DLAOHHKI HTGEKP H F, C I, ECGKA FTQ L S H L 1 274
rat SVLSKHRRIHTGEKPYECNECGKAFRVSSDLAQHHKIHTGEKPHECLECGKAFTQLSHLI 273
human SVLSKHRRIHTGEKPYECNECGKAFRVSSDLAQHHKIHTGEKPHECLECRKAFTQLSHLI 299
mouse OH OR I HTGERPY VC PLCGKAFNHST VI.RS iiQRViiTGSKPHGCS ECGKT FS VKRT LLQHQR 334
rat QHQRIHTGERPYVCPLCGKAFNHSTVLRSHQRVHTGEKPHGCSECGKTFSVKRTLLQHQR 333
human QHQRIHTGERPYVCPLCGKAFNHSTVLRS HQRVHTGEKPHRCNECGKT FSVKRTLLQHQR 35 9
mouse VHTGEKPY TCSKCGKAFSDRS VP i 0HUN VHTGEKPY F.CS ECGKT FS H RSTLMN H ER I HTQ 394
rat VHTGEKPY TCSECGKAFSDRSVLIQHHNVHTGEKPY ECSECGKTFSHRSTLMNHERIHTQ 3 93
human IHTGEKPYTCSECGKAFSDRSVLIQHHNVHTGEKPYECSECGKTFSHRSTLMNHERIHTE 419
mouse EKPY ACY ECGKAFVOHS HLIOHORVHTGEKPY VCGECGHAFSARRSI, IQHF.R I HTGEKPF 454








Figure 3.6 Protein alignment of KRAB-ZFP 492 homologues
The CLUSTALW algorithm was used to align KRAB-ZFP 492 protein sequences from human
(NM_021061), mouse (NM_172817) and rat (ENSRNOG0000004523). Identical amino acids are
highlighted. The KRAB domain is boxed and the ZF motifs are underlined. Red text indicates the
sequences used to make antibodies. Bold italics represent antigenic regions in the linker sequence
as predicted by PIX analyses.
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by Mark el al. (1999) (Fig. 3.7A). ES510/Zfp97/DNABPZ, ESI 13, ES9, F9/30A6
and ES261 were found to be members of the KRAB A family. Those proteins with
an A box similar to those observed in conjunction with a B box (ESKN205 and
ES492) were further aligned with known B and b boxes from 8 mouse KRAB-ZFPs
also used in the initial study (Fig. 3.7B). This shows ES492 to be a member of the
KRAB A+B family. ESKN205 was found to lack a B box, even though it aligns
within the A+B family. This has been reported for other KRAB-ZFPs (Mark et al.,
1999) and suggests that the B box may either not exist, or be differentially spliced, in
this isoform. I favour the former since in this case some similarity can be seen with
the highly divergent B box, but it seems that ESKN205 has further diverged from
this consensus and this sequence may be a remnant of a previous B/b box. With the
KRAB A family members, I aligned the 21 amino acid region subsequent to their
KRAB A box with 14 known KRAB C containing mouse KRAB-ZFPs, identified in
a recent study by Looman et ah, (2004). ES9 (MZF6D) and ES510
(Zfp97/MUSDNABPZ) were already known to contain a KRAB C domain and had
been previously aligned in this study. Out of the 3 remaining sequences, ESI 13 and
ES261 were also found to contain KRAB C boxes (Fig 3.7C). The protein sequence
of F9/30A6 deteriorates after the KRAB A domain preventing further analysis with
the C box although the RACE sequence suggests that a 21 amino acid long domain
may be present.
Of the possible 4 KRAB-ZFP families, 3 are represented in this gene-trap panel (A,
A+C, A+B). ESKN205 appears to be a KRAB A+B family member without a B
box. A few residues were conserved with the b box so ESKN205 may represent a
I
KRAB-ZFP whose b box has rapidly diverged. The KRAB A+B family is thought to
'
be the origin of both the KRAB A+b and KRAB A families (Looman et al., 2002).
' This is based on the fact that all human members of the KRAB A+b family are
< located in one single cluster on chromosome 19 (ZNF45 family; Dehal et al., 2001)
1 and some genes encoding KRAB A-ZFPs completely lack the B/b encoding exon
1 (Vissing et al., 1995; Mark et al., 1999). The discovery of the KRAB C box and the
£ results presented here indicates that this may not be the case. Since all human KRAB
t C containing KRAB-ZFPs are found on chromosome 19, one might be tempted to
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speculate that the KRAB C box diverged subsequent to the KRAB A+ B family, as is
the case with the A+b family. However, in mice, KRAB C containing proteins are
found on chromosomes 7, 17, 11, 13 and 16 (Looman et ah, 2004 and this thesis) and
in both isolated KRAB-ZFPs (ES261) and in ZFP clusters (ESI 13) further
supporting the KRAB A+C family as a founder family. The only two KRAB-ZFPs
found in vertebrates other than mammals are Xenopus Xfin and chicken cKrl. They
both have KRAB domains that fall into the A+B family based on comparative
alignments of their ZF regions with those of mouse and human (Looman et ai,
2002). In this study, the relationship between each KRAB sub-family is the same
regardless of the region used to perform alignments (Looman et al., 2002). Whether
a domain similar to the KRAB C box exists in these vertebrates remains to be
determined. The fact that 4 of the KRAB-ZFPs (possibly 5) contain a KRAB C box
may signify an as yet uncharacterised importance for this domain. Whilst the KRAB
C is not obviously required for gene repression its high conservation suggests it may
be responsible for vital protein-protein interactions that remain to be identified. The
presence of a KRAB A and B box in ES492 suggests that this protein does not
belong to any larger sub-family of KRAB-ZFP genes and is possibly an ancestral
gene. In support of this, only one other KRAB-ZFP gene possessing a significantly
different KRAB domain is found -500 kb downstream. ES261 and ES492 would
both be postulated to be ancestral genes since they are in orthologous regions in
human and rat.
3.5 Cloning and structural analyses of KRAB-
ZFP 492
Since strong identity was found between the ES492 gene-trap RACE sequence and
hypothetical Zfp647, 1 decided to sub-clone and sequence (section 2.2.13) the cDNA
encoding KRAB-ZFP 492 (EST BI656339, IMAGE clone 5326813) to ensure that
the whole coding sequence of the gene was present in the IMAGE clone. The
primers used for all sequencing reactions of ES492 are shown in figure 3.8B (arrows)
and these have been used for all confirmations of 492 sequences throughout this





























































































Figure 3.7 CLUSTALW alignments of gene-trap KRAB domains
CLUSTALW alignments of the KRAB A (A), KRAB B (B) and KRAB C (C) domains were performed.
The consensus sequence of each KRAB family is shown (taken from Mark et al., 1999) and conserved







5 A K I V T F E D V A V L L S Q E E W A I
grp
149 cgcctgggccctgctcagcggggcctctaccgacacgtcatgatggagacctacgggaatgtagtctcactgggacttccagga











173 ! YICIECGKCFGRSSHLLQHQRIHT G E K
653 ccctacgtatgccatgtatgcggaaaggctttcagccagagttccgtcctgagcaagcacaggcggatccacacgggcgagaag
201 P YVCHVCGKAFSQSSVLS I H T G E K
737 ccctacgagtgtaacgaatgtgggaaagcctttcgcgtgagttccgaccttgcccagcaccacaagatccacaccggagagaag
229 P Y E C N E C G K A F R V S S D L A Q H H K I H 'I' G E K
821 cctcacgagtgtctggaatgtgggaaggcgttcacccagctctcccacctcatccaacatcagcggatccacacgggggagcgg
257 P HECLECGKAFTQLSHLIQHQRIHT G E R
905 ccctacgtgtgtcccttgtgtgggaaagccttcaaccacagcaccgtcctgcggagccaccagagggtgcacactggggagaag
285 P YVCPLCGKAFNHSTVLRSHQRVHT G E K
989 cctcacgggtgcagcgagtgtgggaagaccttcagcgtgaagaggacgctgctgcagcaccagcgggtgcacaccggggagaag
313 P HGCSKCGK T F S V K R T L I, Q H Q R V H T G E K
1073 ccctacacgtgcagcgagtgcgggaaggccttcagcgaccgctccgtgctcatccaacatcacaacgtacacactggggagaag
341 P Y T C S E C G K A F S D R SVL1QHHNVH T G E K
1157 ccgtacgagtgcagcgagtgcggcaagacctttagccaccgctccaccctgatgaatcacgagaggattcacacgcaggagaag
369 P Y E C S E G G K T F SHRSTLMN H E R I H T Q E K
1241 ccctacgcgtgctacgagtgcgggaaggcctttgtccagcactcgcatctcatccagcatcagagagtccacacgggagagaaa
397 P Y A C Y E C G K A F V Q H S H 1, I Q H Q R V 1-1 T G E K
1325 ccctacgtgtgtggcgagtgtggccatgctttcagcgcacgccggtccctgatccagcatgagcgaatccacacaggcgagaaa
425 P Y V C G E C G H A F S A R R S I. I Q_H_E R I H T G E K
1409 ccctttcagtgcacagagtgtggcaaagccttcagcctgaaagcaactctgatcgtgcacctgaggacccacacgggcgagaaa
453 P FQCTECGKAFSLKATLIVHLRTHT G E K
1493 ccctatgagtgcaatagctgcggcaaggcgttcagccagtactcggtgctcatccaacaccagaggatccacaccggagagaaa
481 P YECNSCGKAFSQYSVLIQHQRIHT G E K
1577 ccctatgagtgtggcgagtgcggacgggccttcaaccagcacggccacctgatccaacatcagaaagtacacaagaagctgtga







Figure 3.8 Sequence of KRAB-ZFP 492
A) Cartoon of protein domains present in KRAB-ZFP 492. Arrowhead indicates location of gene-trap
insertion. B) KRAB-ZFP 492 cDNA sequence with corresponding protein sequence. Bold text and
asterix represents the start and termination codons respectively. The KRAB A and B domains (open and
shaded boxes) are indicated and the ZF motifs are underlined. Brackets designate exon/intron boundaries
with conserved splice sites. The site of gene-trap integration is indicated by an arrowhead between 449
and 450 bp. The 5' and 3' UTRs are shown in capital letters with the location of the pA signal italicised
in bold in the 3' UTR. Red text indicates protein sequences used to raise antibodies. Antigenic portions
of the linker region, as predicted by PIX analysis, are italicised in bold. Blue text represents potential
NLS. Sequencing primers used for cloning are shown by arrows. Dashed arrows indicate primers used
for genotyping (Chapter 6).
no
cDNA clone, I deduced that KRAB-ZFP 492 gene has an mRNA of >2110 bp (Fig.
3.8B). It encodes a predicted protein of 536 amino acids (Mw= 59.87 kDa, pl= 8.39)
commencing from the first ATG codon present at nucleotide 53 to the termination
(TGA) codon located at nucleotide 1638. The sequence around the proposed
initiating ATG is similar to the Kozak consensus sequence (A/GNNATGG) (Kozak,
1986) and a potential pA signal (ATTAAA) is found in the 3' UTR at nucleotide
position 2084, and forms the start of the polyA (pA) tail.
The entire gene is separated into the standard 4-exon structure observed with most
other KRAB-ZFPs (Shannon et al., 1998 and references therein). The first exon
contains 5' UTR, a small N-terminal sequence and the initiation codon. The second
and third exons contain the KRAB A and B box respectively, whilst the last and
largest exon contains the linker region, all 13 ZFs and the translation stop codon.
Each of the zinc fingers conform exactly to the consensus sequence
CX2CX3FX5LX2HX3H and are connected by the H/C link consensus sequence
TG/QEKPY, suggestive of a role in DNA binding (Nagaoka et al., 2001). This
consensus is typically found in members of the KRAB C2H2-type zinc finger family.
A linker region of 96 amino acids separates the KRAB domain from the ZFs and a
NLS is present in the second ZF at amino acid position 219 (K1TRR), although the
gene-trap fusion which lacks the ZF is nuclear so either alternative NLSs exist or it is
nuclear via interaction with other proteins, e.g. KAP-1. The length of the introns
between each of these exons is 203 bp, 228 bp and 5053 bp respectively. I
confirmed the predicted exon-intron boundaries by aligning the full-length IMAGE
clone cDNA with the genomic DNA sequence (AY187287) (Fig. 3.8B). Each
boundary obeys the consensus splicing signals, where gt and ag dinucleotides are
located at the 5' donor and 3' acceptor sites, respectively. However, I compared the
RACE sequence to both the genomic DNA and cDNA, and discovered that the gene-
trap has not inserted into the final and longest intron of this gene as envisaged, but
has inserted into the final exon (exon 4) probably by utilising a cryptic splice donor
in the En intron after vector insertion, causing En sequence (Fig. 3.3) to be in frame
with ES492 at nucleotide position 499 (Fig. 3.8). The insertion of this gene-trap
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construct into the exons of trapped genes is not a novel occurrence and -15% of
clones have previously been trapped in this way (Bill Skarnes, Pers. Comm.).
3.6 Discussion
The abundance of KRAB-ZFPs in mammalian genomes may suggest why seven of
such genes have been isolated of the hundred or so genes trapped in ES cells
(Sutherland et al., 2001). Furthermore, although many have been postulated to have
a lineage-specific role during development, these genes must be expressed in ES
cells to allow them to be detected by our screening system. The number and quality
of KRAB-ZFP gene sequences contained in biological databases has improved over
the time course of this PhD, enabling characterisation and comparison of these gene-
trap proteins. The chromosomal locations of some of the gene-traps have been
predicted by Ensembl based on BLAST hits with assembled contigs (section 3.3), but
FISH mapping of gene-trap integration sites has proved to be vital in enforcing these
Ensembl predictions. For example, Ensembl suggests that similar sequences
matching the F9/30A6 gene are situated on -10 different chromosomes, none of
which are MMU9 (Fig. 3.3). Although FISH analysis has proven that the F9/30A6
gene-trap is situated on MMU9 near the telomere, this cell line was found to be
abnormal and so the position of this gene may be the result of a translocation,
although the FISH signal did appear to be in the same region as the MMU9 paint
(data not shown). The complexity in assembling repetitive or highly similar DNA
sequences in the genome is exemplified when attempting to identify the genomic
location of highly similar KRAB-ZFPs, and numerous methods of gene identification
will need to be employed to affirm the correct genes.
A large body of evidence suggests that KRAB-ZFPs can be arranged in clusters of
tandem gene arrays that are scattered throughout many chromosomes (Bellefroid et
al., 1991; Tunnacliffe et al., 1993; Tommerup and Vissing, 1995). These arrays of
head-to-tail KRAB-ZFP genes may be the result of tandem duplications of individual
genes, multiple genes and possibly whole clusters (Bellefroid et al., 1991; Lichter et
al., 1992; Tunnacliffe et al., 1993; Tommerup and Vissing, 1995). These clusters are
also composed of inverted KRAB-ZFP genes and to a much lesser extent,
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pseudogenes (Villa et al., 1996; Krebs et al., 2003). A fewer number of pseudogenes
have accumulated during the expansion of KRAB-ZFP families in stark contrast to
the expansion of the olfactory and MHC gene clusters. Also studies of KRAB-ZFP
genes residing in many clusters have indicated that the bulk of these genes are
expressed and contain a significant number of open reading frames (ORFs)
(Bellefroid et al., 1993; Dehal et al., 2001; Looman et al, 2002; Shannon et al.,
2003). Therefore, tandem clusters of KRAB-ZFP genes are postulated to be
undergoing unusual positive selective pressures that actively favour the maintenance
of gene diversity in the target recognition of duplicated copies. This suggests a role
for KRAB-ZFPs in speciation (Shannon et al., 2003). There are also some KRAB-
ZFP genes that lie out with gene clusters in more isolated regions of the genome that
are close to only a few other ZFP or KRAB-ZFP gene loci (Urrutia, 2003; ES492,
this thesis). Furthermore, human KRAB-ZFPs have a biased distribution to
telomeric, centromeric and/or fragile sites within the human genome (Lichter et al.,
1992; Eichler et al., 1998). More recently, a canine homologue of human KRAB-
ZFP ZNF331 (a putative target gene in thyroid tumourigenesis) has been mapped to
chromosome lq33 (CFAlq33), and cytogenic hotspots associated with canine
tumous have mapped to this chromosome before (Meiboom et al., 2004). The
KRAB-ZFPs identified in this study highlight a similar distribution over the genome
as above, in that they may also be preferentially located in telomeric and centromeric
regions. Moreover, at least 4 of the KRAB-ZFP genes described here (ESKN205,
ES261, ES492 and ES510) seem to be found at breaks in synteny between the mouse
and human genomes. The KRAB domain of ESKN205 is paralogous to that of the
Rex2 gene and whilst this gene appears to have a rat homologue, ESKN205 does not,
reinforcing the idea that some murine KRAB-ZFP clusters have expanded
independently of both the human and even rat genomes after their divergence
(Shannon et al., 2003). The fact that human and rat orthologous genes/regions could
only be found for a few of the gene-trap proteins, is compatible with previous
observations that different species have substantially different repertoires of ZFP
genes (Shannon et al., 2003).
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Three of the trapped genes match to cDNAs that appear to contain KRAB-only
encoding proteins (ESKN205, ES261, F9/30A6). For ES9/MZF6D (AY 149175), the
Ensembl predicted gene, NM183119, whose genomic structure is predicted by EST
and cDNA clones, appears to be an alternative isoform ofMZF6D as it reads through
the spice site located after the MZF6D KRAB box and utilises a stop codon located
in what is also the intron sequence of MZF6D (AY149175) to encode a KRAB-only
containing protein. For this gene it is possible that cryptic splice sites are used to
produce alternative isoforms of the same protein that either do or do not possess ZFs
and therefore alter the function of the protein accordingly. This has recently been
reported for ZFP208 whose KRAB-only isoform interacts with SRY (Oh et al.,
2005). Taken together, this finding sheds new light on the potential number of
KRAB-only proteins in the genome. Also, the KRAB domain has nuclear targeting
capability since all gene-trapped proteins localise to the nucleus (Sutherland et al.,
2001; Chapter 4) even though the predicted NFSs, which are always found in the
linker/ZF domain, are removed. This is of functional relevance suggesting that it is
the protein partners of the KRAB domain that recruit the gene-trapped proteins to the
nucleus.
For the further study of KRAB-ZFP function I chose to clone KRAB-ZFP 492
because at the beginning of my PhD this was the only gene-trap line to which a
correct gene could be assigned, and for which the surrounding region is well
described. The site of insertion of the gene-trap in ES492 indicates that the ZFs of
this protein are missing in the gene-trap line and is likely to represent a partial
knockout of gene function in the homozygous state. Since all gene-traps potentially
remove the ZF domains of the trapped proteins, it is unlikely that these mutant
proteins will be able to bind their target genes. Only one transgenic KRAB-ZFP
mouse line (nrif) had been described in the literature before the onset of my PhD
(Casademunt et al., 1999). I believed that some of the gene-trap lines characterised
in this chapter could be used for the generation of mouse KRAB-ZFP knockouts and
that these would be predicted to result in null, or even dominant negative phenotypes
in the mouse since they lack ZF domains. KRAB-ZFP 492 is an A+B family
member in a non-clustered part of the genome. As it does not have any close
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homologues I decided to choose this KRAB-ZFP for further study. I also chose
KRAB-ZFP 113 (A+C) for further studies because of its genomic location in a ZFP
cluster and because ESI 13 was the only other novel gene at the start ofmy PhD that
showed a good match to a cDNA clone and EST. However, I could not be certain
that this match was correct due to the multiple homologues and poor sequence
information at the genomic locus.
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Chapter 4
Sub-cellular localisation of KRAB-ZFPs
and their co-repressor, KAP-1
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4.1 Introduction
At the start of my PhD, the literature described the localisation of many epitope-
tagged KRAB-ZFPs to the cytoplasm, the nucleus, and sub-structures within the
nucleus (De Lucchini et al., 1991; Grondin et al., 1997; Payen et al., 1998; Huang et
al., 1999; Yano et al., 2000; Cote et al., 2001). Localisation to pericentromeric
heterochromatin had also been reported in some nuclei, with this localisation being
variegated within the cell population (Payen et al., 1998; Sutherland et al., 2001;
Matsuda et al., 2001). In -80% of NIH 3T3 cells, over-expressed, epitope-tagged
KRAZ1 and KRAZ2 have a nuclear diffuse staining pattern, whilst in the remaining
20%, they co-localise at pericentromeric heterochromatin with the KRAB-ZFP co¬
mpressor, KAP-1 (Matsuda et al., 2001). KAP-1 was already known to co-localise
with heterochromatic and euchromatic HP1 proteins in nuclei of NIH 3T3, F9
embryonic carcinoma (EC) and P15 EC cells (Ryan et ah, 1999; Nielsen et al.,
1999). Based on an experiment that shows that Trichostatin-A (TSA), a specific
inhibitor of histone deacetylases (HDACs), can partially relieve HP1 dependent
silencing activity by KAP-1 (Nielsen et al., 1999), Matsuda et al. showed that TSA
treatment disperses KRAZ1 and KAP-1 away from centromeric heterochromatin
(Matsuda et al., 2001). In contrast, HP la remained at centromeric heterochromatin,
indicating that KRAZ1 and KAP-1, but not HP la, are dependent on hypoacetylated
histones for their targeting to heterochromatin and that this chromatin modification
may precede their translocation.
Despite this data, no research had yet been published on how the association of KAP-
1 and/or KRAB-ZFPs with centromeric heterochromatin could be induced and how
this may result in heterochromatin-mediated gene silencing, as suggested by Ryan et
al. in 1999 and again by Schultz et al. in 2001. Hence, I decided to broach this
question by examining how the different stages of the cell cycle and the effects of
cell differentiation affect the sub-nuclear localisation of gene-trapped KRAB-ZFPs
(Sutherland et al., 2001) and KAP-1. I also wanted to know if the occurrence of
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KAP-1 at centromeric heterochromatin was restricted to particular cell types as
inferred by ZFP-37 (a KRAB-ZFP with a truncated KRAB A domain), because
antibodies to ZFP-37 localise to constitutive heterochromatin adjacent to nucleoli in
occulomotor neurones (Payen et al., 1998). Furthermore, during spermatogenesis,
KAP-1 is preferentially associated with heterochromatic structures of specialised
Sertoli cells and round spermatids, as well as with meiotic chromosomes (Weber et
al, 2002).
Apart from the ZFP-37 study, all localisation studies of KRAB-ZFPs utilised
expression vectors in which KRAB-ZFPs were tagged to either the influenza HA
(haemagglutinin) epitope (Grondin et al., 1996), GFP (Yano et al., 2000; Mark et al.,
2001), myc (Matsuda et al., 2001) or other such markers. Subsequent transfections
allowed visualisation of their whereabouts within the cell, but in these experiments,
KRAB-ZFP expression is not under the control of the endogenous promoters so the
proteins are potentially over-expressed and may mis-localise. For these reasons, I
used immunofluorescence to ascertain the sub-nuclear localisations of the 7 KRAB-
ZFPs trapped in the gene-trap screen (Sutherland et al., 2001), since they are under
the control of their endogenous promoters and are being expressed at physiological
levels in the cell and in the correct temporal pattern.
The gene-trapped proteins are not full length KRAB-ZFPs (Chapter 3) and some
gene-trap proteins have been found to mis-localise because they are missing portions
of the endogenous protein (Sutherland et al., 2004). To investigate if either the
gene-trapped 492 KRAB-ZFP or GFP (enhanced green fluorescent protein)-tagged
492 constructs that I made behave in the same way as their endogenous counterpart, I
raised antibodies to the endogenous protein for use in localisation studies.
4.2 Differentiation of ES/F9 cells with retinoic
acid
In the majority of the KRAB-ZFP gene-trap cell lines, the (3-gal-fusion proteins were
found to be nuclear diffuse. However, some lines showed a heterochromatic anti-|3-
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gal (a-(3-gal) localisation of fusion protein in a subset of cells (Sutherland et al.,
2001). These cells were often large, lying out-with the cell clusters and their
morphology suggested that they might be differentiated.
The gene-trap screen was done in mouse E14 ES cells and F9 EC cells, that are
totipotent and pluripotent respectively, and therefore undifferentiated. Gene-trapped
ES cells were routinely cultured in the presence of LIF, but to confirm the
differentiation status, I performed alkaline phosphatase staining (section 2.8.3.1) on
two of the cell lines, ESI 13 and ES492 (Fig 4.1). An intense pink colour indicative
of alkaline phosphatase activity is seen in undifferentiated ES cells (Matsui et al.,
1992). Using this assay I found that the majority of cells in the ESI 13 and ES492
cell lines, which were grown in the presence of LIF, formed densely packed clusters
of cells and were undifferentiated (Fig. 4.1, arrowheads). Elowever ES cells at the
edge of undifferentiated cell clusters often lacked stain, and were more irregularly
shaped, probably indicative of spontaneously differentiated ES cells (Fig. 4.1 A,
arrows).
To differentiate ES and F9 cells, I supplemented LIF free culture media with 5x 10"°
M retinoic acid (RA) for four or two days respectively (section 2.7.2). RA can
induce differentiation in F9 EC cells (Strickland and Mahdavi, 1978) where
morphological changes are first observed. Upon addition of RA, densely packed
cells became much less compact and moved apart from each other as reported. Cell
morphology also alters so that cells become larger, flatter and more irregularly
shaped. In differentiated ES cells, alkaline phosphatase activity is diminished
(Chiquoine, 1954; Donovan et al., 1986) and absence of pink staining confirms that
most cells have differentiated (Fig. 4.1, arrows). It is clear that undifferentiated cells
remain in culture after four days of RA treatment. Even after longer periods of RA
treatment, I could not achieve complete removal of these undifferentiated clusters
(data not shown).
I wanted to be able to distinguish between undifferentiated and differentiated cells on


















Figure 4.1 Alkaline phosphatase staining of ES cells
Before differentiation (-RA), the majorities of ESI 13 and ES492 cells are found in compact clusters and
stain an intense pink colour indicative of alkaline phosphatase activity (arrowheads). These cells are
undifferentiated. When cells are treated with RA (+RA) the majority of cells elongate, protrude extensions
and lack alkaline phosphatase activity (pink stain) indicative of differentiated cells (arrows). Spontaneously
differentiaing cells can be seen before RA treatment (arrows), likewise some undifferentiated cell clusters
remain post RA treatment (arrowheads).
1
with a-SSEA-1 (stage specific embryonic antigen-1) antibody. SSEA-1 is a
glycolipid that is expressed on the surface of teratocarcinoma EC cells (Solter and
Knowles, 1978) and ES cells of the inner cell mass (Matsui et a/., 1992). In contrast
with undifferentiated cells, the majority of RA differentiated ES and F9 cells do not
present the SSEA-1 epitope on their cell surfaces (Fig. 4.2). I therefore concluded
that this method of cell RA differentiation and detection of differentiation status with
a-SSEA-1 could be used to study and compare the sub-nuclear localisations of the P-
gal fusion proteins and their co-repressor KAP-1 with respect to the different
differentiation status of cells.
4.3 Gene-trapped KRAB-ZFPs, and KAP-1,
localise both diffusely and at pericentromeric
heterochromatin in undifferentiated ES cell
nuclei
The sub-nuclear localisations of gene-trapped KRAB-ZFPs were determined by
immunofluorescence of pFa fixed cells (section 2.8.1), with an a-P-gal antibody that
recognizes the P-galactosidase portion of the gene-trapped fusion proteins. Each cell
line was also co-stained with a-KAP-1 monoclonal antibody, kindly donated by Dr
D. Schultz (Schultz et al., 2001), which detects endogenous KAP-1 protein in the
nucleus. Consequently, the sub-nuclear staining patterns of KAP-1 and each KRAB-
P-gal fusion was assessed in what were mainly undifferentiated ES or F9 cell
cultures.
All KRAB-P-gal fusion proteins stained diffusely in a large proportion of nuclei in
the ES cell lines 9, 113, 205, 261, 492 and 510 (Fig. 4.3). However, each of the
KRAB-p-gal fusion proteins were also found at pericentromeric heterochromatin in a
small percentage of these cells, which manifest as bright foci of DAPI staining in
mouse cells (Fig. 4.3, e.g. ES492, arrowheads). For the rest of this chapter, I will
refer to the pericentromeric heterochromatin surrounding mouse centromeres as
simply heterochromatin, unless otherwise stated. Likewise, a-KAP-1 displayed a
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Figure 4.2 Differentiation status of individual ES cells
Immunofluorescence was performed on undifferentiated (-RA) and differentiated (+RA) cell lines with
a-P-gal (green in merge) and a-SSEA-1 (red in merge) antibodies in nuclei counterstained with DAPI
(blue in merge). SSEA-1 positive cells indicate undifferentiated cells, and a-P-gal stains diffusely in
the majority of these nuclei (arrows). In -1% cells, a-P-gal localises to pericentromeric heterochromatin






Figure 4.3 Immunofluorescence of undifferentiated gene-trapped cell lines
with a-p-gal and a-KAP-1 antibodies.
Immunofluorescence of gene-trapped KRAB-ZFPs with a-P-gal (green in merge) and a-KAP-l (red
in merge) antibodies in nuclei counterstained with DA PI (blue in merge). Arrowheads indicate nuclei
with co-staining of a-p-gal and a-KAP-1 at heterochromatin. Arrows indicate nuclei with heterochromatic
staining of KAP-1 only. Bars = 5 mm.
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similar diffuse staining pattern in most ES cell nuclei, but was also found at
heterochromatin in some cells (Fig. 4.3). Moreover, KAP-1 could often be found at
heterochromatin in nuclei where KRAB-ZFPs were diffusely distributed throughout
the nucleus (Fig. 4.3, e.g. ES510, arrows) suggesting that KAP-1 recruitment is
necessary, but not sufficient, for the localisation of KRAB-ZFPs to heterochromatin.
In the gene-trap cell line F930/A6, (3-gal-fusion protein and KAP-1 have a diffuse
localisation in all nuclei, and localisation to heterochromatin is never observed (Fig.
4.3).
4.4 Heterochromatic staining of KRAB-ZFPs
increases upon differentiation of ES cells
To determine if co-localisation of both KAP-1 and KRAB-ZFPs at heterochromatin
could be induced by differentiation I grew each ES cell line in FIF free media
containing 5x 10"6 M RA, as previously described (section 4.1). In the F9/30A6
clone, the only KRAB-ZFP trapped in the F9 cell line, there was no increased
localisation of either KAP-1 or KRAB-p-gal fusion protein to heterochromatin upon
differentiation (Fig. 4.4). However, in all the ES cell lines with trapped KRAB box
proteins the proportion of cells with KAP-1 and KRAB-P-gal fusion protein co-
localisation at heterochromatin significantly increased upon differentiation (Fig. 4.4).
As before, fusion protein was never observed at heterochromatin unless KAP-1 was
present but KAP-1 was found at heterochromatin in nuclei with a diffuse distribution
of KRAB-p-gal-fusion protein (Fig. 4.3 e.g. ESKN205, arrows).
I wanted to confirm that it was indeed the differentiated cells that displayed
heterochromatic ct-p-gal and a-KAP-1 staining, since it is known that not all cells
are likely to be differentiated after RA treatment (Fig. 4.1). To identify differentiated
cells, I performed co-immunofluorescence experiments with a-P-gal and a-SSEA-1
antibodies. Figure 4.2 shows that when KRAB-P-gal fusion proteins are located at
heterochromatin in ES cells, SSEA-1 is not detected on the cell surface indicative of
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Figure 4.4 {Immunofluorescence of differentiated gene-tap ceSi Sines with a-fi-gal and
a-KAP-1 antibodies.
Immunofluorescencewith a-f3-gal (green in merge) and a-KAP-1 (red inmage) antibodies on gene-trap cells differentiated
with 5x KH'M RA for either four days (ES) or for two days (F9/30A6). Arrowheads indicate a-(3-gal and a-KAP-1 co-
staining at heterochromatin manifested as bright DAPI foci (blue in merge). Arrows indicate nuclei with heterochromatic
staining ofa-KAP-1 only. Bars = 5 mm.
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differentiation. Only -1% cells expressing SSEA-1 have KRAB-P-gal fusion protein
at heterochromatic foci. Dual immunofluorescence experiments were not performed
with a-KAP-1 and a-SSEA-1 antibodies, because both were raised in mouse.
However, previous experiments revealed that it would be highly probable for KAP-1
to be situated at heterochromatin if KRAB-P-gal fusion proteins were there (section
4.2).
In conclusion, gene-trapped KRAB-p-gal fusion proteins show increased recruitment
to heterochromatin upon differentiation of ES cells with RA. In F9/30A6 cells, both
KAP-1 and F9/30A6 KRAB-ZFP remain nuclear diffuse after two days of
differentiation and are never found at heterochromatin. This cell line could not
sustain RA treatment for four days, even when the RA concentration was lowered to
5x 10"' M. SSEA-1 positive cells with KRAB-P-gal fusion protein at
heterochromatin may represent transitory cells about to undergo differentiation or a
population of undifferentiated cells with fusion protein, and probably KAP-1, at
heterochromatin. These results support the idea that KAP-1 is required for
redistribution ofKRAB-P-gal fusion protein to heterochromatin upon differentiation.
Immunofluorescence did not suggest that the amount of KAP-1 or KRAB-P-gal
fusion protein within the nuclei differed greatly whether the protein was found at
either heterochromatic or diffuse locations.
4.5 Quantification of heterochromatic
localisation
To quantify the localisation of gene-trapped KRAB-ZFPs and KAP-1, each
immunofluorescence experiment on each gene-trapped cell line (undifferentiated and
differentiated) was repeated three times and -100 cells analysed each time. The
number of cells with either a-P-gal or a-KAP-1 at heterochromatin was calculated as
a percentage of the total number of cells tallied (Fig. 4.5). For KAP-1, percentages
of cells with heterochromatic staining were counted in each ES cell line and the
results pooled under the assumption that KAP-1 behaves similarly in all gene-trapped
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Figure 4.5 Bar chart showing the proportion of cells with heterochromatic
distributions of KRAB-(3-gal fusion protein and KAP-1.
A) The proportion of cells with gene-trapped KRAB-ZFPs concentrated at heterochromatin, before (-
RA) and after differentiation (+RA), was calculated as a percentage of -300 cells tallied from three
independent experiments with each cell line. B) The average number of gene-trapped ES cells with
heterochromatic KAP-1 staining from three independent experiments with each gene-trapped cell line.
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cell lines. Since in some cells KAP-1 is found at heterochromatin without KRAB-P-
gal fusion protein, KAP-1 is always found at heterochromatin in a higher proportion
of undifferentiated and differentiated ES cells (Fig. 4.5). However, the proportion of
ES cells with localisation of KAP-1 and KRAB-P-gal fusion protein to
heterochromatin significantly increases with differentiation (Fig. 4.5).
4.6 Localisation of gene-trapped KRAB-ZFPs to
heterochromatin is independent of the cell
cycle
Increased co-localisation of KRAB-ZFPs and KAP-1 to heterochromatin upon
addition ofRA could result from differentiation per se, or changes in the cell cycle as
rapidly dividing ES cells differentiate. When I started my PhD no studies had been
published on the sub-cellular localisations of KRAB-ZFPs during different stages of
the cell cycle. A link between Kid-1 and the cell cycle had been suggested, since
over-expressed Kid-1, which localises to the nucleolus leads to its disintegration
(Huang et al., 1999). During the cell cycle nucleoli disassemble at prophase (re¬
appearing in telophase) and nucleolar fragmentation is also observed for other
reasons, such as during apoptosis. Only three studies in the literature show KRAB-
ZFPs to have potential roles in cellular proliferation. ZF5128 (ZNF324) mRNA is
up-regulated in S phase (Rue et al., 2001) and GFP-tagged ZZaPK is implicated in
entrance into S phase (Yang, 2002) but the sub-nuclear localisation of these proteins
is unknown. ZBRK1, which binds intron 3 of GADD45, is likely to exert a role in
the cell cycle since GADD45 is implicated in a variety of growth regulatory
processes, including activation of DNA damage-induced G2/M checkpoints (Zheng
et al., 2000 and references therein).
To test if the gene-trapped KRAB-ZFPs localise to heterochromatin during specific
stages of the cell cycle I treated both undifferentiated and differentiated cells with
0.01 M BrdU for 30 min (section 2.8.2). BrdU is a thymidine analogue that is
incorporated into DNA during DNA replication, and can be detected with a specific
antibody. BrdU shows either a nuclear speckle type staining or more punctate foci in
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early or late S phase cells respectively. Immunofluorescence was performed on all
gene-trapped cell lines and the cells stained with a-p-gal antibody. The coverslips
were then removed from the slides after soaking in PBS for 30 min and a second
immunofluorescence step was performed with fixation of cells in 10% formalin.
These two separate fixation steps were necessary because the a-p-gal epitope was
not recognised after fixation of the cells in 10% formalin. Likewise, the a-BrdU
epitope is masked after only pFa fixation because it only recognises the ss DNA that
is obtained with formalin fixation.
KRAB-p-gal fusion protein from ESI 13 and ES492 cell lines was seen at
heterochromatin at both the early and late stages of S phase (Fig. 4.6, single and
double arrowheads respectively) but also in non-S phase cells (Fig. 4.6, arrows). All
other KRAB-P-gal fusion proteins gave the same result (data not shown). Therefore
I concluded that there is no correlation between the presence of KRAB-P-gal fusion
proteins at heterochromatin and S phase of the cell cycle. However, cells with
heterochromatic a-P-gal staining were found in BrdU negative cells more often than
BrdU positive cells (Fig. 4.6) suggesting that cells with heterochromatin-associated
KRAB-p-gal fusion protein may have a decreased proliferative activity.
4.7 Localisation of GFP-tagged 492 KRAB-ZFP
Since all gene-trapped KRAB-ZFPs retain the KAP-1 interacting KRAB domain, but
lack all of the zinc fingers that probably target them to specific genes or are
responsible for interaction with other proteins, it is possible that they may mis-
localise relative to their wild-type proteins. To determine the domains responsible
for sub-cellular localisation of KRAB-ZFPs, I cloned different portions of the 492
cDNA in-frame to GFP in both the pEGFP-Cl and -N1 vectors. The primers used
for PCR are described in Table 2.2.
NIH 3T3 (section 2.7.5.1) and ES cells (section 2.7.5.2) were transiently transfected
with either pEGFP-Cl or -N1 vectors expressing full-length wild type (wt) 492 fused







Figure 4.6 Detection of ES113 and ES492 KRAB-ZFPs in BrdU treated cells
ESI 13 and ES492 gene-trapped cells, before (-RA) and after (+RA) differentiation were treated with
0.01 M BrdU for 30 min and immunostained for a-(3-gal (green in merged) and a-BrdU antibodies
(red in merge).a-P-gal is found at heterochromatin (DAPI foci, blue in merge) in early and late S
phase cells (single and double arrowheads respectively) and also in non S phase cells (arrows).
Bars = 5 mm.
130
epitope-tagged at both their N- and C-termini (Payen et al., 1998; Casademunt et al.,
1999; Yano et al., 2000; Jheon et al., 2001), I therefore decided to construct fusion
proteins with GFP at both ends of the full length 492 protein to determine if the
position of this tag affects its localisation (Fig. 4.7A). All constructs were fully
sequenced to confirm the identity of the insert sequence.
Approximately 14-16 hours later, the cells were pFa fixed and mounted in DAPI.
In cells transfected with control construct expressing GFP alone, GFP was seen
throughout the cell (Fig. 4.7B). Both full-length 492 constructs (pEGFP-Cl/492FL
and pEGFP-Nl/492FL) showed a nuclear diffuse staining pattern with large punctate
spots in -20% of cells, which co-localised with the DAPI bright spots of
pericentromeric heterochromatin (Fig 4.7B, arrowheads). The staining pattern
almost always excluded the nucleolus. Smaller punctate foci that did not co-localise
with DAPI were often found in cells that did not contain the larger punctate foci (Fig
4.7B, arrows). The KRAB+linker construct (pEGFP-Cl/492K) demonstrated a
similar pattern to the full length constructs, but smaller foci and some cytoplasmic
staining was also observed. This is in contrast to the KRAB+partial linker region of
the gene-trap protein, suggesting amino acids 146 to 186 may be responsible for the
smaller foci staining, or alternatively they may be a consequence of over-expression.
The 492 ZF region alone (pEGFP-C1492ZF) showed no staining in either the
heterochromatic or smaller punctate spots, but was diffuse throughout the whole cell
excluding the nucleolus, indicating that amino acids 1 to 145, which comprises the
KRAB domain and part of the linker, is necessary for recruitment of 492 protein to
heterochromatin. The ZF region is not responsible for cytoplasmic localisation but
appears to be required, in combination with the KRAB and/or linker domain, for
nuclear-only distribution (Fig 4.7B).
I attempted to make stable cell lines with the constructs described but none survived
the selection process. I could only obtain low transfection efficiencies with the 492
constructs and any expressing cells were usually the GFP-fusion proteins were
usually expressing the GFP fusion protein at a high level (bright green cells). Many
of the cells were found to be already dead or dying after fixation a day later,
131
A) construct domains localisation
1 149
gene-trap 492 nuc diffuse & hetero
1 536
pEGFP-N1/492FL i GFP nuc diffuse, hetero,
1 ,5,36
pEGFP-C1/492FL GFP nuc diffuse, hetero,
^ 1 186
dEGFP-C1 /492K GFP nuc diffuse, hetero,
187 536
pEGFP-C1/492ZF GFPi nuc diffuse & cyto
J334
pEGFP-C1/KAP-1 GFP f KAP-1 Gp nuc diffuse & cyto
1__ 834—
pEGFP-N1/KAP-1 CT~ KAP-1 GFP nuc diffuse & cyto
2 16








€ %£ 1 » 4)




Figure 4.7 Schematic representation of GFP constructs, and localisation
of their protein products in transfected cells
A) Each 492-insert sequence was cloned into either the pEGFP-C 1 or -N1 vectors, which both encode
GFP under control of the lac promoter. The name of the construct is indicated on the left and its localisation
pattern on the right. Nuc diffuse, nuclear diffuse; hetero, pericentromeric heterochromatin; cyto, cytplasm;
foci, small punctae foci. "Flic K.RAB-ZFP 492 N-terminal peptide sequence (N) and linker (link) region
were used to raise antibodies, and are shown for comparison. Numbers represent amino acid positions
in the 492 ICRAB-ZFP sequence (Fig. 3.8). GFP and GST domains are not to scale. B) GFP-constructs
were transiently transfected into NIH 3T3 or ES cells (data not shown) and their localisation patterns
determined by direct immunofluorescence. Arrows indicate smaller punctate foci, arrowheads indicate
large foci of pericentromeric hcterochromatin. Bars = 5 mm.
13a
suggesting that over-expression of KRAB-ZFP 492 in NIH 3T3 cells and ES cells
(data not shown) is detrimental to cells. Toxicity of over-expressed KRAB-ZFPs has
been previously reported for HKrl8 and HKrl9 (Mark et al., 2001) and NRIF
(Casademunt et al., 1999).
1 also sub-cloned KAP-1 into the pEGFP-Nl and CI vectors to visualise its sub¬
cellular localisation, with a view to perhaps studying the kinetics of the KAP-1 and
KRAB-ZFP 492 interaction in the cell by means of FRAP (fluorescent recovery after
photo-bleaching). However, GFP-tagged KAP-1 did not localise correctly after
transient transfection in NIH 3T3 cells. When GFP was tagged at either the N- or C-
terminus of KAP-1 respectively, it was found to be diffuse throughout the whole cell
(data not shown) and no punctate foci at DAPI bright spots were observed.
Sequencing confirmed the presence of full length KAP-1 in both constructs,
suggesting that mis-localisation is a consequence of either the GFP tag or over-
expression. KAP-1 has previously been tagged with the HA-epitope at the N-
terminus for localisation studies in COS-7 cells, which showed a homogeneous
KAP-1 distribution in the nucleus (Huang et al., 1999). More recently, visualisation
of N-terminal FLAG tagged KAP-1 in COS-7 cells was also reported to have a
nuclear diffuse distribution with dotted nuclear staining (Oh et al., 2005). COS-7
cells do not have visible foci of heterochromatin as marked by DAPI bright spots in
human and mouse cell lines, therefore it is not known whether KAP-1 is localising to
heterochromatic regions in these cells. However these tags are smaller then GFP and
may be less disruptive to KAP-1 localisation. In this regard, Matsuda et al. did
observe myc-tagged KAP-1 at heterochromatin in a sub-population ofNIH 3T3 cells
(2001).
4.8 Analysis of the endogenous 492 KRAB-ZFP
The localisation of GFP-tagged full length 492 is similar to that of the gene-trap (i.e.
heterochromatic in a proportion of cells). Since GFP-tagged protein seems to be
affected by the GFP moiety and its over-expression, I wanted to analyse the
endogenous 492 KRAB-ZFPs by raising an antibody to it. Peptides and fusion
proteins had previously been used to raise antibodies to five different KRAB-ZFPs
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from four different species (De Lucchini et al., 1991; Payen et al., 1998; Katoh et al.,
1998; Jheon et al., 2001; Tanaka et al., 2002). However, only the a-mouse ZFP-37
antibody had been used to study KRAB-ZFP sub-nuclear localisation.
In the adult brain, ZFP-37 is neuron specific and associates with constitutive
heterochromatin adjacent to nucleoli and/or in the interior of the nucleolus depending
on the neuronal cell type (Payen et al., 1998). Moreover, apart from the DNA
binding ZF motif, ZFP-37 preferentially binds ds DNA via its histone HI-like DNA
binding motif, which more closely resembles the carboxy termini of histone Hlu and
H5. These histone variants replace histone HI in terminally differentiated cell types,
and since other nucleolar components also have histone HI-like motifs (nucleolin),
this suggests ZFP-37 to be included in the group of histone HI variants. Thus, it
seems possible that heterochromatic localisation could be due to its linker region
rather than its KRAB domain. This seems more probable in view of the fact that
ZFP-37 also contains a truncated KRAB A domain, which lacks 17 amino acids
previously shown to be important for in vitro repression activity. The question
remains, therefore, whether KAP-1 is able to recruit endogenous KRAB-ZFPs to
pericentromeric heterochromatin via its interaction with the KRAB domain.
4.8.1 Antibody design to the N-terminus and linker
region of KRAB-ZFP 492
Two antigens from KRAB-ZFP 492 were designed in the hope of getting a good
immune response from the host animal, a GST-fusion antibody and a synthetic KLH-
conjugated peptide (Invitrogen/RESgen).
Amino acids 90 to 174 (Fig. 3.8B; Fig. 4.7A), corresponding to the linker region of
KRAB-ZFP 492, were fused in frame to GST, expressed in E. coli, and purified on a
GST column (section 2.5.1) before injection into host animals. Figure 4.8A (arrows)
shows an SDS-PAGE gel of IPTG induced expression of 492-GST fusion protein in
E. coli and its abundance in the soluble protein fraction (section 2.4.1). The linker
region was chosen for two reasons. Firstly, previous studies indicated that the
corresponding regions of other KRAB-ZFPs have successfully been used for
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Figure 4.8 Analysis of 492 antibody production and immune response
detection
A) 492-GST fusion protein expression in E. coli before and after 4 hours induction with IPTG (+/-I).
EV, empty pGEX vector, FP, fusion protein; sol, soluble E. coli fraction; ins, insoluble E. coli fraction.
B) An SDS-PAGE gel was stained with coomassie blue to ensure equal loading of the NIH 3T3 (N) and
HeLa (H) protein extracts used in western blot analyses. C) Western blot analyses of H and N total
protein extracts with 1:1000 dilutions of either rabbit or sheep anti-sera from their respective preimmune
(pre), first (1st), second (2n<t) and third (3rct) bleeds. D) Western blot with third bleed rabbit anti-sera
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antibody production (Payen, et al., 1998; Tanaka et al., 2002) and secondly, since the
size and sequence of the linker region is the most variable part of these proteins, this
region is generally the most specific for a given KRAB-ZFP (Mark et al. 1999). A
BLASTN search at Ensembl with the DNA primers used to generate the 492-linker-
fusion construct (Table 2.2) show 100% identity with NM_172817 (Zfp647).
Sequencing of the GST-fusion construct resulted in KRAB-ZFP 492 DNA and
protein sequence with 100% identity to the corresponding region of NM 172817,
whilst the next best hit (a predicted microtubule associated protein) is only 33%
identical at the protein level. PIX (protein identification of unknown sequences)
analyses (section 2.11) of predicted antigenic regions within the 492 KRAB-ZFP
linker region highlight two antigenic regions between amino acids 108 to 116 and
137 to 144. The former of these has -56% amino acid identity with human ZNF647
(Fig. 3.6). It was therefore possible that the antibody raised against this fusion
protein could cross-react with human ZNF647.
A synthetic peptide, corresponding to N-terminal amino acids 2 to 16 of KRAB-ZFP
492 (Fig. 3.8B; Fig. 4.7A), was also chosen for antibody production because this
sequence is also specific to KRAB-ZFP 492 and its human and rat homologues only.
A cys residue was added at the start of the peptide sequence to allow conjugation to
keyhole limpet hemocyanin (KLH), which maximises the immune response. There
is 76% protein identity in this region between the mouse, rat and human homologues
(Fig. 3.6). The N-terminal sequence of KRAB-ZFP AJ18 has also been successfully
used for antibody production (Jheon et al., 2001).
Both antigens were simultaneously injected into one sheep and one rabbit (section
2.5.2) on the premise that separation of antibodies from either host would be
achieved by affinity purification if necessary.
4.8.2 Immune response detection
Serum was obtained from preimmune animals and each time subsequent to three
booster injections (section 2.5.2). To determine whether a specific immune response
had been elicited, western blot analyses and immunofluorescence with immunised
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serum from both rabbit and sheep were performed. Total protein extracts were
prepared from NIH 3T3 and HeLa cells and after SDS-PAGE resolution, proteins
were transferred to PVDF membranes and the membranes incubated with serum
(diluted 1:1000 with dfbO) from each animal. The resulting western blots show that
an immune response against at least one protein (perhaps two) of the predicted size
of 492 (-60 kDa) was initiated in rabbit after the first booster injection and thereafter
(Figure 4.8C, arrows). A second band of—80 kDa was also detected with this a-sera
compared to preimmune serum (Fig. 4.8C). Furthermore, the rabbit anti-sera detects
the same protein species in both HeFa and NIH 3T3 cells suggesting the purified
antibody could be cross-reactive with the human 492 homologue. Western blots
using non-purified sera from the immunised sheep were dirty, so it was difficult to
see whether specific antibodies had been made (Fig. 4.8C).
Finally, to confirm that the immune response elicited in rabbit was specific to the 492
protein and not GST, I made protein extracts from E. coli cells expressing his-tagged
492-linker TRX-fusion protein (section 4.8.3) and performed a western blot using
third bleed rabbit a-sera. Only antibodies raised to the 492 portion of the 492-GST
fusion protein should bind to his-tagged 492 protein at -30 kDa (Mw. of his-492-
TRX fusion protein). A strong signal of the correct size can be seen by western
blotting (Fig. 4.8D, arrows), confirming the specificity of the rabbit a-sera for the
KRAB-ZFP 492-linker sequence. The blot shows strong background signal because
the rabbit a-serum has not been purified.
4.8.3 Purification of 492 antibodies
I decided to IgG purify and affinity purify both rabbit and sheep a-492 antibodies
from final bleed sera on an IgG column as this would enable IgG antibodies raised to
both the 492 N-terminus and the linker regions to be co-purified (section 2.5.3.1). 7
fractions were collected from the column during IgG purification and samples of
each fraction from both animals were run on 10% SDS-PAGE gels. Heavy and light
immunoglobulin (Ig) chains of -50 kDa and -25 kDa respectively (Fig. 4.9A) were
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Figure 4.9 Purification of 492 antibodies
Analyses of rabbit and sheep antibodies after purification on either; (A) an IgG HiTrap column, for the
purification of 492 IgG antibodies, (B) a CNBr activated column, for affinity purification of antibodies
to the 492-linker region (AP492) or (C) a SulfoLink column, for the affinity purification of492 peptide
antibodies (AP492pep). 10 ml of each antibody fraction (numbered) was added to 10 ml of SDS-LB
and boiled for 5 min. 10 ml of each protein sample was loaded on to a 10% SDS-PAGE gel. 1 mg of
IgG standard was also loaded for quantification ofAP492pep antibody. M, marker; Wl, wash before
elution; W2, wash after elution; P, 1 ml pooled fractions; S, 1 mg IgG standard.
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a-rabbit and a-sheep 492 antibodies (IgG492) were measured at 40 mg/ml and 124
mg/ml respectively (section 2.5.3.1).
I also used the 492-linker region to make an affinity column for the purification of
antibodies raised to the 492-linker region only (section 2.5.3.2). Firstly, the 492-
linker region was expressed in E. coli as a his-tagged TRX-fusion protein (pET-
492L). I then purified the fusion protein on a Ni-agarose column and then coupled it
to CNBr-activated Sepharose™ 4B to produce an affinity column. Two separate
affinity columns were made consisting of immobile 492-linker ionically bound to the
sepharose matrix and each column was used to affinity purify either rabbit or sheep
a-492-linker antibodies (section 2.5.3.3). Unbound proteins and antibodies raised to
either the 492 N-terminal sequence and/or to the GST portion of the fusion protein
where eluted in the flow through following washing of the column with stringent
high salt buffers. 492-linker antibodies remained bound to the column until they
were eluted with a low pH buffer, which altered the degree of ionisation of the
charged groups at the binding sites between the adsorbent and the antibody. Protein
fractions eluted from each column were pooled (Fig. 4.9B) and their final
concentrations measured at 4.75 mg/ml for affinity purified rabbit antibody (AP492)
and 7.27 mg/ml for the sheep antibody.
I also attempted to make an affinity column with the 492 peptide (section 2.5.3.4), by
immobilising it to Sulpholink gel via its reduced cys residue. This column was used
to purify a-rabbit 492 peptide antibodies (AP492pep) from the third bleed anti-sera
that recognise epitopes contained within the peptide. However, purification of 492
peptide antibodies does not appear to have been successful as the main protein
flushed off the column is larger than the heavy chain IgG band (Fig. 4.9C). The
protein eluted from the column could be IgM antibodies or a non-specific serum
protein but I did not check the identity of this band as only a small amount (~1 pg/pl
by IgG standards) was eluted.
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4.8.4 Characterisation of a-492 antibodies by western
blot analyses
Each of the purified antibodies (IgG492 and AP492) from rabbit and sheep, and the
rabbit AP492pep were tested on western blots of NIH 3T3 and HeLa nuclear and
whole cell extracts. Specific bands could not be seen with either of the sheep
antibodies, except perhaps for a faint band detected with a 1:100 dilution of the IgG
antibody (Fig. 4.10B, asterix) suggesting that the immune response elicited by this
animal was not very good. Using both the rabbit IgG492 and AP492 antibodies two
specific protein bands close to the expected size of -60 kDa were detected on NIH
3T3 and HeLa whole cell extracts, with the lower of these two bands being the most
intense (Fig. 4.1 OA, arrows). These bands are approximately the same size bands as
those detected with the third bleed serum before purification (Fig. 4.8B). A 1:1000
dilution of rabbit AP492 and a 1:1500 dilution of rabbit lgG492 were found to be
optimal for western blots (Fig. 4.10B). Interestingly in nuclear extracts of both cell
types, only the upper band of the -60 kDa doublet is observed (Fig. 4.10C,
arrowhead), suggesting that in addition to this larger nuclear protein, AP492 and
IgG492 recognise a cytoplasmic protein. The intensity of the lower band suggests
that this is the more abundant form of the protein. This band may represent a
different 492 isoform as different KRAB-ZFP isofonns have been shown to exist by
alternative splicing (Dreyer et al., 1999; Cote et al., 2001; Li et al., 2003; Resch et
ah, 2004; West et ah, 2004; Oh et al., 2005) and although KRAB-ZFPs are usually
thought to be nuclear proteins, there are examples of those with a cytoplasmic
localisation (De Lucchini et al., 1991; Casademunt et al., 1999). Alternatively, the
cytoplasmic band may be the result of post-translational processing or the nuclear
isoform itself may be post-translationally modified. Finally the isoform may cross-
react with a non-specific cytoplasmic protein. I have not yet distinguished between
all these possibilities.
A larger protein of -80 kDa was also detected with the rabbit IgG492 antibody in
both NIH 3T3 and HeLa cell extracts. This band was also prominent in the
immunised serum before purification (Fig. 4.8C) and in the nuclear extracts (Fig.
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Figure 4.10 Analysis of purified 492 antibodies by western blotting
Western blots ofNIH 3T3 (N) and HeLa (H) whole cell extracts with different dilutions of rabbit (A) and
sheep (B) AP492 and IgG492 antibodies. In (A), long and short exposures are shown for rabbit AP492
to illustrate the specificity of the antibody for the -60 kDa bands (arrows). An asterix denotes a possible
band in (B). C) Western blots with rabbit AP492 and IgG492 antibodies on NIH 3T3 and HeLa whole
cell (W) and nuclear extracts (Nu). Single arrowheads denotes the nuclear specific band. Double
arrowheads indicate the -80 kDa band. D) The left panel shows a western blot of rabbit AP492pep
antibody on NIH 3T3 whole cell (W) and nuclear extracts (Nu). The right panel shows a competition
assay between rabbit IgG492 and unconjugated 492 peptide. Western blots of total NIH 3T3 protein
extracts were incubated with a 1:11 and 1:22 molar excess of IgG492:unconjugated peptide. Cont, control.
The -80 and -60 kDa bands are marked as before.
4.IOC, double arrowhead), but it was not detected with rabbit AP492 antibody.
Therefore this band may be non-specific or due to 492 antibodies recognising the N-
terminal sequence, and therefore a larger or modified isoform of 492.
To try and further characterise this band, I performed competition assays between
rabbit IgG492 antibody and 492 unconjugated peptide (i.e. no KLH). IgG492 was
incubated o/n at 4°C with approximately 1:5, 1:10, 1:20 and 1:100 molar excess of
unconjugated peptide so that any antibodies raised to the 492 N-terminal sequence
would bind the unconjugated peptide leaving only free antibodies to the 492-linker
region. A western blot of NIH 3T3 whole cell extracts was probed with this
competition mix and the bands analysed. The -80 kDa band is still detected on a
western blot after competition with the molar excesses tested (Fig. 4.10D, double
arrowheads). Competition assays with higher molar excesses resulted in blots with a
high level of background due to non-specific binding of unconjugated peptide (data
not shown). I therefore concluded that either a greater than 100 molar excess of
unconjugated peptide was required to compete out this band but most probably this
-80 kDa band is non-specific. I also checked rabbit AP492pep on NIH 3T3 whole
cell and nuclear extracts for the presence of an -80 kDa band. No specific bands
could be detected and the blots had a high level of background (Fig. 4.10D).
For this thesis, I chose to concentrate on the presence of KRAB-ZFP 492 in the
nucleus; therefore in the majority of experiments that follow I have chosen to use the
rabbit AP492 antibody since this antibody identifies one protein species by western
blotting on nuclear extracts (Fig. 4.10C).
4.8.5 Characterisation of endogenous 492 protein
localisation by immunofluorescence
Initially I used both the rabbit IgG492 (1:1500) and AP492 (1:100) antibodies to
examine the sub-cellular distribution of 492 KRAB-ZFP by indirect
immunofluorescence in NIH 3T3 and HeLa cells. Cells were pFa fixed as previously
described and stained with either IgG492 or AP492. AP492 and IgG492 were both
found to have a grainy, nuclear diffuse distribution in both NIH 3T3 and HeLa cells,
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with some weak cytoplasmic staining (Fig. 4.11). In 30-40% cells, there was strong
492 staining in the DAPI 'holes', which often correspond to nucleoli. This nucleolar
staining was confirmed by co-staining with an antibody against fibrillarin, a marker
of the dense fibrillar component of the nucleolus (Fig. 4.11, arrows). Although there
is not complete localisation (as the nucleolus is composed of a number of sub-
compartments), 492 is clearly present in the nucleoli of a subset of cells.
Previously, KAP-1 was shown to have an even, granular pattern in the nucleus of
NIFI 3T3 cells with localisation to pericentromeric heterochromatin in -40-50% of
cells and exclusion from the nucleolus (Ryan et ah, 1999; Nielsen et al., 1999;
Matsuda et ah, 2001). I also observed this result (data not shown). Punctate foci of
492-staining were also observed in -5-10% of NIH 3T3 cells (Fig. 4.11,
arrowheads). Co-staining with cx-KAP-1 showed that whilst some of these foci
associated/appeared adjacent with KAP-1, they did not always overlap.
Interestingly, in contrast to that observed in the ES492 gene-trap cell line, neither
IgG nor affinity purified 492 antibodies co-localised with KAP-1 at heterochromatin
in NIH 3T3 cells. In HeLa cells, both 492 and KAP-1 showed a fine speckled
pattern, but strong association with KAP-1 was not observed. This even, speckled
pattern in HeLa cells has been previously recorded for KAP-1 (Underhill et ah,
2000).
Rabbit IgG and AP492 antibodies were characterised further by immunofluorescence
on undifferentiated, pFa fixed wt ES cells and ES492 gene-trap cells. Although both
antibodies show the same immunofluorescence patterns, I have only shown the
results for AP492 as this gave the cleanest results. In wt E14 ES cells, AP492 stains
diffusely in the nucleus and -80% cells show a strong nucleolar staining pattern (Fig.
4.12, arrows). A small amount of cytoplasmic staining was sometimes apparent,
although the nucleus occupies the majority of the volume of an undifferentiated ES
cell. Surprisingly no heterochromatic staining of 492 was observed, unlike the gene-
trap cell line, even after differentiation with RA. I did notice however, that some
differentiated wt ES cells had small discrete foci similar to those observed in NIH
3T3 cells (data not shown). Using the ES492 gene-trap cell line, AP492 was nuclear
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Figure 4.11 Endogeneous 492 localisation in NIH 3T3 and HeLa cells
Immunofluorescence ofNIH 3T3 and HeLa cells with 1:100 AP492 (green in merge) and either a-KAP-
1 or a-fibri llarin (a-fib) (red in merge) antibodies. Nuclei are counterstained with DAPI (blue in merge).
Arrows indicate cells with nucleolar staining. Arrowheads indicate small punctate foci. Bars = 5 pm.
1+4-
diffuse and in the nucleolus in undifferentiated cells (Fig. 4.1 IB, arrows). In RA
differentiated cells AP492 shows a granular, nuclear diffuse distribution, with co-
localisation at heterochromatin with a-KAP-1 in a similar proportion of cells as that
observed previously with a-p-gal and a-KAP-1 co-staining (Fig. 4.12, double
arrowheads). This suggests that the rabbit 492 antibodies recognise both endogenous
492 and the gene-trapped 492 KRAB-ZFP as a P-gal fusion protein that is recruited
to heterochromatin. Since the AP492 antibody was affinity purified against the
linker region, the epitope recognised by this antibody must be in the portion of the
linker contained within the gene-trapped protein. Co-staining with a-P-gal and
either AP492 or IgG492 antibodies was not performed since the available antibodies
were both raised in rabbit. To ensure that the AP and IgG492 antibodies were
specific and did not recognise any of the other gene-trapped KRAB-ZFPs,
immunofluorescence was performed on ESI 13 cells. In undifferentiated ESI 13
cells, -60-70% of cells had a strong nucleolar staining pattern with even staining in
the rest of the nucleoplasm (Fig. 4.12, arrows). After differentiation of ESI 13 cells,
immunofluorescence with AP492 showed a more diffuse staining pattern in the
nucleus with strong nucleolar staining in a reduced 30-40% of cells (Fig. 4.12,
arrows). If these antibodies were picking up the gene-trapped ESI 13 protein then
the majority of these cells would be showing a heterochromatic staining pattern.
These results show that the 492 antibody I have generated is specific to KRAB-ZFP
492 in the nucleus. Furthermore, these results suggest that the gene-trapped 492
KRAB-containing fusion-protein is mis-localised in the nucleus compared to the
endogenous protein.
Since neither the gene-trap or GFP-tagged 492 protein was found to localise to the
nucleolus, I confirmed presence of the endogenous 492 protein there by western
blotting on HeEa (gift, A. Tamond) and NIH 3T3 (H. Sutherland, Pers. Comm.)
nucleolar extracts with both AP492 and IgG492 antibodies. HeLa nucleolar fractions
were prepared and their purity checked as described by Anderson et a!., 2002. NIH
3T3 fractions were prepared using the same method of fractionation and checked by
western blotting with a-fibrillarin, which shows enrichment of fibrillarin in nucleolar










Figure 4.12 Endogeneous 492 localisation in ES cells
Immunofluorescence ofwt and gene-trapped ESI 13 and ES492 cells, before (-RA) and after differentiation
(+RA), with 1:100 AP492 (green in merge) and a-KAP-1 (red in merge) antibodies. Nuclei are
counterstained with DAPI (blue in merge). Arrows indicate cells with nucleolar staining. Arrowheads
indicate punctate foci and double arrowheads indicate heterochromatic staining. Bars = 5 pm.
from both cell types, AP492 detects the same ~60 kDa band as in the nuclear extracts
(Fig. 4.13, arrowhead). The cytoplasmic HeLa extract does not appear to detect
either of the -60 kDa bands, however it is not known how much protein was in this
extract and I only had limited amounts of material. Further characterisation of the
cytoplasmic band in NIH 3T3 cells would be interesting. IgG492 detects the -80
kDa band in all FleLa and NIH 3T3 cell extracts (Fig. 4.13, double arrowhead), as
well as the -60 kDa bands detected by AP492, suggesting again that the -80 kDa
band is probably non-specific. These results biochemically confirm that endogenous
KRAB-ZFP 492 is indeed found in the nucleolus of both HeTa and NIH 3T3 cells as
suggested by immunofluorescence. Hence, endogenous distribution of KRAB-ZFP
492 appears to differ from the gene-trap and GFP-tagged 492 protein.
Endogenous KRAB-ZFP 492 has a diffuse, granular pattern throughout the
nucleoplasm in which small punctate foci can be found, depending on the cell type
and the effects of RA differentiation. Punctate foci were also observed with 492-
GFP in some NIH 3T3 cells (Fig. 3.7), which suggests that the GFP tag does not
interfere with 492 localisation to the smaller foci, assuming that these are the same
foci. Nevertheless, the foci appear to require the KRAB and/or linker region since
they are not observed with the GFP-492-ZF construct. Thus neither the 492-P-gal
fusion protein nor GFP-tagging of 492 accurately portrays its endogenous
distribution. In ES cells, strong nucleolar staining is found in a higher proportion of
undifferentiated cells than in differentiated ES cells or the fibroblastic NIH 3T3 and
FleLa cell lines. Cytoplasmic staining is also more prominent in the latter but this
could be a result of these cell types having larger cytoplasmic volume.
These results led me to investigate whether or not there is a correlation between the
nucleolar localisation of KRAB-ZFP 492 and the presence of discrete KRAB-ZFP
492 foci with cell differentiation using the AP492 antibody.
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Figure 4.13 Analyses of nucleolar distribution by western blotting
Western blots of NIH 3T3 and HeLa whole cell (W), cytoplasmic (C), nuclear (Nu), nucleoplasms (NP)
and nucleolar (Ni) extracts with 1:1000 and 1:1500 dilutions of AP492 (A) and IgG492 (B) respectively.
Arrowheads and double arrowheads indicate the ~ 60kDa and -80 kDa 492 proteins. NIH 3T3 extracts
were also incubated with a-fibrillarin antibody (1:5000) as a positive control (arrow).
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4.8.6 Nucleolar localisation of KRAB-ZFP 492 is not
dependent on differentiation
To find out if nucleolar localisation of KRAB-ZFP 492 is related to cell
differentiation I used OS25 ES cells (E14 derived) (a gift of A. Smith). These cells
have [3-geo integrated into the Sox2 locus and hygromycin thymidine kinase (tk) into
the Oct4 locus by homologous recombination (Billon et al., 2002). Undifferentiated,
(Sox2 positive) ES cells can be selected with G418 and RA-differentiated cells
selected with gancyclovir (section 2.7.4). The differentiation status of the ES cells
were ensured by alkaline phosphatase staining (data not shown) before plating onto
slides and fixing in 3% pFa for immunofluorescence. Undifferentiated OS25 cells
were co-stained with AP492 and a-KAP-1 antibodies. Signal from AP492 is present
in the nucleolus in -80% of undifferentiated OS25 cells (Fig. 4.14, arrows). KAP-1
stains diffusely in the nucleus in -80-90% of OS25 cells but can be found at
pericentromeric heterochromatin in the remaining cells. OS25 cells were
differentiated with RA (5x 10-6 M) for two days then RA in the presence of
gancyclovir (2.5 pM) for a further two days. Differentiation status was confirmed by
alkaline phosphatase staining (data not shown) and by immunofluorescence with a-
SSEA-1 antibodies. KRAB-ZFP 492 appears to be in the nucleolus of -26% of
differentiated cells and a-KAP-1 was present at pericentromeric heterochromatin in
-80-90% cells (Fig. 4.14, double arrowheads), but KAP-1 was often found to co-
localise with AP492 in smaller punctate foci (Fig. 4.14, arrowheads). AP492 very
rarely co-localised with pericentromeric heterochromatin (data not shown).
Therefore the majority of KRAB-ZFP 492 relocates from the nucleolus to the
nucleoplasm upon differentiation of ES cells but the relative amount of 492 protein
in the nucleus does not appear to alter. This was confirmed by western blotting (data
not shown). Flowever, the nucleolar localisation is clearly not restricted to
undifferentiated cells (Fig. 4.14, differentiated SSEA-1 negative cells, with AP492
signal in nucleolus), suggesting that nucleolar distribution of KRAB-ZFP 492 may
be cell-cycle/cell proliferation related. -15% of OS25 cells, whilst undergoing
selection for undifferentiation, do not stain with a-SSEA-1 (Billon et al., 2002).
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Figure 4,14 Localisation of endogeneous 492 KRAB-ZFP in
OS25 cells
Immunofluorescence on undifferentiated (-RA) and differentiated (+RA) OS25 ES cells with 1:100
AP492 (green in merge) and either a-KAP-1 or a-SSEA-1 (red in merge) antibodies. Nuclei are
counterstained with I)API (blue in merge). Arrows indicate cells with nucleolar staining. Arrowheads
indicate punctate foci and double arrowheads indicate heterochromatic staining. Bars = 5 mm.
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Non-staining of the antibody may account for this phenomenon, or these cells may
overcome the selection process and spontaneously differentiate in culture as SSEA-1
negative cells. AP492 was found to be nucleolar in both SSEA-1 positive and
negative undifferentiated cells (Fig. 4.14), suggestive of a possible cell cycle
regulated, nucleolar distribution ofKRAB-ZFP 492.
4.9 Discussion
At the start of this thesis, the localisation of KRAB-ZFPs with respect to KAP-1 had
not been extensively studied. Reports described the co-localisation of epitope-tagged
KRAZ1 with KAP-1 at heterochromatin in NIE1 3T3 cells (Matsuda et al., 2001), and
ZFP-37 (Payen et al., 1998) and the gene-trapped KRAB-ZFPs (Sutherland et al.,
2001) were also found to be situated at heterochromatin in a subset cells. Flence I
investigated the localisation of the gene-trapped KRAB-ZFPs by
immunofluorescence with respect to cellular differentiation and the cell cycle. In
undifferentiated gene-trap ES cells, I found that two populations of cells exist, those
with and those without KRAB-ZFPs and KAP-1 concentrated at heterochromatin.
Although, a-KAP-1 and a-SSEA-1 dual immunofluorescence experiments could not
be performed, it is highly probable that KAP-1 is concentrated at pericentromeric
heterochromatin of some undifferentiated cells. However, I found a striking re-
localisation of both KAP-1 and the gene-tapped fusion proteins to pericentromeric
heterochromatin upon differentiation. KAP-1 is probably required (but not
sufficient) for KRAB-(3-gal localisation. Concomitant with this study, Cammas et al.
showed a significant re-localisation of KAP-1 to heterochromatin in ES and F9 cells
after 48 hr of RA differentiation, but they did not examine any KRAB-ZFPs
(Cammas et al., 2002). Heterochromatic localisation of the gene-trapped KRAB-
ZFPs, like KAP-1, was also found to be independent of the cell cycle (section 4.6;
Cammas et al, 2002) although there appears to be a correlation with the proliferative
state of cells in that cells with heterochromatic a-(3-gal staining were found in BrdU
negative cells more often than BrdU positive cells.
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To determine if full-length proteins behave the same way as the gene-traps I made
full-length 492-GFP constructs with the GFP tag in both orientations and generated
various mutant 492 constructs which contained either the KRAB (+linker) or ZF
domains only. With the tag in either orientation, 492-GFP localised to
pericentromeric heterochromatin in -20% of transfected cells similar to epitope
tagged KRAZ1 and KRAZ2. Flowever, the staining pattern slightly differs due to the
additional appearance of smaller punctate foci that were not associated with
heterochromatin. I decided to generate an antibody to the endogenous 492 gene-trap
protein as it is possible that transfection of tagged proteins could lead to protein mis-
localisation or aggregates of over-expressed protein. The small foci were often
observed by immunofluorescence with AP/IgG492 antibodies, but interestingly, in
contrast to both the gene-trap fusion protein and GFP-tagged 492, pericentromeric
localisation was rarely observed. Similarly, GFP-tagged ZFP-57 was found to have
large punctate foci in the nuclei of transfected NIH 3T3 cells that co-localise with
HP la in heterochromatin rich areas as revealed by Hoechst dye which identifies
A/T-rich repeat sequences in heterochromatin (Alonso et ah, 2004). In Schwann
cells, endogenous ZFP-57 antibody staining is described as small punctate foci in
contrast to the larger distinct patches seen in transfected cells and this euchromatic
staining also overlaps with HP la, although these pictures are not clear in the paper
(Alonso et ah, 2004).
In the case of the gene-traps and GFP-tagged 492, heterochromatic targeting via
KAP-1 must be due to the KRAB+linker domain. Interestingly, some ESTs in the
databases appear to encode KRAB-domain only containing proteins. I predict that
these proteins might be distributed in cells in a similar way to the gene-traps. In
support of this, a recent report describes an alternatively spliced isoform of the
Zfp208 locus that encodes a KRAB-only protein (KRAB-O). When FLAG-tagged
and over-expressed in COS7 cells this construct was found to be nuclear and
cytoplasmic (Oh et ah, 2005) similar to GFP-492K. Additionally, a punctate staining
pattern in the nucleus was described with the number and size of the punctate spots
being variable. Co-localisation of these large spots with heterochromatin is not
obvious in this monkey cell line, but KRAB-O was shown to co-localise with FTAG-
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tagged KAP-1 when both constructs were transiently transfected into COS7 cells and
more cells expressed KRAB-0 when co-transfected with KAP-1 suggesting over-
expression of KAP-1 may stabilise the KRAB-0 protein. However, endogenous
antibody staining on primary cells from mouse embryonic gonads demonstrated a
more granular, nuclear diffuse staining pattern that overlapped with euchromatic
HPly proteins in a grainy, nuclear diffuse manner. Importantly, the localisation
studies of KRAB-ZFP 492 in the light of this recent evidence suggests that
endogenous KRAB-ZFPs may have very minor roles at pericentromeric
heterochromatin, if any and the effects of epitiope tagging KRAB-ZFPs may not be
the best way to study their cellular distributions. Such experiments should be
interpreted with caution since distribution patterns may depend on the epitope tag,
their level of expression and the cell type chosen for transfection. Whilst co-
localisation studies of over-expressed KRAB-ZFPs may define interactions that are
physiologically possible, they may not be mechanistically sound when compared to
endogenous co-localisation studies.
Indeed, the expression level of GFP-492 varied widely among individual transfected
cells, and there appeared to be a correlation between high levels of 492-GFP
expression and cell death. The transfection efficiency was only ever between 10%
and 20% and although it is possible that only cells in a particular stage of the cell
cycle express KRAB-ZFP 492, as postulated for NRIF (Casademunt et al., 1999), I
propose that KRAB-ZFP 492 or its target genes, are tightly regulated by the cell and
that over-expression of GFP-492 may cause excess 492 to be deposited at
heterochromatin via an in vivo interaction with KAP-1 and not because of mis-folded
protein aggregates. This over-expression may be directly or indirectly detrimental to
cells, as many nuclei with heterochromatic GFP-492 staining appeared smaller and
less healthy. The possible over-expression of tagged KRAB-ZFPs means that excess
protein may be recruited to heterochromatin and this could be the case for KRAZ1
and KRAZ2 (Matsuda et al., 2001).
Endogenous 492 KRAB-ZFP was also found in the nucleoli of both undifferentiated
ES cells and NIH3T3 cells, but this staining pattern was neither observed in the gene-
153
trap cells nor in cells transfected with tagged 492. The nucleolar localisation of
KRAB-ZFP 492 adds to the number of KRAB-ZFPs that have been found in the
nucleolus (Payen et al., 1998, Huang et al., 1999, Yano et al., 2000; and Leung et al.,
2003). This may reflect a nucleolar function, such as for Kid-1, which has a role in
nucleolar disintegration (Huang et al., 1999), or it may be one of a growing list of
proteins sequestered in the nucleolus. Nucleolar localisation of ZFP-37 is restricted
to certain neuronal cell types (cerebellar Purkinje cells) (Payen et al., 1998) and I
have shown a re-localisation of KRAB-ZFP 492 from the nucleolus during
differentiation; therefore, a potential role for 492 in the nucleolus may be for storage.
Proteins involved in developmentally regulated pathways, as is likely for KRAB-ZFP
492 (Chapter 6), are often compartmentalised in cells as a way of regulating their
function. For example, ARL5 (a member of the ARF family of Ras-related
GTPases), when in its GDP bound state, is concentrated in the nucleoli but once
bound to GTP it relocates to the nucleus where it can bind to HP1 a (Lin et al., 2002).
Recently, PML was found to regulate p53 stability by sequestering Mdm2, a negative
regulator of p53, to the nucleolus (Bernardi et al., 2004). KRAB-ZFP 492 may
function in such way since it is probably a negative regulator and during cell
differentiation could be released from the nucleolus whereupon it can bind to its
target genes to repress them. This hypothesis coincides with nuclear diffuse re-
localisation of KRAB-ZFP 492 and the formation of euchromatic foci in what are
predominantly differentiated ES cells. Flow KRAB-ZFP 492 is targeted to the
nucleolus is currently unknown as none of the tagged constructs showed enrichment
of the protein in the nucleolus. For ZNF274, nucleolar-targeting ability is restricted
to a minimal domain consisting of the third and fourth ZF (Yano et al., 2000). The
presence of 492 in the nucleolus may depend on its association with RNA and/or
DNA or other nucleolar and/or nuclear proteins, and such interactions may be
affected by protein modifications since nucleolar localisation of PML is dependent
on ATR activation and subsequent phosphorylation of PML by ATR (Bernardi et al.,
2004).
Recent evidence suggests that although the same domains are contained within
KRAB-ZFPs, they are not necessarily responsible for the same cellular targeting and
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this has vital functional implications. Construction of mutant/truncated versions of
some KRAB-ZFPs and their subsequent epitope tagging has elucidated the domains,
at least in part, involved in cellular targeting (Grondin et ah, 1996; Yano et al., 2000;
Jheon et ah, 2001; Mark et ah, 2001; Sun et ah, 2003; Hennemann et ah, 2003; Gou
et ah, 2004; Alonso et ah, 2004). For 492,the gene-trapped protein suggests that the
KRAB (+linker) domain is exclusively responsible for nuclear targeting, but GFP-
492K shows cytoplasmic staining also. Similarly, the KRAB domain of ZNF300 is
diffuse throughout the whole of the cell whilst the ZF domain is targeted to the
nucleus (Gou et ah, 2004). In both cases, cytoplasmic staining may be the result of
over-expression. The ZF domain of 492 is not responsible for nuclear targeting and
none of the 492 constructs were responsible for enrichment of the protein in nucleoli.
Other protein-binding partners of KRAB-ZFP 492 may therefore be responsible for
its localisation, as is the case for NR1F (Gentry et ah, 2004). C-terminal mutants of
NRIF (lacking ZF domain), which were able to associate with TRAF6 (a member of
the TNF receptor subfamily), were never observed within the nucleus, but
accumulated in perinuclear regions. It is speculated that the KRAB domain ofNRIF
prevents its entry into the nucleus and that this block is only relieved upon binding to
TRAF6, although how TRAF6 allows this nuclear targeting is unknown (Gentry et
ah, 2004). The N-terminal mutants that were unable to bind TRAF6 were found
exclusively in the nucleus. Therefore the binding of these two proteins is required
for changes in sub-cellular distribution of NRIF suggesting that KRAB-ZFPs can
shuttle between the nucleus and the cytoplasm depending on protein-protein
interactions (Gentry et ah, 2004). Endogenous 492 localisation in the nucleus and
nucleolus provides further evidence for KRAB-ZFP shuttling.
Matsuda et ah (2001) suggest that pericentromeric localisation of KRAZ1 and
KRAZ2 is central to their ability to repress transcription. Based on the results of this
chapter, my supposition is that KRAB-ZFPs need not be recruited to pericentromeric
heterochromatin for KAP-1 mediated repression. Furthermore, it is perhaps at the
smaller foci, which form on differentiation, that repression of a specific or set of
target genes may occur since KAP-1 was also localised at some of these foci. Since
KRAB-ZFP 492 was rarely enriched at heterochromatin, it is possible that the
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KRAB-KAP-1 interaction at heterochromatin is a transient one. On this note,
KRAB-ZFP 492 was never completely excluded from heterochromatin. The
question remains therefore, as to why KAP-1 is enriched at heterochromatin upon
differentiation if not to mediate gene repression via the KRAB domain? The report
of a novel KAP-1-associated histone H3, lysine 9 (H3-K9) specific
methyltransferase, SETDB1, which was shown to contribute to KAP-1-HP1-
mediated silencing of euchromatic genes (Schultz et al., 2002) influenced me to
pursue the small punctate foci that I observed for KRAB-ZFP 492, with a view to
further understanding the role ofKRAB-ZFPs in KAP-1 mediated repression.
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Chapter 5
Investigation into the role of KRAB-
ZFPs in KAP-1 mediated repression
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5.1 Introduction
In the last two years, only a few papers have built on the initial KRAB-KAP-1
mediated repression hypothesis (Schultz et al., 2002; Cammas et al., 2002;
Ayyanathan et al., 2003; Cammas et al., 2004) (Fig. 1.6 and 5.1 Al). The first of the
KRAB-KAP-1 mediated repression models suggests that regulation of cell-type
specific genes or sub-sets of genes could be a direct result ofKRAB-ZFPs binding to
target promoters, with subsequent translocation of the gene to centromeric
heterochromatin via the KRAB-KAP-1-HP 1 interaction (Fig. 1.6 and 5.1Al).
Evidence for this model is suggested from the finding that the PxVxL motif ofKAP-
1 is essential for both HP1 interaction, centromeric localisation, and thus gene
silencing (Matsuda et al., 2001; Cammas et al., 2002). Whilst this interaction and
dynamic re-location to heterochromatin of KAP-1 is not required for initial RA
differentiation of F9 EC cells into primitive endoderm cells (PrE), it is required for
differentiation into visceral endoderm (VE) and parietal endoderm-like (PE) on
addition of cAMP (cyclic AMP) (Cammas et al., 2004). The KAP-1-HP 1
interaction is required during a short window of time within early differentiating PrE
cells (between 1 -2 days of RA treatment) for their terminal differentiation into PE
and VE and the necessity of the KAP-1-HP 1 interaction during this time frame
coincides precisely with re-localisation of KAP-1 from eu- to heterochromatin. The
consequent down-regulation of 3 endoderm-specific genes (GATA6, HNF4 and
Dab2) during PrE differentiation of cells with a disrupted KAP-1-HP 1 interaction
lends support to the idea that the KAP-1-HP 1 co-repressor complex may trigger the
translocation of their direct target genes from eu- to heterochromatin for their
silencing in order to allow the normal expression of GATA6, HNF4 and Dab2. That
KRAB-ZFPs may relocate their target genes to heterochromatin for silencing is
based on the model of Ikaros-mediated silencing of the Tdt genes during T-cell
activation (Brown et al., 1997; Brown el al., 1999) and is suggested by the
observation that two KRAB-ZFPs (KRAZ1 and KRAZ2) co-localise with KAP-1
and HP1 proteins within pericentromeric heterochromatin (Matsuda et al., 2001). In
support of this model, a euchromatic luciferase transgene has recently been shown to
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Figure 5.1 The KRAB-KAP-1 repression model
A) Proposed model for KRAB-KAP-1 mediated repression. Refer to Figure 1.6 for legend. B) KRAB-
ZFPs are stored in the nucleolus in undifferentiated cells. Upon differentiation, KRAB-ZFPs are released
from the nucleolus were they can bind to their specific target genes. (I) Localised repression ofKRAB-
ZFP genes, mediated by KAP-1, occurs in KRAB and KAP-1 associated (KAKA) foci and is Suv39h
independent. (II) KAP-1 recruitment to heterochromatin is Suv39 dependent.
re-locate to heterochromatin upon repression by a hormone-regulatable DNA-
binding KRAB-domain fusion protein (Ayyanathan et al., 2003).
The second proposed model is that individual KRAB-ZFPs target specific genes for
silencing by recruitment of KAP-1, whose oligomerisation could form the basis of a
molecular platform to co-ordinate the subsequent recruitment of the NuRD HDAC
complex, SETDB1 and HP1 (Fig. 1.6 and 5.1All). This would facilitate the
nucleation of facultative heterochromatin at the locus (Schultz et al., 2002;
Ayyanathan et al., 2003). The formation of a local heterochromatic environment is
based on evidence, initially uncovered in a yeast two-hybrid assay, that showed the
interaction of a novel SET-domain protein, SETDB1 with the PHD and
bromodomain of KAP-1 (Schultz et al., 2002). A different region of this interaction
surface was previously found to be responsible for interaction with Mi-2a (a novel
subunit of the NuRD HDAC complex, see section 1.3.3). The SETDB1 H3-K9
histone methyltransferase (HMT) localises exclusively in euchromatic regions of
NIH 3T3 cells and overlaps with euchromatic HP la staining (Schultz et al., 2002).
The study of KAP-1, SETDB1 and HP1 recruitment to euchromatic genes targeted
by KRAB-ZFPs then ensued with a series of experiments on NIH 3T3 cells
comprising a hormone inducible two-plasmid system (Schultz et al., 2002;
Ayyanathan et al., 2003). This system comprises a reporter plasmid that has been
stably integrated into a highly transcribed region of euchromatin, and an expression
plasmid encoding a hormone-regulatable DNA-binding KRAB-domain fusion
protein. The transient and reversible targeting of endogenous KAP-1 and its
associated factors to the tk promoter and its effects on luciferase transgene
expression in the presence/absence of oestrogen (KRAB-fusion protein binding does
not occur in the absence of oestrogen) was analysed. ChIP (chromatin
immunoprecipitation) analysis showed enrichment of SETDB1, KAP-1, HP la and
H3-methylated K9 at the tk promoter upon oestrogen induction but HPly remained
constitutively bound. These chromatin changes were highly localised to the
luciferase transgene and did not spread to the linked promoters of the selection
cassettes (zeocin expression from the linked zeocin cassette -2.8 kb away was
unaffected). Localised chromatin compaction in the promoter region was
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demonstrated by lack of nuclease accessibility. Similar results were achieved with
ChIP on an endogenous target gene, Coll 1 a2, using antibodies to its cognate KRAB-
ZFP, NT-2, although importantly, whether the target gene re-localised to
pericentromeric heterochromatin was not analysed in this study (Ayyanathan et al.,
2003).
Whilst the above models are not mutually exclusive, both can be corroborated by the
sub-nuclear distribution of KAP-1, neither has yet been proven by a thorough study
of localisation of an endogenous KRAB-ZFP or a target gene, due to the scarcity of
both KRAB-ZFP antibodies or known targets. In this chapter I have attempted to
build on the two proposed models of KRAB-KAP-1 mediated repression with the
reagents available. To this end, I have characterised the euchromatic foci of KRAB-
ZFP 492 (Chapter 4) and have tried to address whether these foci are specific to 492
or whether they are a general frequent of KRAB-ZFPs by investigating the sub-
nuclear distribution of another KRAB-ZFP, NT-2. Since SETDB1 is reported to be
euchromatic, I surmise that it is not involved in localisation of KAP-1 to
pericentromeric heterochromatin and have therefore examined whether or not the
Suv39hl and Suv39h2 H3-K9 HMTs, which direct DNA methylation to major and
minor satellite repeats at pericentromeric heterochromatin (Lehnertz et al, 2003),
play a role here instead by investigating what happens to KAP-1 and the 492 foci in
Suv39h dn cells. Since DNA methylation might play a role in the mitotically
heritable gene silencing of the luciferase transgene (Ayyanathan et al., 2003), I have
also examined the sub-nuclear distribution of KAP-1 and the 492 foci in Dnmt3ab" "
cells, which lack any DNA methylation (Jackson et al., 2004).
5.2 Euchromatic foci of KRAB-ZFP 492 co-
localise with HP1a and HP1(3
I think it most likely that the discrete 492 euchromatic foci (section 4.8.5) correspond
to small territories, or islands, of facultative heterochromatin as predicted by the
latter of the two models described above. These foci could represent the capacity of
KAP-1 to co-ordinate the biochemical activities required to induce and maintain the
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assembly of a local, but higher-order, chromatin structure at a genomic region
targeted by a given KRAB-ZFP. I therefore decided to test for the presence of the
HP1 proteins within these discrete foci.
In mammalian cells, the HP1 proteins have specific nuclear staining patterns
depending on the cell type and the level of expression. HP la is mostly concentrated
at sites of constitutive heterochromatin in both human HT1080 cells (Gilbert et al.,
2003), and murine cells, for example, NIH 3T3, C127 and EC cells (Horsley et al.,
1996; Neilsen et al. 1999; Mine et al. 2000; Cammas et al., 2002). HP 1(3 and y are
also detectable at sites of pericentromeric heterochromatin in mouse cells, but there
is also a large pool of these proteins distributed more diffusely throughout the
nucleoplasm. HPly is predominantly found at euchromatic sites (Horsley et al.,
1996; Neilsen et al., 1999). In contrast, HP 1(3 and y cannot be seen associated with
centromeric domains in human cells but there are clear non-centromeric foci, which
most likely correspond to other heterochromatin domains (Gilbert et al., 2003). In
mouse elongating spermatids HP la is expressed at very low levels and goes
undetected by immunofluorescence, whereas HP 1(3 and y both exhibit a predominant
localisation to the chromocenter and other additional sites dispersed within the
nucleoplasm of this cell type (Khetchoumian et al., 2004). Notably, KAP-1 is not
expressed in elongating spermatids (Weber et al., 2002) although TIF 18 is, and co-
localises with HPly at these additional nucleoplasm^ sites that are postulated to be
heterochromatin or heterochromatin-like repressive structures (Khetchoumian et al.,
2004). This shows that the HP1 proteins have distinct euchromatic roles in addition
to their function at pericentromeric heterochromatin.
Undifferentiated and differentiated OS25 cells and NIH 3T3 were fixed with 3% pFa
onto slides for immunofluorescence (section 2.8.1). Cells were incubated with
AP492 and either a-HPla, a-HPl(3 or a-HPly antibodies. Dual HP1 and KAP-1
immunofluorescence could not be performed because all antibodies were raised in
mouse. HP1 sub-nuclear localisation in OS25 cells was comparable with that
reported in other mouse cell types. As shown previously in undifferentiated OS25
cells, 492 was enriched in nucleoli and also showed diffuse nucleoplasmic staining.
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However, in a small proportion of NIH 3T3 cells, and more particularly in
differentiated OS25 cells (-5-10%), 492 foci were observed. These were found to be
juxta-positioned to both non-pericentromeric foci of both HPla and HPip (Fig. 5.2,
arrowheads). Confocal imaging confirmed these staining patterns with HPla (Fig.
5.3, arrowheads). KRAB-ZFP 492 foci were not always adjacent to HP1 (Fig 5.3)
and/or KAP-1 foci (Fig. 4.14) verifying that merged signal is not a result of bleed-
through fluorescence. Nuclei containing more prominent 492/HP1 foci were often
larger and flatter than other differentiated cells on the same slide (Figures 4.12, 4.14
and 5.2). Co-localisation of foci with HPly was not observed (Fig. 5.2). This may
be due to the stronger euchromatic staining observed with this antibody so that
defined and discrete foci cannot often be visualised. However, enrichment of HPly
also does not occur in ChlP experiments with the integrated luciferase transgene
(Ayyanathan et al., 2003).
The foci of staining with AP492 might represent a novel nuclear domain or co-
localisation to a known nuclear compartment. Therefore I performed dual
immunofluorescence with antibodies to PML (promyelotic leukaemia) nuclear
bodies and CREST anti-sera, to see if these foci marked either of these nuclear sub-
compartments. Centromeres are composed of both major and minor satellite DNA,
the latter of which form distinct sub-nuclear compartments not necessarily
represented by the DAPI bright spots of associated major satellites, and are
associated with different sets of non-histone proteins (Guenatri et al., 2004). The
well-characterised nuclear dot-like structures previously described for PML, SC35
and BRCA1 had already been tested for co-localisation with KAP-1, but the
emphasis of co-localisation was with respect to the large foci of pericentromeric
KAP-1 staining (Ryan et al., 1999). PML has been implicated as a cofactor of
TIF la-dependent enhancement of RARa-mediated transcriptional activation (Zhong
et al., 1999) and a splice variant of a major constituent of PML bodies, SP100C, has
homology to the TIF1 proteins, with all homologues being covalently modified by
SUMO (Seeler et al., 2001). SP100 is also known to bind to HP1 proteins (Seeler et
al., 1998). It is therefore conceivable that PML bodies may also contain KRAB-
























Figure 5.2 Localisation of endogenous 492 KRAB-ZFP and the HP1 isoforms
Immunofluorecence ofNIH 3T3 and undifferentiated and differentiated OS25 ES cells with 1:100 AP492
(green in merge) and a-HPl (red in merge) antibodies. Nuclei are counterstained with DAPI (blue in
merge). Arrowheads indicate 492 punctate foci and double arrowheads indicate heterochromatic staining.
Bars = 5 pm.
Figure 5.3 Confocal microscopy of KRAB-ZFP 492 foci
Immunofluorecence of NIH 3T3, undifferentiated (-RA) and differentiated (+RA) OS25 ES cells with
AP492 (green in merge) and either a-HPla, a-PML or human CREST a-sera. A confocal image is
not shown for AP492 and a-PML co-staining. Arrows indicate cells with nucleolar staining. Arrowheads
indicate 492 punctate foci and double arrowheads indicate heterochromatic staining. Bars= 5 pm.
immunofluorescence with AP492 and either a-PML antibodies or human CREST
anti-sera with subsequent fluorescent/confocal imaging demonstrated that the 492
foci did not significantly overlap with either of these nuclear sub-compartments (Fig.
5.3).
The KRAB-ZFP 492 foci could represent regions occupied by target genes, or they
could be a consequence of other protein-protein interactions mediated by the ZF or
linker region. Various KRAB-ZFPs are known to interact with other proteins via
their ZF, KRAB or linker regions (section 7.6). But whilst homo-oligomerisation of
ZBRK1 and NRIF has been reported (Tan et al., 2004a; Gentry et al., 2004), there is
no evidence to suggest that different KRAB-ZFPs can directly interact. Hence the
KRAB-ZFP 492 foci may represent a novel sub-nuclear compartment in which other
KRAB-ZFPs may also be present and this nuclear organisation may help them to
achieve their common function of gene silencing. The co-localisation of transcribed
genes to functional sub-nuclear compartments called 'transcription factories' for
gene transcription has recently been described (Osborne et al., 2004). In pursuit of
whether the 492 foci represent the assembly of a novel repression complex at a
euchromatic gene or whether they represent a 'silencing factory' to where different
KRAB-ZFP target genes migrate upon regulation by a number of individual KRAB-
ZFPs, I decided to investigate the sub-nuclear localisation pattern of the only other
murine KRAB-ZFP, NT-2, for which an antibody was available at that time (Tanaka
et al., 2002), and for which the nuclear localisation had not yet been reported.
5.3 Analysis of the sub-nuclear localisation of
another KRAB-ZFP, NT-2
Until October 2003, NT-2 was the only murine KRAB-ZFP for which a
physiological target gene was known. NT-2 is a SCAN domain-containing KRAB-
ZFP and binds in a 24 bp region of the Coll la2 promoter. The role of NT-2 as a
negative regulator of the cartilage specific Collla2 (<x2[XI] collagen) gene in a
differentiating cell system has been documented; and during differentiation of the
murine EC-derived chondrogenic cell line, ATDC5, NT-2 mRNA levels are inversely
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correlated with those of Coll la (Tanaka et al., 2002). NT-2 mRNA is abundant in
undifferentiated ATDC5 cells, but decreases when the cells differentiate into
proliferative chondrocytes (d6-dl5) and begin to express Collla2 (Fig. 5.4A).
Further culturing into hypertrophic chondrocytes (dl5-d21), concomitant with the
formation of cartilage nodules, up-regulates NT-2 mRNA expression and expression
of Collla2 is repressed with the onset of CollOal expression. Thanks to Dr
Yoshihiko Yamada, who kindly provided NT-2 antibody, I was able to examine the
localisation of NT-2 by immunofluorescence during the differentiation of ATDC5
cells.
Firstly, I analysed the NT-2 antibody by western blotting. As previously described,
NT-2 antibody detects a prominent band of -75 kDa in NIH 3T3 and ATDC5 cells
(Fig. 5.4B), although lower MW bands could also be identified after longer
exposures (data not shown) (Tanaka et al., 2002; Ayyanathan et al., 2003). In OS25
cell extracts additional bands were detected including a very prominent -38 kDa
species (Fig. 5.4B). These bands could be non-specific, or alternative isoforms of the
NT-2 KRAB-ZFP. Despite the concern of specificity, I tested the a-NT-2 antibody
by immunofluorescence in NIH 3T3 and in undifferentiated and differentiated OS25
cells. -30-50% of NIH 3T3 cells showed nucleolar localisation of NT-2 which co-
localised with fibrillarin (data not shown). The remaining cells showed a nuclear
diffuse localisation with discrete foci in -10% of cells (Fig. 5.4C, arrowheads), but
there was no co-localisation with KAP-1 (data not shown) or HP la (Fig. 5.4C).
Dual immunofluorescence in undifferentiated OS25 cells with a-NT-2 and a-
fibrillarin showed NT-2 to be in one or more nucleoli or a patch adjacent to one, but
never the largest nucleoli (Fig. 5.4C, arrows) and often no co-localisation was seen at
all (data not shown). However, re-distribution of NT-2 from 'minor
nucleoli/patches' in undifferentiated OS25 cells (Fig. 5.4C, arrows) to the
nucleoplasm was observed upon differentiation. This is reminiscent of 492 re¬
distribution. Foci were observed in differentiated OS25 cells, but again no obvious
co-localisation with HP la or with KAP-1 was observed (Fig. 5.4C, arrowheads). No
co-localisation was observed with the other HP1 isoforms (data not shown). I








Figure 5.4 Analysis of NT-2 antibodies by western blotting and
immunofluorescence
(A) Schematic to show NT-2 and CollIa2 mRNA levels in differentiating ATDC5 cells. X, undetected.
(B) Western blots of NIH 3T3, ATDC5 and wt OS25 whole cell extracts with a-NT-2 antibody (1:1250).
An arrow indicates the prominant ~75 kDa band after a 45 sec exposure. (C) Immunofluorescence of
Nlil 3T3 and OS25 ES cells before ( RA) and after differentiation (+RA) with 1:1(K) a-NT-2 (green in
merge) and either a-HPla or a-fibrillarin (a-fib) (red in merge) antibodies. Nuclei are counterstained
with DAPI (blue in merge). Arrows indicate a-NT-2 localisation in an unknown domain in undifferentiated
OS25 cells. Arrowheads indicate punctate foci and double arrowheads indicate heterochromatic staining.
Bars = 5 pm.
expression of Colli u2 during ATDC5 cell differentiation. I differentiated ATDC5
cells for 26 days as previously described (Shukunami et al., 1996) (section 2.7.3) and
assayed the differentiation status of the cells at days 6, 10, 14, 21 and 26 of
differentiation by staining in 0.1% alcian blue, which stains the extra-cellular
cartilage matrix. Small amounts of alcian blue positive cartilage formation were first
detectable at day 6 of differentiation after which they increased in size due to
maturation of cells and accumulation of collagen matrix (Shukunami et al., 1996)
(Fig. 5.5A). Immunofluorescence on pFa fixed cells with a-NT-2 showed that in
undifferentiated ATDC5 cells NT-2 is diffusely localised within the nucleoplasm, but
~50% cells showed nucleolar staining that co-localised with a-fibrillarin (Fig.5.5B).
KAP-1 has a diffuse nucleoplasmic distribution at this time point. From day 6
onwards, a proportion ofATDC5 nuclei were smaller and more rounded compared to
control nuclei, which reflects the time when ATDC5 cells are known to undergo a
transient condensation of cells before the formation of nodules (Shukunami et al.,
1996). Between day 6-8, NT-2 has a granular nuclear diffuse staining pattern that
appears gradually less intense in some cells, consistent with NT-2 down-regulation in
nodule forming cells where Collla2 expression is high (data not shown) but
nucleolar staining is still present in some cells at day 7 of differentiation (data not
shown) and no obvious foci could be seen. During this time frame, KAP-1 remained
dispersed throughout the nucleoplasm in both nodule and non-nodule forming cells,
with no localisation to pericentromeric heterochromatin (Fig. 5.5B). Flowever,
HP la was at pericentromeric heterochromatin in most cells. Between days 9-15,
NT-2 staining became more intense and punctate. Some cells showed
adjacent/overlapping NT-2/KAP-1 signal, reminiscent of the KRAB-ZFP 492 foci
(Fig. 5.5B, arrowheads). It is not known whether these cells represent nodule or non-
nodule forming cells. The appearance of these foci may correlate with transition
from Collla2 expression to CollOal expression during nodule formation but they
may also represent cells that have already undergone the transition when Coll la2 is
being repressed. At day 15, HP la remained predominantly localised to
pericentromeric heterochromatin (Fig. 5.5B). NT-2 was still nucleolar in a
proportion of cells (data not shown) but this was difficult to quantify because most of
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Figure 5.5 Analysis of sub-nuclear distribution of NT-2 during ATDC5
differentiation
(A) The differentiation status of ATDC5 cells was monitored by 0.1% alcian blue staining throughout
the 26 day (d) differentiation procedure. (B) Immunofluorescence of undifferentiated and
differentiatedATDC5 cells with 1:100 a-NT-2 (green in merge) and either a-KAP-1, a-fibrillarin
(a-fib) or a-HPla antibodies (red in merge). Nuclei are counterstained with DAP1 (blue in merge).
Arrows indicate cells with nucleolar staining. Arrowheads indicate punctate foci and double













the cells were nodule forming and growing in polylayers due to the loss of contact
inhibition (Shukunami et al., 1996). At day 21-26, cells were smeared onto slides
before fixation and allowed to air dry so that antibodies could have better access to
the cells with as little disruption to the immediate cellular environment as possible.
The DNA in these cells is considerably condensed at this time point and a layer of
heterochromatin, as visualised with DAPI staining, is observed surrounding the
nuclear periphery of many cells. In -30-40% cells KAP-1 was enriched at this
perinuclear heterochromatin (Fig. 5.4B). In many cells KAP-1 and NT-2 are in
adjacent/overlapping euchromatic foci (Fig. 5.5B), which often appear close to or in
nucleoli, but the nucleolus is not an obvious structure at day 21 and dual
immunofluorescence experiments were not performed with a-fibrillarin at day 21.
NT-2, similar to KRAB-ZFP 492, appears to be re-distributed from the nucleolus to
the nucleoplasm upon differentiation. It seems plausible that these two KRAB-ZFPs,
could either be stored in the nucleolus before the onset of differentiation, or at
particular stages of the cell cycle, or that they may even carry out a function there
such as RNA binding. In some cells KAP-1 appears to be enriched at
heterochromatin upon ATDC5 cell differentiation into hypertrophic chondrocytes but
I did not test FlPla at this stage of differentiation. 1 predict that it is likely to be co-
localised with KAP-1 in these cells unless the HP1 interaction is not responsible for
KAP-1 localisation in this cell type.
5.4 Investigation into KAP-1 recruitment to
pericentromeric heterochromatin in ES cells
To further understand the conditions of KAP-1 translocation to pericentromeric
heterochromatin and the formation of 492 foci I decided to investigate this in both
Suv39h dn cells and Dnmt3a/b~'~ (Dnmt3a and 3b double knockout) cells. The
Suv39hl and h2 (Suv39h) HMTs are enriched at pericentromeric heterochromatin
(Aagaard et al., 1999) and selectively tri-methylate histone 143 at K9 to create a high-
affinity binding site for HP1 (Lachner et al., 2001; Bannister et al., 2001). They
therefore play a central role in gene silencing at heterochromatin (Schotta et al.,
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2002). In Suv39h dn cells, lack of tri-methylated H3-K9 causes HP la and HP 1(3 to
be de-localised from pericentromeric heterochromatin (Peters et al., 2001; Lehnertz
et al, 2003). Since HP1 interaction is known to be vital for KAP-1 translocation
(Cammas et al., 2004), I hypothesised that KAP-1 translocation would be lost in
Suv39h dn cells. Dnmt3a and 3b also localise to pericentromeric heterochromatin in
ES cells (Bachman et al., 2001) via their PWWP domain (Chen et al., 2004) and
Dnmt3a interacts, both in vitro and in vivo, with Suv39hl via its PHD-like motif
(Fuks et al., 2003). HP1|3, a physical and functional partner of Suv39hl, also binds
directly to Dnmt3a (Fuks et al., 2003). Moreover, in Suv39h dn cells, Dnmt3b fails
to localise to pericentromeric heterochromatin. However, H3-K9 trimethylation is
not impaired in Dnmt3a/b~'~ cells (Fehnertz et a/., 2003). That both of these
enzymatic activities might be required for KRAB-KAP-1 mediated repression was
hinted at in recent experiments by Ayyanathan et al. in 2003 when increased DNA
methylation of the tk promoter region (also enriched in KAP-1, HP1 and SETDB1
proteins) was found in stably silenced luciferase clones. Re-activation of the silent
locus by the combined action of 5-azacytidine (5-AZ) and TSA, to relieve both
histone methylation and histone deacetylation respectively, suggests that H3-K9
methylation and HP1 recruitment on a euchromatic gene may ultimately lead to
DNA methylation.
I first confirmed that pericentromeric heterochromatin is enriched for H3-K9 tri¬
methylation and HP1 localisation in wt ES cells, from which the Suv39h dn cell line
was generated (Table 2.6). I then performed immunofluorescence on
undifferentiated and differentiated Suv39h dn cells with AP492 and a-KAP-1
antibodies (Fig. 5.6). In undifferentiated wt and Suv39h dn cells, 492 was nucleolar
in a similar proportion of cells to that reported for OS25 cells (Fig. 5.6, arrow). As
expected, HP la and KAP-1 were not concentrated at heterochromatin in
differentiated Suv39h dn cells supporting the idea that tri-methylation of H3-K9 at
major satellite DNA via HP1 is required for KAP-1 targeting to heterochromatin
(Cammas et al., 2004). However, in differentiated Suv39h dn cells discrete 492 foci
were still observed, similar to wt cells, (Fig. 5.6, arrowheads) and these co-localised
with both KAP-1 and HP1 proteins suggesting that Suv39hl and h2 are not required
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Figure 5.6 Analysis of sub-nuclear distribution of KAP-1 and KRAB-
ZFP 492 in Suv39h dn cells
Immunofluorescence of undifferentiated (-RA) and differentiated (+RA) wt vv41 and Suv39h dn
cells with combinations of either 1:100 AP492 (green in merge), a-met3H3-K9 (red/green in merge),
a-KAP-1 or a-HPl antibodies (both red in merge). Nuclei are counterstained with DAPI (blue in
merge). Arrows indicate cells with nucleolar staining, arrowheads indicate punctate foci and double
arrowheads indicate heterochromatic staining. Bars = 5 pm.
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for the formation of these foci. If these foci are 'silencing factories' then SETDB1 is
likely to be the HMT responsible for histone methylation at these euchromatic sites.
I also analysed KAP-1 and AP492 localisation in Dnmt3a/b~'~ undifferentiated cells
and in contrast to Suv39h dn cells, KAP-1 localisation at heterochromatin was not
impaired (Fig. 5.7). Therefore, methylated DNA at pericentromeric heterochromatin
is not a pre-requisite for KAP-1 localisation. Ayyanathan et al. (2003) suggests that
DNA methylation is a secondary response to KRAB-KAP-1 mediated repression and
is involved in the heritability of genes targeted for silencing by KRAB-ZFPs. These
results suggest that KAP-1 localisation to heterochromatin is not the result of a
repressed gene being targeted for DNA methylation. Rather any DNA methylation at
the target gene is a separate event to KAP-1 function at heterochromatin. I also
attempted to differentiate the Dnmt3a/b~'~ cell line with RA to observe whether DNA
methylation is required for the formation of non-pericentromeric foci of 492 and
KAP-1. However, after a couple of days, all cells had died and therefore these could
not be studied. Recently, Dnmt3a/b~'~ cells were found to be unable to differentiate
by removal of LIF, but remained viable and they retained stem cell-like
characteristics such as Oct4 expression (Jackson et al., 2004). Therefore Dnmt3a/b~ ~
cells appear to be sensitive to RA, and these experiments suggest that DNA
methylation is crucial in the RA response pathways employed by ES cells.
5.6 Discussion
The results presented in this chapter suggest localised chromatin changes rather than
a translocation of KRAB-ZFP target genes to pericentromeric heterochromatin for
KRAB-KAP-1 mediated repression. I found that neither endogenous KRAB-ZFP
492 nor NT-2 localised to pericentromeric heterochromatin. Rather, I have identified
foci of KRAB-ZFPs that form in differentiated cells. Intriguingly, as well as being
present at pericentromeric heterochromatin in differentiated cells, KAP-1 and HP Is
are also found associated with these foci. I have named these foci KRAB and KAP-1
associated foci (KAKA foci). Finally in Suv39h dn cells which lack H3-K9
trimethylation, KAP-1 and HP1 were delocalised from pericentromeric







Figure 5.7 Analysis of sub-nuclear distribution of KAP-1 and KRAB-
ZFP 492 in Dnmt3a/b~/~ cells
Immunofluorescence of undifferentiated (-RA) and differentiated (+RA) wt Jl and Dnmt3a/b
cells with l: 100 AP492 (green in merge) and either a-KAP-1 or a-SSEA-1 antibodies (red in
merge). Nuclei are counterstained with DAPI (blue in merge). Arrows indicate cells with nucleolar
staining and double arrowheads indicate heterochromatic staining. Bars = |jm .
DAPI AP492 merge
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I propose that the KAKA foci are sites of KRAB-KAP-1-HP1 mediated gene
repression. As they still appear to form in Suv39h dn cells, this would occur via a
Suv39hl/2 independent mechanism, even though Suv39hl has previously been
reported to have some euchromatic roles (Firestein et al., 2000; Nielsen et al.,
2001a). In this way specific repression of KRAB-ZFP target genes would therefore
be predicted to occur in euchromatic regions by construction of facultative
heterochromatin during specific stages of proliferation or differentiation. As the
SETDB1 FIMTs has been found to interact with KAP-1, it is likely that in this system
it cooperates with KAP-1 and HP Is to mediate repression of KRAB-ZFP target
genes (Schultz et al., 2002; Ayyanathen et al., 2003). SETDB1 has previously been
shown to have a euchromatic distribution in NIH 3T3 cells, but it would be
interesting to investigate the localisation of SETDB1 (ESET) with respect to KAKA
foci in differentiating cells (Schultz et al., 2002). SETDB 1 catalyses the conversion
of histone H3-K9 di- to tri-methylation but docs not appear to affect global H3-K9
tri-methylation or DNA methylation (Dodge et al., 2004). Instead, the favoured
model is that SETDB 1 regulates gene expression at specific euchromatic sites
(Schultz et al., 2002; Dodge et al., 2004). SETDB 1 can methylate H3-K9 despite
H3-K4 methylation, in stark contrast to Suv39hl, whose enzymatic ability is severely
compromised by methylated H3-K4 (Schultz et al., 2002). Therefore SETDB 1 may
function to repress KRAB-ZFP target genes in specially 'marked' regions of
chromatin. It has also been suggested that SETDB 1 may be instrumental in
maintaining H3-K9 methylation at boundary elements, thus preventing the spread of
transcriptionally active chromatin domains from juxta-posed regions enriched in H3-
K4 methylation (Schultz et al., 2002). In this way SETDB 1 would be a good
candidate for inducing facultative heterochromatic in KAKA foci. HP1 deposition at
the tk promoter was totally dependent on H3-K9 methylation but optimal HP1
binding in an in vitro binding assay was also dependent on a functional
chromoshadow domain for stabilisation of the H3-K9-HP1 interaction (Schultz et al.,
2002). The chromoshadow of HP1 interacts with the HP1BD of KAP-1 and would
therefore be considered important for foci formation. Since KAP-1 exists as a
homotrimer in solution and two HP1 proteins bind per KAP-1 monomer (Peng et al.,
2000; Lechner et al., 2000), this might potentiate the propagation of facultative
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heterochromatin at a target locus, but whether the chromodomains of a single HP1
molecule can bind to the methylated H3-K9 tails of a single or two adjacent
nucleosomes remains to be answered.
KAKA foci in differentiated cells were observed with both AP492 and NT-2
antibodies. I have not been able to show if both antibodies occupy the same KAKA
sites, as the antibodies were both raised in rabbit. I also attempted direct labelling of
AP492 with fluorescently labelled IgG, but this was not successful. In order to
answer this question I would need to raise an antibody in a different organism. It is
not yet known whether KAKA foci are euchromatic regions specified by the
presence of KAP-1-PIP 1 repression machinery or by the KRAB-ZFP target genes
themselves. Sub-nuclear distribution of TIF la suggests the presence of TIF la
docking sites where it functions as a chromatin docking protein to which liganded
nuclear receptors bind (Remboutsika et al., 1999). The KAKA foci characterised in
this chapter could represent similar docking sites or 'silencing factories', which form
during differentiation so that many KRAB-ZFPs can recruit their target genes for
KAP-1-HP1 mediated silencing. The ATDC5 differentiation system in conjugation
with the NT-2 antibody would be ideal for testing whether a target gene, for
example, coll la2, is recruited to KAKA foci for silencing. However, due to both
technical issues and limited amounts of NT-2 antibody, I was not able to do this
critical experiment. Interestingly, like KRAB-ZFP 492, NT-2 was also found to be
in or adjacent to the nucleolus in undifferentiated cells. This suggests either a
nucleolar role for these proteins during cellular proliferation or that spatial
organisation of KRAB-ZFPs within the nucleus may be important for regulating their
activity.
If KRAB-ZFPs are not recruited to heterochromatin for silencing, then the
enrichment of KAP-1 at heterochromatin in differentiated ES and ATDC5 cells
suggests that it may have a function there other than KRAB-mediated repression.
For example, heterochromatic KAP-1 localisation has been proposed as a KAP-1
storage site (Cammas et al., 2002; Gammas et al., 2004). In this regard accumulation
of KAP-1 into regions of heterochromatin may control KAP-1 levels in the
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nucleoplasm therefore creating different sub-nuclear compartments of KAP-1 which
may exert different functions. In this respect, KAP-1 was reported to act as a co-
activator and physically interact with both the glucocorticoid receptor (GR) and
C/EBPp to augment C/EBPp transcriptional activity at the promoters of endogenous
C/EBPp-responsive genes during macrophage differentiation (Chang et al., 1998;
Rooney et al., 2001). Whether KAP-1 has both co-activator and co-repressor
functions in the same nuclei and whether different KAP-1 functions are separated in
vivo by nuclear compartmentalisation remains to be determined.
Importantly, Cammas et al. (2004) reported KAP-1 localisation at heterochromatin to
be critical for PE and VE differentiation. During differentiation of F9 cells, the
KAP-1-HP 1 interaction, and subsequent translocation to heterochromatin was
required during a small window of time after the onset ofRA treatment for complete
differentiation into PE cells. However, my results show that in Suv39h dn cells, the
translocation of KAP-1 to heterochromatin is abolished. This mis-localisation is
certainly not critical to survival of cells or even the whole organism as 33% of
knockout mice are viable (Peters et al., 2001). Interestingly KAP-1 preferentially
associates with regions of heterochromatin in the differentiated Sertoli and
spermatogenic cell types (Weber et al., 2002). Suv39h dn males display a complete
spermatogenic failure at the transition between early to late spermatogenesis, and
with delayed entry into meiotic prophase triggering apoptosis of spermatocytes
during the mid- to late pachytene (Peters et al., 2001). Therefore, KAP-1 mis-
localisation in Suv39h dn cells may be related to the inability of spermatocytes to
differentiate. Hence, KAP-1 localisation to heterochromatin could occur at crucial,
decision-making stages of development. I would predict from localisation of the
gene-trap fusion proteins, that any KRAB-box only splice forms of KRAB-ZFPs
would localise with KAP-1. Also, I cannot rule out that a transient association of
KRAB-ZFPs and their target loci to heterochromatin may also be important for their
repression as suggested by Ayyanathen et al., 2003. On this note, KRAB-ZFP 492
was not specifically excluded from heterochromatin in my studies.
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Neither KAP-1 nor HP1 re-localised from pericentromeric heterochromatin with the
formation of KAKA foci. However, the importance of HP1 localisation at
euchromatic sites has recently been demonstrated. A dynamic re-location of HP la
from centromeric heterochromatin to the nucleoplasm was found to occur during the
transition from proliferation to quiescence, in contrast to HP 1(3 remaining at
heterochromatin (Grigoryev et al., 2004). This re-location coincides with the
formation of facultative heterochromatin and transcriptional down-regulation, hence
HP la is predicted to assist in this global chromatin repression and facultative
heterochromatin formation. The correct nuclear distribution of euchromatic HP1
proteins might be crucial for the various regulatory aspects of cell proliferation and
differentiation. This has been demonstrated most recently in ICF patients who show
aberrant HP1 signal of all 3 isoforms in the under-condensed lqh or 16qh chromatin,
which is thought to be the result of prolonged association of HP1 with satellite DNA
as a consequence ofDNA hypomethylation (Tuciani et al., 2005).
Finally the step-wise model of KAP-1 co-ordinated gene repression at euchromatic
sites shares similarity with only one other co-repressor, Rb (retinoblastoma protein).
The Rb protein co-ordinates similar activities in the repression of euchromatic E2F
target genes in bringing the Suv39hl enzyme to the promoters of E2F target genes
where it can methylate K9 of histone H3 and provide a binding site for HP1 (Nielsen
et al., 2001a). The HDAC activity associated with Rb may be a preceding step to
Suv39hl-mediated methylation since methylation cannot take place on an already
acetylated lysine. Likewise, for KRAB-KAP-1 repression, the HDAC activity
associated with the NuRD complex may precede SETDB1 methyltransferase activity
allowing HP1 binding and subsequent heterochromatinisation of the promoter
specified by a particular KRAB-ZFP (Schultz et al., 2002). The visualisation of
these foci in cells provides further evidence ofpromoter heterochromatinisation. The
key question is whether these foci are associated with endogenous KRAB-ZFP target
genes and this remains the key unanswered question in this field of research. A way
to identify the physiological function and hence target genes of KRAB-ZFP 492 is to
generate knockout mice and compare the gene expression profiles of wt and
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homozygous mutant mice. The final results chapter of this thesis will describe the
initial results of these studies.
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Chapter 6




The effective trapping and mutating of genes with the (3-geo cassette provided a way
in which to study the KRAB-ZFP family that had not previously been utilised. I
wanted to establish some mutagenic KRAB-ZFP mouse lines from gene-trapped cell
lines as a first step in the initiation of their functional analysis. Since in mice, no
KRAB-ZFP target genes were known at the start ofmy PhD, it was thought that the
establishment of transgenic mouse lines, in addition to giving specific clues as to the
spatial and temporal expression pattern of a particular KRAB-ZFP, would eventually
prove to be useful for target gene assessment.
Only two mice have been reported with mutant KRAB-ZFP function (Casademunt et
al., 1999; Krebs et al., 2003) although KRAB-ZFP genes are deleted in the
embryonic lethal mutation (Crossley et al., 1991; Shannon et al., 1999). NRIF
(neurotrophin receptor interacting factor) is a ubiquitously expressed KRAB-ZFP of
the A+B KRAB box family (Casademunt et al., 1999). It physically interacts with
tumour suppressor protein, p75NTR, which is a neurotrophin receptor of the TNF
(tumour necrosis factor) receptor family of transmembrane proteins. Mice carrying a
deletion of the p75N1R-binding domain (pseudofinger region) and four of the five
C2H2 ZFs of NRIF, cannot survive beyond E12 in a congenic BL6 strain. In the
Svl29 background, mice are viable and healthy to adulthood. In the retinal cells of
these mice, NRIF appears to play a role in p75NTR mediated apoptosis since retinal
cells in mutant mice exhibit reduced cell death, a phenotype similar to that ofp75~'~
mice (Frade and Barde, 1999). More recently, Krebs et al. (2003) described the
necessity of a pair of KRAB-ZFPs in sexually dimorphic liver gene expression
during efforts to elucidate the gene responsible at the Rsl (regulator of sex limitation)
locus. This locus confers repression of sex-limited protein (Sip) that is normally
expressed in adult males only. Recessive rsl mutant alleles have arisen in
populations of inbred mice and result in aberrant expression of S/p in the livers of
female mice at 3 weeks of age and increased expression of Sip in males (Tullis et al.,
2003). In transgenic rsl mice, two KRAB-ZFP paralogues (Rslcan-4 and Rslcan-9)
have 94% protein similarity, and were consistently polymorphic in rsl strains (Krebs
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et al., 2003). Each of these genes was subsequently found to restore the appropriate
expression of a distinct sub-set of the male-specific liver genes. Therefore these
proteins act together to perform the function of Rsl and the small number of amino
acid differences between them is predicted to account for their different target
selection (Krebs et al., 2003).
From the work I have described in previous chapters, the gene-trap fusion proteins
mis-localise in the nucleus compared to endogenous KRAB-ZFPs. Therefore I
would predict the gene-trap lines to functionally disrupt the relevant KRAB-ZFP.
They therefore provide an opportunity to expand the number of genes for which a
mouse knockout is available. Also, as mapping KRAB-ZFP genes is difficult
because of repetitive arrays, using gene-trap lines overcomes the challenge that may
prevent these genes being knocked out by conventional means.
I have established transgenic mouse lines from the ESI 13 and ES492 cell lines
because KRAB-ZFP 492 is well conserved between species and KRAB-ZFP 113
appears to be in a large rodent specific cluster (Chapter 3). I have performed an
initial analysis on their spatial and temporal tissue expression and in doing so we are
closer to analysing both the in vivo functions of KRAB-ZFPs 113 and 492 and
investigating the consequences of their mis-localisation via the KAP-1 interaction.
6.2 Generation and establishment of ES113 and
ES492 KRAB-ZFP transgenic lines
6.2.1 Generation of chimeric mice
KRAB-ZFP mutant mice were produced using gene-trapped ES cells from lines 113
and 492 for reasons discussed in section 3.6. Early passage ES cells (ESI 13p5 and
ES492p6) were injected into C57BL/6 blastocyst recipients at 2.5 days post coitum
(dpc) as described in section 2.6.2. Two chimeras (identified by a mottled coat
colour), designated chimera 63 and 64 respectively were obtained from the ES492p6
blastocyst injections but only one chimera (chimera 65) was obtained from the
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ESI 13p5 blastocyst injections. Each chimera was then backcrossed to the C57BL/6
inbred and the MF1 outbred strains (Table 6.1). Chimera 64 produced one offspring
in a C57BL/6 cross, but fortunately transmitted the pGT gene-trap transgene. In
crosses with C57BL/6, chimera 63 transmitted the gene-trapped chromosome to 50%
of offspring, but produced few offspring with outbred MFl mice of which none were
LacZ positive. The ESI 13 chimera 65 transmitted the gene-trap locus to 60% of
offspring when bred to C57BL/6, but these did not breed successfully with MFl
mice. The lack of MF1 offspring from chimera 64 and 65 is likely due to the fact
that these chimeras had reduced breeding capability after the first few matings with
C57BL/6, as opposed to mating ability being strain dependent.

















6.2.2 Genotyping of transgenic mice for LacZ
transgene expression
A genotyping PCR assay has previously been used in the lab to assay for the
presence of the LacZ transgene, in mice generated from ES cells that carry the fi-geo
cassette (Heidi Sutherland Pers. Comm.). Heterozygous mice (het) (section 6.2.1)
carrying both a LacZ negative, wt allele ('+') and a targeted disruption (LacZ
positive) in either the 113 or 492 gene-trapped allele ('LacZ') were identified by
PCR with primers specific for a 413 bp fragment of the LacZ transgene. The primers
and amplification programme used are described in section 2.2.12 and can be found
in Table 2.1. This method of heterozygous genotyping has been used throughout this
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thesis for both the ESI 13 and ES492 transgenic lines to distinguish heterozygous
mice (1 !3+/z-acZ 0r 492+//'acZ) from wt mice (113+ or 492+) by visualisation of the 413
bp band after resolution of PCR products on a 2% agarose gel. Figure 6.1A shows
the results from a typical genotyping PCR of offspring from a het x wt cross. A
positive and negative control is performed for every batch of genotyping PCRs to
confirm that the LacZ primers are working correctly in that reaction.
6.2.3 Establishment and propagation of ES113 and
ES492 transgenic mouse lines
Chimeric offspring were subsequently backcrossed into both C57BL/6 and MF1
genetic backgrounds to produce both congenic inbred and outbred heterozygotes
respectively for subsequent heterozygous intercrosses. Genotypes of whole litters
were assayed by LacZ PCRs (section 6.2.2) and analysed for the predicted 1:1
Mendelian ratios of wt:heterozygote (if the heterozygotes are viable). Table 6.2
shows that the genotypic ratios for both transgenic lines backcrossed into the
C57BL/6 background approximate to Mendelian ratios. Whilst this might also be
true of the ES113p5 line backcrossed into MF1 (the slightly fewer than 50%
heterozygotes (42%) might be correlated with the fewer number of mice analysed),
the proportion of heterozygotes in the ES492p6 strain backcrossed to MF1 is only
36%. Therefore the fewer number of heterozygotes from the ES492p6 and possibly
the ESI 13p5 transgenic lines when backcrossed into MF1 could initially suggest that
the survival of heterozygotes may be compromised in the outbred line. Genotyping
by PCR suggests a chance occurrence of false negative results, which must be
considered when analysing the percentages of heterozygous offspring. There did not
appear to be any correlation between the sex of progeny and their heterozygosity













Figure 6.1 Genotyping of homozygous and heterozygous mice
A) PCR with primers specific for LacZwere performed on -300 mg/ml mouse genomic DNA from either
the ESI 13 or ES492 transgenic mouse lines. A 413 bp fragment can be seen (arrow) indicative of
heterozygous mice (numbered 113-107 to -119 and 492-175 and -176) carrying the fi-geo insertion.
Positive (+ve) and negative (-ve) PCR controls are performed with DNA from confirmed transgenic mice
carrying fi-geo or with no DNA respectively. B) LacZ (+) and wt 492 (-) PCRs on 9.5 dpc embryos
from a 492 het x het cross. Asterisks indicate wt mice. Embryo 6 (E6) was later confirmed as heterozygous
(data not shown). C) Genotyping of KRAB-ZFP 492 wt (492-60) and heterozygous (492-70) mice by
Southern blotting on 10 pg of genomic DNA digested with either Pstl and BamHI restriction enzymes
and with a [a-32p] dCTP labelled PCR probe to the 492-linker region.
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Table 6.2 Genotype analyses of 492+/L"cZ and \\2>+lu,cZ backcross progeny
Mouse line Background Genotypic ratio Unknown Total
+/LacZ +
ESI13p5 C57 44 42 11 97
MF1 29 38 1 68
ES492p6 C57 35 40 10 85
MF1 43 70 6 119
6.3 Production of homozygous mutant mice
Heterozygous mice from both lines were backcrossed at least three times into either
the C57BL/6 or MF1 backgrounds and were subsequently mated for the production
of mutant homozygotes (113LacZ or 492LacZ). Over 70 progeny per line were
generated from these crosses and their genotypes analysed by LacZ PCR, and in the
case of ES492p6 transgenic mice, by PCR of the undisrupted 492-linker region.
6.3.1 ES113
6.3.1.1 Genotyping of homozygous ES113 mice (113LacZ)
I was unable to decipher the gene trapped in the ESI 13 cell line by bioinformatics
analyses (section 3.3.2). I originally chose to make transgenic ESI 13 mice on the
basis that this gene-trap insertion was likely in a ZFP cluster with a view to
addressing the question of KRAB-ZFP redundancy. Since the insertion is in a large
ZFP cluster and the region is unassembled and unorientated, I cannot be sure that the
gene-trap has only disrupted one gene. I therefore need more genomic sequence data
to confirm the precise location of the gene-trap in this line. Using primers within the
5' RACE sequence and within either the SA region of 13-geo or within LacZ itself, I
endeavoured to PCR the intron sequence between the KRAB domain and where their
gene-trap had inserted. All attempts were unsuccessful (data not shown). It is likely
that the SA region of j3-geo has been disrupted in some way during integration or that
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the intron length is too great. A more comprehensive study of the genomic sequence
surrounding the ESI 13 gene-trap integration is therefore needed and this study was
not undertaken in this thesis. However, I continued to interbreed heterozygous mice
to generate some DNA samples from offspring on the premise that homozygote
detection might eventually be achieved.
6.3.1.2 Generation of homozygous mutant mice
The results for the ES113p5 line suggest a phenotype consistent with a mutant
homozygous lethal mutation, which would give a ratio of 2:1 for LacZ positive
offspring compared to 3:1 that would be expected if homozygotes (horn) survive.
Out of 72 surviving progeny, 64% carry the LacZ transgene and 36% are wt (LacZ
negative) (Table 6.3). In the C57BL/6 background, only 38 progeny out of 8 litters
were obtained (~4 progeny per litter), 38% of which were found dead at various time
points after birth. For this reason heterozygous crosses are now being continued in
the MF1 background only, since litters with a greater number of progeny are
consistently achieved in the outbred mice. The lack of progeny in the C57BL/6
background could be due to age dependent parental fertility problems as mice only
appeared to breed once or twice with partners. However, it could be that some
heterozygotes and homozygous embryos have survival problems in the C57BL/6
background. A similar scenario has been recorded for nrif-/- mice were embryonic
death occurs at ~E12 in the C57BL/6 train but nrif-/- pups survive in the 129Sv
inbred strain even after 10 backcrosses (Casademunt et al., 1999). In ESI 13 het x
het crosses (C57BL/6 background) I observed some re-adsorped embryos in litters at
E12.5 and El6.5. Thus, it appears as though C57BL/6 heterozygous mice can
interbreed, but perhaps there are also problems with the heterozygotes during
embryonic development. Although the ES113 gene is in a large KRAB-ZFP cluster,
heterozygous matings suggest its function is non-redundant. A greater number of
progeny will need to be assessed in this line to conclude the phenotype of
homozygous lethal.
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Table 6.3 Genotype analyses of \\2,+lu,cZ intercross progeny






E12.5 ND ND 2/9 9
E16.5 ND ND 4/10 10
Adult 5 7 14 12 38(8L)
MF1 Adult 38 22 0 5 65 (5L)
Total
(MF1+C57BU6)
Adult 43 29 NA 72
lFD, found dead. The number ofmice found dead between 1 to 23 days after birth. Their genotype was not determined.
"
Un, unknown. The genotypes of these mice are unknown due to either the quality of the DNA and/or missing progeny whose
genotypes were not determined.
mL, litters
6.3.2 ES492
6.3.2.1 Genotyping of homozygous ES492 mice (492+)
6.3.2.1.1 Genotyping by PCR
I wanted to develop a quick and simple genotyping assay to assess homozygous
mutant 492 mice. I therefore designed PCR primers to the linker region of ES492
(Fig. 3.8, dashed arrows) that flank the gene-trap integration site. The primer
sequences and PCR amplification programme are described in detail in section 2.2.12
and Table 2.1. By PCR and product resolution on a 2% agarose gel, these primers
successfully amplified a 256 bp region of the wt 492 allele only as it was predicted
that this primer set would be incapable of amplifying the pGT insert as well. The
LacZ and wt 492 primers could not be combined in the same PCR without the
generation of non-specific bands (data not shown). Therefore two sets of PCRs were
performed on all progeny from a het x het cross (section 6.3.2.2). Wt mice would be
predicted to carry two wt 492 alleles and thus only the 256 bp band is amplified by
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PCR (Fig. 6.IB, asterisks). Heterozygotes carry both the wt allele (256 bp band) and
the gene-trap allele (413 bp band). Homozygotes would be predicted to carry the
gene-trap allele only (i.e. two copies of LacZ) and therefore only the 413 bp band
would be seen on a gel.
6.3.2.1.2 Genotype confirmation by Southern Blotting
In order to confirm some of the homozygous and heterozygous mice as identified by
PCR, I began the generation of a Southern blot assay. I made a PCR probe of the wt
492-linker region, i.e. the same region used for wt 492 PCRs (primers are described
in Table 2.1) and labelled it with [a-32P] dCTP as described in section 2.2.14.2. I
decided to use the linker as a probe because this region is the most variable within
the KRAB-ZFP family. The probe was used for Southern blotting of genomic DNA,
which was digested with a variety of restriction enzymes beforehand (section 2.2.14).
I wished to be able to detect a difference in banding pattern between wt homo- and
heterozygous mice after their DNA had been digested with restriction enzymes.
Initial results show that genomic DNA digestion with BamHI shows a clear
difference in banding pattern between homozygous wt (492-60) and heterozygous
mice (492-70) confirming previous identification by PCR (Fig. 6.1C). The size of
the wt band in the BamHI digest was also confirmed bioinformatically (data not
shown). PstI may also show a slight difference in banding pattern, although it is not
as clear. It would therefore be expected that only the top band would be detected for
a BamHI digestion of DNA from a homozygote, however, I have not tested any
homozygotes by Southern blotting.
6.3.2.2 Generation of homozygous ES492 mice
Similar to the ESI 13 transgenic line, the number of LacZ positive mice obtained
from het x het crosses of ES492p6 mice suggests a phenotype consistent with a
mutant homozygous lethal mutation i.e. close to 2:1. Out of 79 surviving progeny,
64% carry the LacZ transgene and 36% are wt (Table 6.4). Furthermore, using DNA
obtained from 4-week adult mice, no homozygotes were identified by PCR. In the
C57BL/6 background, 95 progeny out of 20 litters were obtained (-7-8 progeny per
litter). -13% of progeny were found dead shortly after birth and of these mice, the
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majority were genotyped as heterozygotes, with 1 possible but as yet unconfirmed
homozygote (Table 6.4). Timed C57BL/6 heterozygous matings were set up to
collect embryos at ~ E8.5-9.5. The genotypes of the parents of these matings were
confirmed as heterozygous by PCR but the mice were also used for backcrossing,
with progeny genotypes reflecting the expected mendelian ratios, as further proof of
their heterozygosity. Out of 29 progeny, the wt band (256 bp) for only 1 embryo
could not be amplified by PCR. The percentage of heterozygous and wt mice is 41%
and 44% respectively, although the DNA samples and therefore genotypes of 4 mice
were not obtained. Although these numbers would suggest that some lethality is
occurring in 492+/iocZ mice, in the C57BL/6 background, the results of adult mice
obtained for het x wt (Table 6.2) and het x het (Table 6.4) crosses do not corroborate
this. More embryos at this time point are required to draw further conclusions from
this data. Heterozygous matings with at least N6 (6tn generation) backcrossed
C57BL/6 mice yielded less progeny and in most cases of timed heterozygous
matings, mice did not appear pregnant. The 492 mutation may affect fertility in the
heterozygous state, but lack of progeny may also be independent of the ES492 gene-
trap because backcrossing into C57BL/6 is known to result in impaired breeding.
Therefore, I perfonned timed heterozygous matings in the MF1 background. At
E8.5, there were no re-adsorped embryos, but in a litter at E13.5, three re-adsorped
embryos were obtained. A greater number of progeny will need to be assessed in
this line in order to conclusively describe this mutant phenotype as homozygous
lethal and more timed matings are required to assess the time at which the lethality is
occurring.
The lack of homozygous mice and the ratio of heterozygous to wt mice in this line
suggest the function of KRAB-ZFP 492 is vital and non-redundant for survival.
Moreover, the phenotype of homozygous 492 mice is likely to be linked to the mis-
localisation observed with this protein due to deletion of its ZF domain.
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Table 6.4 Genotype analyses of 492+/L"cZ intercross progeny









C57/BL6 E8.5-9.5 1? 12 13 4 0 29 (3L)






MF1 E8.5 ND ND ND 0 13
E13.5 ND ND ND 3 15
Adult 0 10 4 0 14 (2L)
Total (MF1/
C57BL/6)
Adult 0 51 28 NA 79
1
Question mark indicates mice whose wt band is repeatedly not amplified by PCR
11FD, mice found dead shortly after birth. The genotype was not determined for 6 of these mice. Question mark indicates mice
whose wt band is repeatedly not amplified by PCR
111 Un, unknown. The genotypes of these mice are unknown due to either the quality of the DNA and/or missing progeny whom
had not been genotyped.
WL, litters
6.4 Expression analysis of KRAB-ZFPs 113 and
492
The tissue specific expression of many KRAB-ZFPs has been studied mainly by
northern Blot analysis (Bellefroid et al., 1993; Lee et al., 1997; Mark et al., 1999;
Kim et a\., 2000). Although these studies do not necessarily detect the presence of
translated KRAB-ZFP they do potentially show the many different tissue specific
and temporal patterns of protein expression during differentiation, ranging from very
specific expression in various types of cells (Shannon et al., 1999; Kim et al., 2000;
Mark et al., 2001; Kim et al., 2001; Looman et al., 2003) to otherwise ubiquitous
expression patterns (Casademunt et al., 1999; Dreyer et al., 1999; Mark et al., 2001;
Kim et al., 2001; Dai et al., 2003; Gou et al., 2003). In fact, their broad and non-
descriptive role as regulators of differentiation and development stems from the vast
number of mRNA analyses and protein expression studies. Expression of some
KRAB-ZFPs are controlled in a cell cycle or differentiation specific manner (Jheon
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et al., 2001; Rue et al., 2001; Jheon et al., 2002; Zhou et al., 2002; Luo et al., 2002)
whereby expression may remain in the same tissue but with changing levels
throughout different stages of differentiation or development (Luo et al., 2002;
Tanaka et al., 2002; Zhou et ah, 2002). Expression may vary between different
tissues during development (Tanaka et al., 2002; Zhou et al., 2002).
I have generated expression data for the 113 and 492 KRAB-ZFPs, which will be
essential for the future study of these proteins. Although at the sub-cellular level,
their distribution is mis-localised, their temporal expression is under control of the
endogenous protein as the same promoter and upstream regulatory elements of the
endogenous gene are utilised by the gene-trap vector. The following expression
studies are a result of het x wt matings in the C57BL/6 background.
6.4.1 Wholemount X-Gal staining of embryos and
their analysis by paraffin wax sectioning
Both ESI 13 and ES492 genes were trapped in ES cells therefore I decided to
examine their gene expression patterns at various stages of embryonic development.
Firstly embryos were harvested from their mothers at various time points and freed
from their extra-embryonic membranes and yolk sac using scissors and forceps
(section 2.6.3). They were rinsed in PBS before fixation in either 4% pFa or
gluteraldehyde fixative for 1 hr (section 2.8.4.1) and then staining o/n in X-Gal. For
each litter, -50% of embryos stained blue (indicative of X-Gal being metabolised by
(3-galactosidase) as expected from a het x wt cross. The wholemount expression
patterns for each transgenic line at each stage of embryonic development analysed
are described in sections 6.4.1.1 (ESI 13) and 6.4.1.2 (ES492) respectively. I then
analysed every wholemount staining pattern further by processing embryos at each
developmental stage in paraffin wax (section 2.8.5.1). Wax embedded embryos were
subsequently sectioned using a microtome followed by dewaxing and staining in
nuclear fast red (nfr), which stains cell nuclei (section 2.8.5.2). The results of these
analyses are described concomitantly with the wholemount expression data below.
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6.4.1.1 Tissue specific expression of KRAB-ZFP 113 during
embryonic development
Figure 6.2 illustrates the tissue specific expression of the KRAB-ZFP 113-fusion
protein at 8.5 and 10.5 dpc. During the early stages of embryonic development
(E8.5-E10.5), KRAB-ZFP 113 is strongly expressed in the nuclei of a population of
myocardial cells (Fig. 6.2B, B'+D') but is absent from cells of the pericardial wall
and endocardial cushion (Fig6.2B, E+D'), which is associated with the wall of the
atrio-ventricular canal. Expression can also be seen in the endothelial lining of the
dorsal aorta (Fig6.2B, D+D'). Interestingly, cells in the location of the thymus
primordium also stain intensely blue at E8.5 and El0.5 (Fig 6.2B, A+C). By 12 dpc,
LacZ expression is found in the skin and appears more ubiquitous.
6.4.1.2 Tissue specific expression of KRAB-ZFP 492 in the
during embryonic development
Wholemount X-Gal staining showed that KRAB-ZFP 492-fusion protein is strongly
expressed from at least 8.5 dpc (data not shown). At 10.5 dpc, strong expression is
found in the cephalic region (Fig. 6.3A). This region is involved in differentiation of
the branchial arches and components of the face and nose and expression is observed
in the eye (Fig. 6.3A) and nose (Fig. 6.3B, B) at all stages of development presented.
Expression is also clearly seen in the hillocks on either side of the first branchial
cleft, which are associated with the formation of the external ear (Fig. 6.3A, El 1.5
and E15.5). From 10.5 dpc onwards, expression is seen in the limb buds (Fig. 6.3A
and 6.3B, C) and in a distinct banding pattern that reflects the joints of the limb (Fig.
6.3A, arrows). At 10.5 dpc, clear expression of LacZ is observed in parts of the
brain (Fig. 6.4B; D, E+F) and expression here continues to at least 15.5 dpc (Fig.
6.3A). Sectioning of 10.5 dpc embryos, gives a clear indication of the tissue
specificity of KRAB-ZFP 492. X-Gal stained many tissues of the developing gut
and noticeably the pericardial wall and endocardial cushions (Fig. 6.3B, A+C), which
coincidently, were not stained in 1 \ y^'-acZ embryos of the same age. A strong and
specific expression pattern was observed in the ventral horn of the neural tube and in
the dorsal root ganglia (Fig. 6.2A, El3.5 and Fig. 6.3B, F). The afferent (sensory)
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Figure 6.2 Tissue specific expression of KRAB-ZFP 113
A) Wholemount X-Gal staining (blue) of l \?>+ILacZ embryos expressing LacZ. The respective control
embryos are shown for comparison (+/+). B) LacZ expression in saggital sections of 113+!LacZ embryos
at 8.5 dpc(A-C) and 10.5 dpc (D-E). Expression can be seen in the myocardium of the common ventricular
and atrial chambers of the heart (B,B',D,D',E), in the endothelial lining of the dorsal aorta (D,D") and
in the primitive thyroid (A, C). a, common atrial chamber of the heart; as, aortic sac (outflow tract from
primitive heart); bl, mandibular component of first branchial arch; da, dorsal aorta; ec, endocardial cusion;
hi, primitive heart; pc, pericardial wall; tp, thymus primordium; lb, trabeculated wall of common ventricular
chamber of the heart; v, common venticular chamber. 5x, lOx, 20x and 40x magnifications.
H5
Figure 6.3 Tissue specific expression of KRAB-ZFP 492
A) Wholemount X-Gal staining (blue) of 492+ILacZ embryos expressing LacZ . Control embryos (+)
at El 0.5 and El3.5 are shown for comparison. External expression is seen in limb joints (arrows) and
in the ear (arrowheads). Strong expression is also found in the cephalic region (cr, branchial arches and
fonto-nasal derivatives). B) LacZ expression in saggital sections of 492+!LacZ and 492+ embryos at
10.5 dpc (A-F). Expression can be seen in various embryonic tissues derived fom all three germ layers.
Note strong expression in the spinal cord (ectoderm) (A+F), inner epithelial linings of the gut (endoderm)
(A+B) and the mesodermal derived branchial arches (A+B) and limb buds (B). bl, mandibular
component of first branchial arch; e, eye; ec, endocardial cusion;/ neuroepithelium of forebrain; //, fore
limb bud; h, neuroepithelium of hindbrain; hlb\ hind limb bud; hp, hepatic primordium (embryonic
liver); /, lung bud; m, neuroepithelium of midbrain; mg, midgut; n, nose; nl, neural luman; nt, neural
tube; pc, pericardial wall; tb, trabeculated wall of common ventricular chamber; vh, ventral hom. 5x
and lOx magnifications.
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neurones have their cell bodies in the dorsal root ganglia and carry information to the
central nervous system. The efferent motor neurones have their cell bodies in the
ventral (motor) horn and carry infonnation to the muscles (Rhoades and Pflanzer,
1996), suggesting that KRAB-ZFP 492 may have a prominent role in the developing
spinal cord. Nervous tissue including the brain is derived from ectoderm,
cartilaginous tissue (and bone) is derived from mesoderm and linings of the gut,
respiratory, and urogenital tracts are derived from endoderm (Kaufman, 1992).
Therefore, KRAB-ZFP 492 is clearly expressed in all three germ layers deriving
from the epiblast. It will be interesting in the future to identify the earliest time-point
at which KRAB-ZFP 492 is expressed since no degenerating embryos were found at
8.5 dpc in progeny from het x het crosses.
6.4.2 KRAB-ZFP expression in adult mice
6.4.2.1 Wholemount X-Gal staining of adult tissues
In vivo expression of KRAB-ZFPs 113 and 492 was analysed in adult tissues by
wholemount X-Gal staining of dissected organs (section 2.8.4) from confirmed
heterozygous mice at least 4 weeks of age (Fig. 6.4A). Endogenous X-Gal staining
was observed in some wt tissues; for example, in the bronchi of the lungs (probably
bacteria), the medulla of the kidney and in the ovaries, uterus and testes. Of the
tissues tested, KRAB-ZFP 113 only showed a comparable difference from wt tissues
in the spleen and thymus. No expression was observed in the heart unlike during
early embryonic development (E8.5-E10.5). Table 6.5 shows a comparison between
the adult tissues stained in this analysis alongside the respective embryonic staining
patterns. Although a splenic primordium can be observed at E8.5 and beyond, I did
not observe X-Gal staining in the respective region at E8.5-E10.5. There was also a
noticeable difference in X-Gal staining pattern between the thymus of 492+/IacZ
compared to wt mice. However, the X-Gal staining pattern appears different again
between 492+//acZ and 113+ILacZmice (Fig. 6.4A, comparison is illustrated by arrows).
The thymus is composed ofmany irregularly shaped lobules separated by connective
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(competent) and an inner medulla where mature thymocytes reside (Rhodes and
Phlanzer, 1996). In the future it will be interesting to clarify the X-Gal staining
pattern in both transgenic lines, which will give a more precise indication of their
function.
Table 6.5 Comparison of KRAB-ZFP expression in embryonic and adult tissues
Tissue 113 492
embryo (E8.5-E10.5) adult Embryo (E10.5)' adult
liver - - - -
lung - - V -
spleen - V un -
thymus V V un V
pancreas - - un -
heart V - V -
kidneys - - V -
ovaries - - un -
uterus - - un -
brain - - V -
testes - - un -
1 Un, unknown. X-Gal staining in these primitive embryonic organs has not been confirmed.
6.4.2.2 Preliminary northern blot analysis of KRAB-ZFP 492
mRNA
To identify the number of KRAB-ZFP 492 mRNA transcripts in selected adult
tissues and to lend support to X-Gal expression data I performed a northern blot on
RNA samples from selected adult tissues (section 2.3.3). I used the same [a-32P]
dCTP labeled PCR probe to the linker region of 492 as I used for Southern blotting
(section 6.3.2.1.2). In initial experiments with this probe, I could detect a faint
mRNA transcript of approximately 3 kb (Fig. 6.4B), although it gave high
background and so was not very clear. This suggests that in some adult tissues (for
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example, liver, kidney and testes, there is only one splice-form of KRAB-ZFP 492
that contains the linker region. By western blot I could detect two possible protein
species of very similar size in whole cell extracts (Fig. 4.IOC). Therefore, it is
possible that these two bands are due to post-translational modifications of the same
protein isoform, or it is possible that I have not detected every mRNA splice-form
since a probe to the linker region was used. The number ofmRNA transcripts during
embryogenesis remains to be determined.
There is some discrepancy between in vivo LacZ expression data and tissues
transcribing KRAB-ZFP 492 mRNA as determined by northern blotting. For
example, a possible mRNA band is observed in the liver by northern blotting,
however in X-Gal stained tissue, the level of X-Gal staining is comparable to wt
levels. However, due to technical reasons the latter experiment is confounded by
high levels of background on the northern blot, and these experiments must be
repeated to clarify these preliminary results.
6.5 Discussion
The gene encoding KRAB-ZFP 492 is in a non-KRAB-ZFP clustered region of the
genome and has homologues in rat and human (chapter 3). As the gene-trap fusion
protein mis-localises and as cells transfected with GFP-tagged 492 do not survive
(chapter 4), my prediction was that this null-function KRAB-ZFP line would give an
important phenotype and this appears to be the case. However, since ESI 13 likely
resides in a KRAB-ZFP cluster, it will be very interesting to determine whether the
knockout of this gene really causes lethality. Rslcan-4 and ~9 of the rsl locus are
amidst a 22 KRAB-ZFP cluster (Krebs et ah, 2003). Whilst it has been speculated
that many members of KRAB-ZFP clusters may be redundant, mutations in Rslcan-4
and -9 expose the importance of individual but highly similar cluster members
(Krebs et al., 2003). My data, as a result of establishing mouse lines with disrupted
KRAB-ZFP genes, also appears to show the importance of two more KRAB-ZFPs
and in the future it may be possible to use the ESI 13 line to address the question of
redundancy between the many members of this KRAB-ZFP cluster.
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In a C57BL/6 background, the KRAB-ZFP 113 and 492 mutation appears to be
embryonic lethal either before E12.5 or between E8.5 and E13.5 respectively but
further work is needed to clarify the exact stage of embryonic development when
these KRAB-ZFPs are required. For KRAB-ZFP 492, the 3 re-adsorped embryos at
E13.5 appeared to be at different stages of re-adsorption (data not shown). One of
these embryos has since been confirmed as homozygous mutant, whilst the
remaining two are heterozygotes (data not shown).
Expression data suggests that the 113 and 492 KRAB-ZFPs are involved in
differentiation of specific tissues during embryogenesis. Coincidently, both proteins
appear to be expressed in the adult thymus. There are a number of different cell
types in the thymus and it will be interesting to identify which cells express these
proteins and if they are expressed in the same cell type. A number of KRAB-ZFPs
are expressed in either the thymus alone or in the spleen and thymus (Bellefroid et
al., 1993; Rue et al., 2001; Eiennemann et al., 2003). In particular, a whole cluster of
human KRAB-ZFPs (the ZNF91 cluster on HSA19) have been shown to have a
significantly higher level of expression in human T-cells but no equivalent cluster in
mouse has been identified (Bellefroid et al., 1993). Northern blot analyses has
indicated that ZNF382 is broadly expressed in embryonic tissues, but similar to
KRAB-ZFP 492, is tissue restricted in adults where it is expressed in heart (Luo et
al., 2002). Flowever, KRAB-ZFP 113 and 492 may also be expressed in many other
tissues on which I have not performed wholemount staining. The weak level of X-
Gal staining in the skin of 113T" mice at 12 (Fig. 6.2A) and 13.5 dpc (data not
shown) may be indicative of its expression their in adult mice and these possibilities
should be born in mind for future experiments.
This expression data will be vital for pinpointing the organs/tissues to focus on, with
respect to finding a cause for the phenotypes observed, and for future target gene
identification. It will be important to find target genes and to determine whether
their nuclear organisation is important for KRAB-ZFP repression, i.e. at KAKA foci,
heterochromatin or elsewhere. Cloning of ChlPed sequences with AP492 antibody
would be one way to obtain target sequences. Comparison of micro-array gene
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expression data from homozygous wt and homozygous mutant tissues will also
indicate genes with differential expression that may be directly regulated by either
KRAB-ZFPs 113 or 492 and this data could enhance ChIP experiments. For micro-
arrays, it is important to choose a tissue were these KRAB-ZFPs are being expressed.
In the case of KRAB-ZFP 492, this could be any number of embryonic tissues, but
the choice of tissue for 113 is more restricted. Expression data will also be useful for
future yeast two hybrid experiments were the choice of cDNA library may be
important for the discovery ofprotein interactors
To conclude, the results presented in this chapter show that KRAB-ZFPs 113 and
492 may be vital for embryogenesis. Moreover, mice with a disrupted KRAB-ZFP
492 gene exhibit a mis-localisation of KRAB-ZFP 492 upon differentiation due to
interaction with KAP-1 at pericentromeric heterochromatin. I predict that such an
interaction may cause aberrant regulation of KRAB-ZFP 492 target genes. In this
case, the ensuing mis-regulation of genes may therefore be detrimental to the
development of homozygous mutant mice, but more experiments are required to





7.1 Project development enabled by emerging
resources and on-going research
In this thesis I have identified and characterised novel members of the largest
transcription factor family in the mammalian genome, the KRAB-ZFP family
(Chapter 3). Initially, my choices in regard to the specific KRAB-ZFPs I proposed
to study were restricted by lack of complete sequence characterisation ofmost of the
KRAB-containing genes. During the course of my PhD, I was able to characterise
most of the remaining genes due to vast improvements in the annotation and
sequence quality of mouse genome databases. This enabled me to draw parallels
between the trapped genes and broaden my understanding of their genomic structure.
As a way of assessing the biological function of KRAB-ZFPs in ES cells, I studied
their sub-cellular distribution before and after cell differentiation (Chapter 4).
During my thesis the re-localisation of KAP-1 to pericentromeric heterochromatin
upon cellular differentiation was reported (Cammas et al., 2002). However there was
no analysis of KRAB-ZFPs in this paper. I decided to shift the focus of my
localisation studies to the analysis of endogenous KRAB-ZFP distribution compared
with gene-trap distribution. My data, in conjunction with KRAB-ZFP epitope-
tagging experiments and a thorough review of the past and emerging literature,
provided me with new insights into the relationships between function of these
proteins and their sub-nuclear distribution. Contemporary with the development of
my project, it became clear that the concerted role of KAP-1 and HP1 in gene-
repression may occur at euchromatic sites (Schultz et al., 2002; Ayyanathan et al.,
2003). I therefore proposed to explore the distribution of KRAB-ZFPs in this
context. In Chapter 5, I addressed how endogenous KRAB-ZFP distribution fits in
with the current model ofKRAB-KAP-1 mediated repression (Chapter 5).
To date, my thesis demonstrates the first thorough study on the sub-nuclear
distribution of a KRAB-ZFP. My data, confirms a more general euchromatic role for
KRAB-ZFPs whilst proposing an explanation for the presence of KAP-1 at
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heterochromatin and the enigma that is pericentromeric localisation of KRAB-ZFPs.
Additionally, I propose a novel role for the nucleolus in KRAB-ZFP sequestration.
In the latter year of my studies (2004), a second KRAB-ZFP knockout mouse was
published, exposing for the first time how essential individual members of this
protein family are during development (Krebs et al., 2003). In Chapter 6, I describe
the generation of mutant KRAB-ZFP mouse lines to further study the biological
functions of novel KRAB-ZFPs and to investigate the importance of KRAB-ZFPs
during development. These studies show that at least two other KRAB-ZFPs are
critical for embryonic development and in the future it may be possible to use these
results to address the question of redundancy between the many members of the
KRAB-ZFP family.
7.2 Identification and characterisation of novel
KRAB-ZFPs
A number of KRAB-containing proteins, originally isolated in a previous gene-trap
screen, were identified by 5' RACE, FISH mapping and by sequence comparisons
with genomic databases (Chapter 3). Five of the trapped genes were novel KRAB-
ZFPs, two ofwhich I chose for further study (KRAB-ZFP 113 and 492).
The distribution and genomic structure of the KRAB-ZFPs identified in this study
enforce previous observations (Lichter et al., 1992; Eichler et al., 1998). At least 4
of these genes (ESKN205, ES261, ES492 and ES510) are found at breaks in synteny
between the mouse and human genomes signifying the independent expansion of
KRAB-ZFP clusters at such boundaries in different species (Shannon et al., 2003).
Some of the genes identified were found to have related sequences in either the rat
genome alone (ES9, ESI 13, ESKN205) or both human and rat genomes (ES261,
ES492) but further sequence analysis is required to confirm their orthology.
I identified three genes that potentially encode proteins containing the KRAB domain
only (by virtue of their similarity to KRAB-only encoding cDNAs) and that lack any
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ZF domain. Such proteins have been described previously as functionally important
(Li et al., 2003; Oh et a/., 2005). Alternative spicing of ZnF197 results in a KRAB-
only protein named VHLaK. VHLaK mediates pVFIL binding and subsequent
repression ofHIF-la transactivation (Li et al., 2003). Furthermore, VFILaK, pVHL
and KAP-1 were found in a single complex suggesting that KAP-1 may participate in
this repression. KRAB domain removal by alternative splicing may contribute to
other biological pathways by redirecting protein interactions. The impact of
alternative splicing on protein interactions in the human genome has recently been
assessed (Resch et al., 2004). Bioinformatics analysis of the proteome showed that a
major impact of alternative splicing is removal of protein-protein interaction domains
that mediate key links in protein interaction networks. Furthermore, the KRAB
domain was highlighted as being selectively removed by alternative splicing at a
much higher frequency than average, although C2H2 ZF domains were not listed
among the 50 most common domains to be removed.
7.3 The implications of endogenous KRAB-ZFP
localisation
In Chapter 4, I investigated the localisation of the gene-trapped KRAB-ZFPs with
respect to cellular differentiation and the cell cycle. In differentiated gene-trap ES
cells, I found that both KAP-1 and the gene-trapped KRAB-ZFPs relocate to
pericentromeric heterochromatin, and that KAP-1 is probably required, but is not
sufficient, for this localisation. This finding was in agreement with Cammas et al.
(2002) who also showed a significant re-localisation ofKAP-1 to heterochromatin in
ES and F9 cells after 48 hr of RA differentiation. That the distribution of KAP-1
alters with cell differentiation was not unexpected, given its known role as a co¬
mpressor during differentiation and development (Cammas et al., 2000, Weber et al.,
2002) but it is interesting to note that KAP-1 is also required as a co-activator for
induced differentiation of the myelomonocytic cell line U937 (Rooney and Calame,
2001). It would therefore be interesting to study whether KAP-1 re-locates to
heterochromatin in this cell line after differentiation. Heterochromatin association of
the gene-trapped KRAB-ZFPs and KAP-1, were also found to correlate with changes
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in proliferation of cells but not with any particular stage of the cell cycle, which was
also in agreement with Cammas et al. (2002).
I furthered the investigation into KRAB-ZFP localisation by cloning KRAB-ZFP 492
(Chapter 3), generating full-length and mutant GFP tagged constructs and raising an
antibody to the endogenous protein (Chapter 4). Neither the KRAB nor ZF domains
are solely responsible for nuclear targeting, but the GFP-tagged constructs confirmed
that the KRAB-domain is required for localisation to heterochromatin. Full-length
GFP-tagged 492 was found at other discrete foci in the nucleoplasm suggesting the
formation of such foci require the ZF domain. By antibody staining I confirmed that
endogenous 492 protein (Zfp647) is present in discrete euchromatic foci but no
concentration of protein was observed at pericentromeric heterochromatin.
Moreover, endogenous KRAB-ZFP 492 was found in nucleoli of undifferentiated
cells, and re-localised to euchromatic foci in a sub-population of differentiated ES
cells. These foci often co-localised with KAP-1 and HP1 proteins (Chapter 5). A
similar sub-nuclear localisation pattern was seen for another endogenous KRAB-
ZFP, NT-2, in differentiating ATDC5 cells (Chapter 5).
The production of antibodies to endogenous KRAB-ZFP 492 has enabled a more
thorough study of KRAB-ZFP distribution and the fact that this antibody can also
recognise its human homologue will prove useful for future functional studies.
These localisation studies suggest that epitope tagging of KRAB-ZFPs may lead to
erroneous results. For example, none of the gene-trapped or GFP-tagged 492
proteins were enriched in nucleoli. In both cases the tag may interrupt associations
with other nucleolar proteins and/or RNA/DNA causing them to mis-localise. A
potential role for nucleolar localisation ofKRAB-ZFP 492 and NT-2 in the nucleolus
may be for storage, or because it has RNA or DNA targets in this location. Proteins
are often stored in the nucleolus and released for later use. In yeast, cell cycle-
regulation is linked to nucleolar sequestration. For example, CDC14 belongs to a
group of genes that have a critical role in exit from mitosis. During Gl, Cdcl4 is
inactive and localises to the nucleolus. Following entry into mitosis and specifically
during anaphase, Cdcl4 is liberated from its nucleolar binding partner, Netl/Cfil,
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and becomes active (reviewed by Carmo-Fonseca et al., 2002). Section 4.9 gives
more examples.
What determines the localisation of KRAB-ZFPs in the cell and particularly their
localisation in KAKA foci? The linker region and ZF domains of KRAB-ZFPs may
also contribute to the sub-cellular localisation of KRAB-ZFPs. RBaK interacts with
pRB via its linker region (Skapek et al., 2000), as does NRIF with p75NTR
(Casademunt et al., 1999). In addition to protein interactions mediated by the linker
and ZF domain, the ZF domain may also be responsible for DNA interactions. Both
of these would be expected to affect KRAB-ZFP distribution and in transfected cells,
the ZF domain of KRAB-ZFP 492 is required for the formation of KAKA foci.
Therefore, foci of NT-2 and 492 may be a direct representation of protein or DNA
interactions mediated via the ZF domain. There is evidence to suggest thai either of
these models is plausible. KAKA foci may represent 'silencing factories'
determined by the clustering of repressed genes by a common KRAB-ZFP, similar to
the 'transcription factories' described by Osborne et al., 2004. To prove this I will
need to show that target genes, which are repressed, are localised at these factories.
Otherwise, KAKA foci might represent a sub-nuclear compartment where KRAB-
ZFPs, along with other proteins they interact with, are either stored or used in a
different facet of transcriptional regulation. Flowever, in the case of ZBrKl, the
same ZFs are required for interaction with BRCA1, homo-oligomerisation and DNA
binding (Tan et al., 2004a; Tan et al., 2004b). Therefore competition for this binding
domain might therefore play a role in its functional localisation. Competition for
binding sites has also been postulated for NRIF where it competes with TRAF6 for
binding to p75N1R (Casademunt et al., 1999) and this directly affects its sub-cellular
distribution (Gentry et al., 2004). If such competition were to occur between
proteins that bind to the KRAB domain, for example KAP-1 and pVHL (Li et al.,
2003) or KAP-1 and TRAF6 (Gentry et al., 2004) then this too may affect both
KRAB-ZFP localisation and also the extent of target gene repression.
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7.4 The mechanism of KRAB-KAP-1 mediated
repression
The euchromatic 492 foci also contain KAP-1 and HP1 proteins and are likely to
mark heterochromatic-like structures involved in KRAB-KAP-1-HP 1 mediated gene
repression (Chapter 5). This is in broad agreement with Ayyanathen et al., 2003. By
using mutant ES cells, 1 discovered the formation of KAKA foci is independent of
the HMT Suv39hl/2. However, the localisation of KAP-1 at pericentromeric
heterochromatin is Suv39hl/2 dependent but independent of DNA methylation by
Dnmt3a/b (Chapter 5). This suggests the permanent inactivation of genes by KAP-1
at heterochromatin does not necessarily involve their DNA methylation and calls into
question the role of KAP-1 at heterochromatin. Therefore, together with current
evidence, I predict that a KAP-1 recruits the HMT, SETDB1, to methylate histone
H3-K9 residues as a prerequisite to HP1 binding and the subsequent formation of
discrete KAKA foci (Schultz et al., 2002; Ayyanathen et al., 2003). In the future it
would be interesting to investigate the localisation of SETDB1 (ESET) with respect
to these foci. There is no mutant SETDB 1 ES cell line reported to date, but it would
be interesting to deplete this protein by RNAi, and then examine the sub-nuclear
localisation of KRAB-ZFPs and KAP-1. In order for SETDB 1 to methylate K9
residues, deacetylation of K9 must first occur. KAP-1 interacts with Mi-2a of the
NuRd HDAC complex (Schultz et al., 2001) and has also been isolated in complex
with N-CoR-1 and HDAC3 (Underhill et al., 2000), although KAP-1 is only in a
complex with these proteins some of the time. Nevertheless, the mechanism of
KAP-1-KRAB-ZFP repression may involve histone deacetylation since TSA can
interfere this repression (Matsuda et al., 2001). Therefore it would be interesting to
see ifKAKA foci are dissociated by TSA treatment.
My results support the idea that the consistent coupling of chromatin remodelling
enzymes with KRAB-ZFPs results in localised chromatin changes in the vicinity of
target genes, rather than translocation of KRAB-ZFP target genes to pericentromeric
heterochromatin for KRAB-KAP-1 mediated repression (Fig. 5.IB). The fact that
Ayyanathen et al., (2003) reported translocation of a luciferase transgene to
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heterochromatin may be because it is a transgene and not an endogenous locus. It is
also important not to forget the role of active repression by the KRAB-KAP-1
complex. KRAB-KAP-1 repression is efficient in the short term (Pengue et al.,
1996; Agata et al., 1999) and repression is specific to RNA polymerase II and III
reporters, suggesting that KRAB-KAP-1 may interfere with some components of the
transcription machinery (Moosmann et al., 1997) (section 1.1.5.2).
In this thesis I focused on KRAB-ZFP repression mediated by interaction with the
co-repressor KAP-1, but it is important to remember that KRAB-ZFPs can also
interact independently with other co-repressors, some of which contain protein
motifs similar to KAP-1 such as RING or PHD motifs. BRCA1 contains a RING
motif at the N-terminus but interaction occurs with ZBrKl via its C-terminal domain.
ZBrKl thus has two repression domains, an N-tcrminal KRAB domain and a
BRCA1 interaction domain which functions in a HDAC and promoter-specific
manner (Tan et al., 2004a). NSD1 is a HMT that specifically methylates histone H3
at K36 and histone H4 at K20 (Rayasam et al., 2003) via its SET domain, but it also
contains five PHD domains. Interaction with KRAB-ZFP Nizpl is via a cysteine-
rich motif and when tethered to an RNA polymerase II promoter repression is NSD1
dependent (Nielsen et al., 2004). These interactions suggest that KRAB-ZFPs are
involved in the sequence specific repression of genes by a number of different
mechanisms that depend on interactions with various co-repressors, and that they
may even function as a bridging protein, linking one repression pathway to the next.
7.5 KRAB-ZFP transgenic mice
When the 113 and 492 KRAB-ZFP genes are disrupted, the phenotype in mice
appears to be homozygous lethal, based on the number of offspring resulting from
het x het matings. Both expression patterns in mice point towards a role in
embryonic development and such expression patterns are common within the
KRAB-ZFP family (section 6.5). There is speculation as to why there are so many
KRAB-ZFPs in mammals and whether they have redundant functions during
development. I generated two transgenic mice whose mutated gene was situated in
different genomic environments. Although I do not know the identity of the gene
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encoding KRAB-ZFP 113, I anticipated that the phenotype of this knock-out might
not be as severe as the 492 knock-out. KRAB-ZFP 492 has homologues in human
and rat. However, although there are many KRAB-ZFP genes in this cluster, 113
appears to be essential for development. In the future, this mouse may be useful in
addressing the question of redundancy at this locus.
Since mammals have substantially different repertoires of KRAB-ZFPs it has been
suggested that as these genes evolve, they acquire novel functions over evolutionary
time and this contributes to species-specific development (Shannon et al., 2003).
The presence of TIF 1 orthologues in lower animals reflects the emergence ofKRAB-
ZFPs. TIF la and/or -y orthologues have been found in Drosophila, Xenopus, and
zebrafish (Beckstead et al., 2001; Ransom et al., 2004), but so far no orthologues of
KAP-1 have been found in zebrafish or fugu. Homologues of the KRAB-domain
have neither been found in zebrafish nor fugu, although they have been found in
many species of frog but not in Drosophila (Shannon et al., 2003). I found that
gene-trapped KRAB-ZFPs did not localise to heterochromatin unless KAP-1 was
present (Chapter 4), suggesting that KAP-1 was the initial member of this
partnership. It has been proposed that KAP-1 brings together different KRAB-ZFPs
under a similar mechanism of KAP-1-mediated control, and this is consistent with
the idea that the evolution of body-plans, especially among mammals, is mostly due
to remodelling of regulatory circuits that control gene expression patterns (Carroll,
1995). Therefore, an explanation for the large number of essential, non-redundant
KRAB-ZFPs required in mammals is to allow for the complexity of their body-plans,
and the KRAB domain permits for their concerted control by KAP-1 (Shannon et al.,
2003).
7.6 Future directions
Comparative analysis of mouse and human draft genomes reveals that -99% of
mouse genes have an orthologue in man, underscoring the importance of studying
gene function in mouse (Krebs et al., 2003 and reference therein). The remaining
1% of genes includes differentially expanded members of multi-gene families, which
function in reproduction, xenobiotic metabolism, and immunity. This complex group
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of genes may encode functions either related to speciation, or encode the regulators
of such genes. Their individual characterisation and functional importance are
usually more difficult to assess experimentally. The majority of KRAB-ZFPs fall
into this latter class of genes and despite the advances made in this area of research
during the course of my PhD; there remains an abundance of questions to be
answered about this protein family.
Perhaps the most intriguing question of all is that of speciation. What makes us
human after all? This question can only be answered by the study of protein families
such as the KRAB-ZFP family. In this respect, further analysis of the genes
identified in this thesis will provide a greater selection of KRAB-ZFP genes with
various evolutionary backgrounds that can be studied from a functional perspective
by taking advantage of the gene-trap system. The difficulty of working with this
group of proteins is twofold however, and should be considered for future
experimentation. Firstly, their sequence similarity can be a factor of inconvenience
(NT-2, section 5.3) and endogenous proteins should always be tested if possible.
The little information we have on transcriptional repression by KRAB-ZFPs stems
from a gap in knowledge derived from the limited availability of KRAB-ZFP target
sequences. This will undoubtedly be the next hurdle to cross with respect to the
future direction of this research area. The mouse model generated in this thesis will
be of considerable help in identifying the targets of KRAB-ZFP 492 as well as
addressing the more functional questions such as the impact of an abnormal KAP-1-
KRAB-ZFP 492 interaction during embryonic differentiation. However, the
presumed role of KRAB-ZFPs in sequence-specific DNA binding is unlikely to be
their only mode of gene repression. Protein-protein interactions are likely to play an
indirect but significant role. To my knowledge, KRAB-ZFPs have been reported to
interact with at least 10 other proteins, excluding KAP-1 and viral proteins (Tiao et
al., 2005). Intriguingly, six of these are either tumour suppressors or oncogenes and
the interacting KRAB-ZFPs have been isolated and characterised because of their
association with them (Casademunt et al., 1999; Zheng et al., 2000; Skapek et al.,
2000; Ti et al., 2003; Hennemann et al., 2003; Nielsen et al., 2004). On this
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premise, it would be interesting to identify protein interactors of KRAB-ZFP 492 by
yeast-two hybrid assays for example and such experiments will provide clues as to
the pathways individual KRAB-ZFPs are involved in.
Many KRAB-ZFPs are known to have direct roles in human disease (Wagner et al.,
2000; Alders et al., 2000; Garcia et al., 2004) and many more are implicated in
disease-associated pathways (Skapek et al., 2000; Li et al., 2003; Nielsen et al.,
2004). Surprisingly and despite their overwhelming numbers, this thesis (Chapter 6)
and previous evidence points to the sum of four KRAB-ZFPs being critically
important for embryonic development by virtue of mouse models. No functional
redundancy has been shown as yet, despite the large number of similar KRAB-ZFPs
in the genome. Therefore, we should continue to study this protein family in such a
way, firstly to understand in full the functional implications of a given KRAB-ZFP,
but secondly for the potential discovery of new human disease causing genes.
Finally, I predict that KRAB-ZFPs will be major players in the linking and switching
of different biological networks throughout differentiation and development.
Alternative splicing and their ability to bind both protein and/or DNA gives them this
functional capacity. Interaction with chromatin-associated proteins also indicates a
link between various repression pathways and the temporary and permanent
inactivation of genes. An important future goal with respect to this work will be to
analyse the dynamics of a KRAB-ZFP target gene in the context of the model
proposed in this thesis as not all KRAB-ZFPs are likely to behave the same way-or
are they? Many more need to be studied in order to assess whether the formation of
endogenous foci are a common attribute. Surely KRAB-ZFPs are an important and
essential area of future research, as the ultimate goal of molecular biology is to not
only map the intricate gene-regulatory processes of the human body but to assemble
them into one pathway and KRAB-ZFPs could be the missing link.
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